{
"instance": {
"ahco-20200930x10q.htm": {
"axisCustom": 0,
"axisStandard": 30,
"contextCount": 371,
"dts": {
"calculationLink": {
"local": [
"ahco-20200930_cal.xml"
]
},
"definitionLink": {
"local": [
"ahco-20200930_def.xml"
],
"remote": [
"http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
"http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
]
},
"inline": {
"local": [
"ahco-20200930x10q.htm"
]
},
"labelLink": {
"local": [
"ahco-20200930_lab.xml"
],
"remote": [
"http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml",
"https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
]
},
"presentationLink": {
"local": [
"ahco-20200930_pre.xml"
]
},
"referenceLink": {
"remote": [
"https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml",
"http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml"
]
},
"schema": {
"local": [
"ahco-20200930.xsd"
],
"remote": [
"http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
"http://www.xbrl.org/2003/xl-2003-12-31.xsd",
"http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
"https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
"http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
"http://www.xbrl.org/2005/xbrldt-2005.xsd",
"http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
"http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
"http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
"http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
"http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
"http://www.xbrl.org/2006/ref-2006-02-27.xsd",
"http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
"http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
"https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
"http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
"http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
"http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
"http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd",
"http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
]
}
},
"elementCount": 644,
"entityCount": 1,
"hidden": {
"http://fasb.org/us-gaap/2020-01-31": 28,
"http://www.adapthealth.com/20200930": 4,
"http://xbrl.sec.gov/dei/2020-01-31": 5,
"total": 37
},
"keyCustom": 60,
"keyStandard": 390,
"memberCustom": 51,
"memberStandard": 51,
"nsprefix": "ahco",
"nsuri": "http://www.adapthealth.com/20200930",
"report": {
"R1": {
"firstAnchor": {
"ancestors": [
"p",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "dei:DocumentType",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "document",
"isDefault": "true",
"longName": "00090 - Document - Document and Entity Information",
"role": "http://www.adapthealth.com/role/DocumentDocumentAndEntityInformation",
"shortName": "Document and Entity Information",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"p",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "dei:DocumentType",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R10": {
"firstAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "10201 - Disclosure - Revenue Recognition and Accounts Receivable",
"role": "http://www.adapthealth.com/role/DisclosureRevenueRecognitionAndAccountsReceivable",
"shortName": "Revenue Recognition and Accounts Receivable",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R11": {
"firstAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "ahco:SignificantTransactionsTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "10301 - Disclosure - Significant Transactions",
"role": "http://www.adapthealth.com/role/DisclosureSignificantTransactions",
"shortName": "Significant Transactions",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "ahco:SignificantTransactionsTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R12": {
"firstAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "10401 - Disclosure - Equipment and Other Fixed Assets",
"role": "http://www.adapthealth.com/role/DisclosureEquipmentAndOtherFixedAssets",
"shortName": "Equipment and Other Fixed Assets",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R13": {
"firstAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "10501 - Disclosure - Goodwill and Identifiable Intangible Assets",
"role": "http://www.adapthealth.com/role/DisclosureGoodwillAndIdentifiableIntangibleAssets",
"shortName": "Goodwill and Identifiable Intangible Assets",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R14": {
"firstAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:FairValueDisclosuresTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "10601 - Disclosure - Fair Value of Assets and Liabilities",
"role": "http://www.adapthealth.com/role/DisclosureFairValueOfAssetsAndLiabilities",
"shortName": "Fair Value of Assets and Liabilities",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:FairValueDisclosuresTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R15": {
"firstAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "10701 - Disclosure - Derivative Instruments and Hedging Activities",
"role": "http://www.adapthealth.com/role/DisclosureDerivativeInstrumentsAndHedgingActivities",
"shortName": "Derivative Instruments and Hedging Activities",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R16": {
"firstAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "10801 - Disclosure - Accounts Payable and Accrued Expenses",
"role": "http://www.adapthealth.com/role/DisclosureAccountsPayableAndAccruedExpenses",
"shortName": "Accounts Payable and Accrued Expenses",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R17": {
"firstAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:DebtDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "10901 - Disclosure - Debt",
"role": "http://www.adapthealth.com/role/DisclosureDebt",
"shortName": "Debt",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:DebtDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R18": {
"firstAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "11001 - Disclosure - Stockholders' Equity",
"role": "http://www.adapthealth.com/role/DisclosureStockholdersEquity",
"shortName": "Stockholders' Equity",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R19": {
"firstAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:EarningsPerShareTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "11101 - Disclosure - Earnings Per Share",
"role": "http://www.adapthealth.com/role/DisclosureEarningsPerShare",
"shortName": "Earnings Per Share",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:EarningsPerShareTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R2": {
"firstAnchor": {
"ancestors": [
"p",
"td",
"tr",
"table",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "As_Of_9_30_2020_JIO9M6IRxEGEtUbp64Edvw",
"decimals": "-3",
"first": true,
"lang": null,
"name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
"reportCount": 1,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
},
"groupType": "statement",
"isDefault": "false",
"longName": "00100 - Statement - Consolidated Balance Sheets",
"role": "http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets",
"shortName": "Consolidated Balance Sheets",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"p",
"td",
"tr",
"table",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "As_Of_9_30_2020_JIO9M6IRxEGEtUbp64Edvw",
"decimals": "-3",
"lang": null,
"name": "us-gaap:AccountsReceivableNetCurrent",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
}
},
"R20": {
"firstAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:LeasesOfLesseeDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "11201 - Disclosure - Leases",
"role": "http://www.adapthealth.com/role/DisclosureLeases",
"shortName": "Leases",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:LeasesOfLesseeDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R21": {
"firstAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:IncomeTaxDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "11301 - Disclosure - Income Taxes",
"role": "http://www.adapthealth.com/role/DisclosureIncomeTaxes",
"shortName": "Income Taxes",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:IncomeTaxDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R22": {
"firstAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "11401 - Disclosure - Commitments and Contingencies",
"role": "http://www.adapthealth.com/role/DisclosureCommitmentsAndContingencies",
"shortName": "Commitments and Contingencies",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R23": {
"firstAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "11501 - Disclosure - Related Party Transactions",
"role": "http://www.adapthealth.com/role/DisclosureRelatedPartyTransactions",
"shortName": "Related Party Transactions",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R24": {
"firstAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:SubsequentEventsTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "11601 - Disclosure - Subsequent Events",
"role": "http://www.adapthealth.com/role/DisclosureSubsequentEvents",
"shortName": "Subsequent Events",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:SubsequentEventsTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R25": {
"firstAnchor": {
"ancestors": [
"us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "20102 - Disclosure - General Information (Policies)",
"role": "http://www.adapthealth.com/role/DisclosureGeneralInformationPolicies",
"shortName": "General Information (Policies)",
"subGroupType": "policies",
"uniqueAnchor": {
"ancestors": [
"us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R26": {
"firstAnchor": {
"ancestors": [
"us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "ahco:ScheduleOfUsefulLivesOfIdentifiableIntangibleAssetsTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "30103 - Disclosure - General Information (Tables)",
"role": "http://www.adapthealth.com/role/DisclosureGeneralInformationTables",
"shortName": "General Information (Tables)",
"subGroupType": "tables",
"uniqueAnchor": {
"ancestors": [
"us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "ahco:ScheduleOfUsefulLivesOfIdentifiableIntangibleAssetsTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R27": {
"firstAnchor": {
"ancestors": [
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "30203 - Disclosure - Revenue Recognition and Accounts Receivable (Tables)",
"role": "http://www.adapthealth.com/role/DisclosureRevenueRecognitionAndAccountsReceivableTables",
"shortName": "Revenue Recognition and Accounts Receivable (Tables)",
"subGroupType": "tables",
"uniqueAnchor": {
"ancestors": [
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R28": {
"firstAnchor": {
"ancestors": [
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "30303 - Disclosure - Significant Transactions (Tables)",
"role": "http://www.adapthealth.com/role/DisclosureSignificantTransactionsTables",
"shortName": "Significant Transactions (Tables)",
"subGroupType": "tables",
"uniqueAnchor": {
"ancestors": [
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R29": {
"firstAnchor": {
"ancestors": [
"us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "30403 - Disclosure - Equipment and Other Fixed Assets (Tables)",
"role": "http://www.adapthealth.com/role/DisclosureEquipmentAndOtherFixedAssetsTables",
"shortName": "Equipment and Other Fixed Assets (Tables)",
"subGroupType": "tables",
"uniqueAnchor": {
"ancestors": [
"us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R3": {
"firstAnchor": {
"ancestors": [
"p",
"td",
"tr",
"table",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "As_Of_9_30_2020_JIO9M6IRxEGEtUbp64Edvw",
"decimals": "INF",
"first": true,
"lang": null,
"name": "us-gaap:PreferredStockParOrStatedValuePerShare",
"reportCount": 1,
"unitRef": "Unit_Divide_USD_shares_Z0ZygQvF3U6fNSlEQOB3lg",
"xsiNil": "false"
},
"groupType": "statement",
"isDefault": "false",
"longName": "00105 - Statement - Consolidated Balance Sheets (Parenthetical)",
"role": "http://www.adapthealth.com/role/StatementConsolidatedBalanceSheetsParenthetical",
"shortName": "Consolidated Balance Sheets (Parenthetical)",
"subGroupType": "parenthetical",
"uniqueAnchor": {
"ancestors": [
"p",
"td",
"tr",
"table",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "As_Of_9_30_2020_JIO9M6IRxEGEtUbp64Edvw",
"decimals": "INF",
"lang": null,
"name": "us-gaap:PreferredStockSharesAuthorized",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_shares_on3vbUZds0eWVBfJ2b3mgw",
"xsiNil": "false"
}
},
"R30": {
"firstAnchor": {
"ancestors": [
"us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfGoodwillTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "30503 - Disclosure - Goodwill and Identifiable Intangible Assets (Tables)",
"role": "http://www.adapthealth.com/role/DisclosureGoodwillAndIdentifiableIntangibleAssetsTables",
"shortName": "Goodwill and Identifiable Intangible Assets (Tables)",
"subGroupType": "tables",
"uniqueAnchor": {
"ancestors": [
"us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfGoodwillTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R31": {
"firstAnchor": {
"ancestors": [
"us-gaap:FairValueDisclosuresTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "30603 - Disclosure - Fair Value of Assets and Liabilities (Tables)",
"role": "http://www.adapthealth.com/role/DisclosureFairValueOfAssetsAndLiabilitiesTables",
"shortName": "Fair Value of Assets and Liabilities (Tables)",
"subGroupType": "tables",
"uniqueAnchor": {
"ancestors": [
"us-gaap:FairValueDisclosuresTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R32": {
"firstAnchor": {
"ancestors": [
"us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "30703 - Disclosure - Derivative Instruments and Hedging Activities (Tables)",
"role": "http://www.adapthealth.com/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesTables",
"shortName": "Derivative Instruments and Hedging Activities (Tables)",
"subGroupType": "tables",
"uniqueAnchor": {
"ancestors": [
"us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R33": {
"firstAnchor": {
"ancestors": [
"us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "30803 - Disclosure - Accounts Payable and Accrued Expenses (Tables)",
"role": "http://www.adapthealth.com/role/DisclosureAccountsPayableAndAccruedExpensesTables",
"shortName": "Accounts Payable and Accrued Expenses (Tables)",
"subGroupType": "tables",
"uniqueAnchor": {
"ancestors": [
"us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R34": {
"firstAnchor": {
"ancestors": [
"us-gaap:DebtDisclosureTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "30903 - Disclosure - Debt (Tables)",
"role": "http://www.adapthealth.com/role/DisclosureDebtTables",
"shortName": "Debt (Tables)",
"subGroupType": "tables",
"uniqueAnchor": {
"ancestors": [
"us-gaap:DebtDisclosureTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R35": {
"firstAnchor": {
"ancestors": [
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "31003 - Disclosure - Stockholders' Equity (Tables)",
"role": "http://www.adapthealth.com/role/DisclosureStockholdersEquityTables",
"shortName": "Stockholders' Equity (Tables)",
"subGroupType": "tables",
"uniqueAnchor": {
"ancestors": [
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R36": {
"firstAnchor": {
"ancestors": [
"td",
"tr",
"table",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "31103 - Disclosure - Earnings Per Share (Tables)",
"role": "http://www.adapthealth.com/role/DisclosureEarningsPerShareTables",
"shortName": "Earnings Per Share (Tables)",
"subGroupType": "tables",
"uniqueAnchor": {
"ancestors": [
"td",
"tr",
"table",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R37": {
"firstAnchor": {
"ancestors": [
"us-gaap:LeasesOfLesseeDisclosureTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "31203 - Disclosure - Leases (Tables)",
"role": "http://www.adapthealth.com/role/DisclosureLeasesTables",
"shortName": "Leases (Tables)",
"subGroupType": "tables",
"uniqueAnchor": {
"ancestors": [
"us-gaap:LeasesOfLesseeDisclosureTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R38": {
"firstAnchor": {
"ancestors": [
"p",
"td",
"tr",
"table",
"ahco:ScheduleOfUsefulLivesOfIdentifiableIntangibleAssetsTableTextBlock",
"us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_ContractBasedIntangibleAssetsMember_PtEMyhlg8E-qp494SJkiCg",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "40101 - Disclosure - General Information (Details)",
"role": "http://www.adapthealth.com/role/DisclosureGeneralInformationDetails",
"shortName": "General Information (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"p",
"td",
"tr",
"table",
"ahco:ScheduleOfUsefulLivesOfIdentifiableIntangibleAssetsTableTextBlock",
"us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_ContractBasedIntangibleAssetsMember_PtEMyhlg8E-qp494SJkiCg",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R39": {
"firstAnchor": {
"ancestors": [
"p",
"td",
"tr",
"table",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_7_1_2020_To_9_30_2020_10Ws9DDMzUuX9PRHtI-KKg",
"decimals": "-3",
"first": true,
"lang": null,
"name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
"reportCount": 1,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "40201 - Disclosure - Revenue Recognition and Accounts Receivable (Details)",
"role": "http://www.adapthealth.com/role/DisclosureRevenueRecognitionAndAccountsReceivableDetails",
"shortName": "Revenue Recognition and Accounts Receivable (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"p",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_4_1_2020_To_4_30_2020_QQNiBy5x-k2rN09NuRW4EQ",
"decimals": "-5",
"lang": null,
"name": "ahco:CaresActRecoupableAdvancePayment",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
}
},
"R4": {
"firstAnchor": {
"ancestors": [
"p",
"td",
"tr",
"table",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_7_1_2020_To_9_30_2020_10Ws9DDMzUuX9PRHtI-KKg",
"decimals": "-3",
"first": true,
"lang": null,
"name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
"reportCount": 1,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
},
"groupType": "statement",
"isDefault": "false",
"longName": "00200 - Statement - Consolidated Statements of Operations",
"role": "http://www.adapthealth.com/role/StatementConsolidatedStatementsOfOperations",
"shortName": "Consolidated Statements of Operations",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"p",
"td",
"tr",
"table",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_7_1_2020_To_9_30_2020_10Ws9DDMzUuX9PRHtI-KKg",
"decimals": "-3",
"lang": null,
"name": "us-gaap:CostOfGoodsAndServicesSold",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
}
},
"R40": {
"firstAnchor": {
"ancestors": [
"p",
"td",
"tr",
"table",
"us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "As_Of_9_30_2019_-TKXgcUGmEKYtN5cynR-yw",
"decimals": "-3",
"first": true,
"lang": null,
"name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "40301 - Disclosure - Significant Transactions - Consideration and Allocation (Details)",
"role": "http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails",
"shortName": "Significant Transactions - Consideration and Allocation (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"p",
"td",
"tr",
"table",
"us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "As_Of_9_30_2019_-TKXgcUGmEKYtN5cynR-yw",
"decimals": "-3",
"first": true,
"lang": null,
"name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
}
},
"R41": {
"firstAnchor": {
"ancestors": [
"p",
"td",
"tr",
"table",
"us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_7_1_2020_To_9_30_2020_10Ws9DDMzUuX9PRHtI-KKg",
"decimals": "-3",
"first": true,
"lang": null,
"name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "40302 - Disclosure - Significant Transactions - Pro-forma Financial Information and Results of Business Acquired (Details)",
"role": "http://www.adapthealth.com/role/DisclosureSignificantTransactionsProFormaFinancialInformationAndResultsOfBusinessAcquiredDetails",
"shortName": "Significant Transactions - Pro-forma Financial Information and Results of Business Acquired (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"p",
"td",
"tr",
"table",
"us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_7_1_2020_To_9_30_2020_10Ws9DDMzUuX9PRHtI-KKg",
"decimals": "-3",
"first": true,
"lang": null,
"name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
}
},
"R42": {
"firstAnchor": {
"ancestors": [
"p",
"td",
"tr",
"table",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": "-3",
"first": true,
"lang": null,
"name": "us-gaap:PaymentsToAcquireMarketableSecurities",
"reportCount": 1,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "40303 - Disclosure - Significant Transactions - Business Combination (Details)",
"role": "http://www.adapthealth.com/role/DisclosureSignificantTransactionsBusinessCombinationDetails",
"shortName": "Significant Transactions - Business Combination (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"p",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "As_Of_11_8_2019_srt_OwnershipAxis_ahco_AdaptHealthHoldingsLlcMember_1IP5dm4znEG3WN6FekAtwg",
"decimals": "2",
"lang": null,
"name": "us-gaap:MinorityInterestOwnershipPercentageByParent",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_pure_VC1uswUYU0eGHyM_VZ2Wkg",
"xsiNil": "false"
}
},
"R43": {
"firstAnchor": {
"ancestors": [
"p",
"td",
"tr",
"table",
"us-gaap:PropertyPlantAndEquipmentTextBlock",
"us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "As_Of_9_30_2020_JIO9M6IRxEGEtUbp64Edvw",
"decimals": "-3",
"first": true,
"lang": null,
"name": "us-gaap:PropertyPlantAndEquipmentGross",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "40401 - Disclosure - Equipment and Other Fixed Assets (Details)",
"role": "http://www.adapthealth.com/role/DisclosureEquipmentAndOtherFixedAssetsDetails",
"shortName": "Equipment and Other Fixed Assets (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"p",
"td",
"tr",
"table",
"us-gaap:PropertyPlantAndEquipmentTextBlock",
"us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "As_Of_9_30_2020_JIO9M6IRxEGEtUbp64Edvw",
"decimals": "-3",
"first": true,
"lang": null,
"name": "us-gaap:PropertyPlantAndEquipmentGross",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
}
},
"R44": {
"firstAnchor": {
"ancestors": [
"p",
"td",
"tr",
"table",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "As_Of_12_31_2019_0sidqbPCzkGz-F_XBgLRsQ",
"decimals": "-3",
"first": true,
"lang": null,
"name": "us-gaap:Goodwill",
"reportCount": 1,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "40501 - Disclosure - Goodwill and Identifiable Intangible Assets (Details)",
"role": "http://www.adapthealth.com/role/DisclosureGoodwillAndIdentifiableIntangibleAssetsDetails",
"shortName": "Goodwill and Identifiable Intangible Assets (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"p",
"td",
"tr",
"table",
"us-gaap:ScheduleOfGoodwillTextBlock",
"us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": "-3",
"lang": null,
"name": "us-gaap:GoodwillAcquiredDuringPeriod",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
}
},
"R45": {
"firstAnchor": {
"ancestors": [
"us-gaap:AmortizationOfIntangibleAssets",
"p",
"us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_7_1_2020_To_9_30_2020_10Ws9DDMzUuX9PRHtI-KKg",
"decimals": "-5",
"first": true,
"lang": null,
"name": "us-gaap:AmortizationOfIntangibleAssets",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "40502 - Disclosure - Goodwill and Identifiable Intangible Assets - Intangible Assets (Details)",
"role": "http://www.adapthealth.com/role/DisclosureGoodwillAndIdentifiableIntangibleAssetsIntangibleAssetsDetails",
"shortName": "Goodwill and Identifiable Intangible Assets - Intangible Assets (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"us-gaap:AmortizationOfIntangibleAssets",
"p",
"us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_7_1_2020_To_9_30_2020_10Ws9DDMzUuX9PRHtI-KKg",
"decimals": "-5",
"first": true,
"lang": null,
"name": "us-gaap:AmortizationOfIntangibleAssets",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
}
},
"R46": {
"firstAnchor": {
"ancestors": [
"p",
"td",
"tr",
"table",
"us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
"us-gaap:FairValueDisclosuresTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "As_Of_9_30_2020_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_VMb8TNCWfkeBm1q3Ek_Fww",
"decimals": "-3",
"first": true,
"lang": null,
"name": "us-gaap:AssetsFairValueDisclosure",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "40601 - Disclosure - Fair Value of Assets and Liabilities - Valuation of Financial Assets and Liabilities (Details)",
"role": "http://www.adapthealth.com/role/DisclosureFairValueOfAssetsAndLiabilitiesValuationOfFinancialAssetsAndLiabilitiesDetails",
"shortName": "Fair Value of Assets and Liabilities - Valuation of Financial Assets and Liabilities (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"p",
"td",
"tr",
"table",
"us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
"us-gaap:FairValueDisclosuresTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "As_Of_9_30_2020_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_VMb8TNCWfkeBm1q3Ek_Fww",
"decimals": "-3",
"first": true,
"lang": null,
"name": "us-gaap:AssetsFairValueDisclosure",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
}
},
"R47": {
"firstAnchor": {
"ancestors": [
"p",
"td",
"tr",
"table",
"us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "As_Of_12_31_2019_0sidqbPCzkGz-F_XBgLRsQ",
"decimals": "-3",
"first": true,
"lang": null,
"name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "40602 - Disclosure - Fair Value - Contingent Consideration (Details)",
"role": "http://www.adapthealth.com/role/DisclosureFairValueContingentConsiderationDetails",
"shortName": "Fair Value - Contingent Consideration (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"p",
"td",
"tr",
"table",
"us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "As_Of_12_31_2019_0sidqbPCzkGz-F_XBgLRsQ",
"decimals": "-3",
"first": true,
"lang": null,
"name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
}
},
"R48": {
"firstAnchor": {
"ancestors": [
"p",
"td",
"tr",
"table",
"us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisTextBlock",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "As_Of_9_30_2020_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember_AcYflrRqXUawTpc7kHyMPA",
"decimals": "-3",
"first": true,
"lang": null,
"name": "us-gaap:GoodwillFairValueDisclosure",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "40603 - Disclosure - Fair Value of Assets and Liabilities - Non-financial Assets Measured on Non-recurring Basis (Details)",
"role": "http://www.adapthealth.com/role/DisclosureFairValueOfAssetsAndLiabilitiesNonFinancialAssetsMeasuredOnNonRecurringBasisDetails",
"shortName": "Fair Value of Assets and Liabilities - Non-financial Assets Measured on Non-recurring Basis (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"p",
"td",
"tr",
"table",
"us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisTextBlock",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "As_Of_9_30_2020_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsNonrecurringMember_AcYflrRqXUawTpc7kHyMPA",
"decimals": "-3",
"first": true,
"lang": null,
"name": "us-gaap:GoodwillFairValueDisclosure",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
}
},
"R49": {
"firstAnchor": {
"ancestors": [
"p",
"td",
"tr",
"table",
"us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
"us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "As_Of_9_30_2020_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_xFR2msd70Uu_ZbF8cLvadQ",
"decimals": "-3",
"first": true,
"lang": null,
"name": "us-gaap:DerivativeLiabilities",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "40701 - Disclosure - Derivative Instruments and Hedging Activities - Financial instruments (Details)",
"role": "http://www.adapthealth.com/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesFinancialInstrumentsDetails",
"shortName": "Derivative Instruments and Hedging Activities - Financial instruments (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"p",
"td",
"tr",
"table",
"us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
"us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "As_Of_9_30_2020_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_xFR2msd70Uu_ZbF8cLvadQ",
"decimals": "-3",
"first": true,
"lang": null,
"name": "us-gaap:DerivativeLiabilities",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
}
},
"R5": {
"firstAnchor": {
"ancestors": [
"p",
"td",
"tr",
"table",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_7_1_2020_To_9_30_2020_10Ws9DDMzUuX9PRHtI-KKg",
"decimals": "-3",
"first": true,
"lang": null,
"name": "us-gaap:ProfitLoss",
"reportCount": 1,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
},
"groupType": "statement",
"isDefault": "false",
"longName": "00300 - Statement - Consolidated Statements of Comprehensive Income (Loss)",
"role": "http://www.adapthealth.com/role/StatementConsolidatedStatementsOfComprehensiveIncomeLoss",
"shortName": "Consolidated Statements of Comprehensive Income (Loss)",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"p",
"td",
"tr",
"table",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_7_1_2020_To_9_30_2020_10Ws9DDMzUuX9PRHtI-KKg",
"decimals": "-3",
"lang": null,
"name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
}
},
"R50": {
"firstAnchor": {
"ancestors": [
"p",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_7_1_2020_To_9_30_2020_10Ws9DDMzUuX9PRHtI-KKg",
"decimals": "-5",
"first": true,
"lang": null,
"name": "us-gaap:DerivativeGainLossOnDerivativeNet",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "40702 - Disclosure - Derivative Instruments and Hedging Activities - Effect on Accumulated Other Comprehensive Income (Details)",
"role": "http://www.adapthealth.com/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesEffectOnAccumulatedOtherComprehensiveIncomeDetails",
"shortName": "Derivative Instruments and Hedging Activities - Effect on Accumulated Other Comprehensive Income (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"p",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_7_1_2020_To_9_30_2020_10Ws9DDMzUuX9PRHtI-KKg",
"decimals": "-5",
"first": true,
"lang": null,
"name": "us-gaap:DerivativeGainLossOnDerivativeNet",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
}
},
"R51": {
"firstAnchor": {
"ancestors": [
"p",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_7_1_2019_To_9_30_2019_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember_OXWAVcNK6k2su4jMjlFtVQ",
"decimals": "-5",
"first": true,
"lang": null,
"name": "us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "40703 - Disclosure - Derivative Instruments and Hedging Activities - Not designated (Details)",
"role": "http://www.adapthealth.com/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesNotDesignatedDetails",
"shortName": "Derivative Instruments and Hedging Activities - Not designated (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"p",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_7_1_2019_To_9_30_2019_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember_OXWAVcNK6k2su4jMjlFtVQ",
"decimals": "-5",
"first": true,
"lang": null,
"name": "us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
}
},
"R52": {
"firstAnchor": {
"ancestors": [
"p",
"td",
"tr",
"table",
"us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
"us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "As_Of_9_30_2020_JIO9M6IRxEGEtUbp64Edvw",
"decimals": "-3",
"first": true,
"lang": null,
"name": "us-gaap:AccountsPayableCurrent",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "40801 - Disclosure - Accounts Payable and Accrued Expenses (Details)",
"role": "http://www.adapthealth.com/role/DisclosureAccountsPayableAndAccruedExpensesDetails",
"shortName": "Accounts Payable and Accrued Expenses (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"p",
"td",
"tr",
"table",
"us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
"us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "As_Of_9_30_2020_JIO9M6IRxEGEtUbp64Edvw",
"decimals": "-3",
"first": true,
"lang": null,
"name": "us-gaap:AccountsPayableCurrent",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
}
},
"R53": {
"firstAnchor": {
"ancestors": [
"p",
"td",
"tr",
"table",
"us-gaap:ScheduleOfDebtInstrumentsTextBlock",
"us-gaap:DebtDisclosureTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "As_Of_9_30_2020_JIO9M6IRxEGEtUbp64Edvw",
"decimals": "-3",
"first": true,
"lang": null,
"name": "us-gaap:DebtInstrumentUnamortizedDiscount",
"reportCount": 1,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "40901 - Disclosure - Debt (Details)",
"role": "http://www.adapthealth.com/role/DisclosureDebtDetails",
"shortName": "Debt (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"p",
"td",
"tr",
"table",
"us-gaap:ScheduleOfDebtInstrumentsTextBlock",
"us-gaap:DebtDisclosureTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "As_Of_9_30_2020_JIO9M6IRxEGEtUbp64Edvw",
"decimals": "-3",
"lang": null,
"name": "us-gaap:LongTermDebt",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
}
},
"R54": {
"firstAnchor": {
"ancestors": [
"p",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2019_To_9_30_2019_vqj_bOXr7kmKbEAutTn9iA",
"decimals": "-5",
"first": true,
"lang": null,
"name": "us-gaap:PaymentsOfDebtIssuanceCosts",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "40902 - Disclosure - Debt - Long term debt (Details)",
"role": "http://www.adapthealth.com/role/DisclosureDebtLongTermDebtDetails",
"shortName": "Debt - Long term debt (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"p",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2019_To_9_30_2019_vqj_bOXr7kmKbEAutTn9iA",
"decimals": "-5",
"first": true,
"lang": null,
"name": "us-gaap:PaymentsOfDebtIssuanceCosts",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
}
},
"R55": {
"firstAnchor": {
"ancestors": [
"p",
"td",
"tr",
"table",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": "-3",
"first": true,
"lang": null,
"name": "us-gaap:ProceedsFromIssuanceOfUnsecuredDebt",
"reportCount": 1,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "40903 - Disclosure - Debt - Notes (Details)",
"role": "http://www.adapthealth.com/role/DisclosureDebtNotesDetails",
"shortName": "Debt - Notes (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"p",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_3_1_2019_To_3_31_2019_gQV_oLRJokaZWC1WKZe_OA",
"decimals": "-6",
"lang": null,
"name": "us-gaap:ProceedsFromIssuanceOfCommonLimitedPartnersUnits",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
}
},
"R56": {
"firstAnchor": {
"ancestors": [
"p",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": "-5",
"first": true,
"lang": null,
"name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
"reportCount": 1,
"unitRef": "Unit_Standard_shares_on3vbUZds0eWVBfJ2b3mgw",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "41001 - Disclosure - Stockholders' Equity (Details)",
"role": "http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails",
"shortName": "Stockholders' Equity (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"p",
"us-gaap:StockholdersEquityNoteDisclosureTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "As_Of_6_30_2020_Jgub2VoZ-UKDMMOuIgL2Hg",
"decimals": "INF",
"lang": null,
"name": "us-gaap:PreferredStockLiquidationPreference",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Divide_USD_shares_Z0ZygQvF3U6fNSlEQOB3lg",
"xsiNil": "false"
}
},
"R57": {
"firstAnchor": {
"ancestors": [
"p",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_7_1_2020_To_9_30_2020_10Ws9DDMzUuX9PRHtI-KKg",
"decimals": "-5",
"first": true,
"lang": null,
"name": "us-gaap:AllocatedShareBasedCompensationExpense",
"reportCount": 1,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "41002 - Disclosure - Stockholders' Equity - Equity-based compensation (Details)",
"role": "http://www.adapthealth.com/role/DisclosureStockholdersEquityEquityBasedCompensationDetails",
"shortName": "Stockholders' Equity - Equity-based compensation (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"p",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2019_To_9_30_2019_vqj_bOXr7kmKbEAutTn9iA",
"decimals": "-5",
"lang": null,
"name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
}
},
"R58": {
"firstAnchor": {
"ancestors": [
"p",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_7_1_2020_To_9_30_2020_10Ws9DDMzUuX9PRHtI-KKg",
"decimals": "-5",
"first": true,
"lang": null,
"name": "us-gaap:AllocatedShareBasedCompensationExpense",
"reportCount": 1,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "41003 - Disclosure - Stockholders' Equity - Common stock awards (Details)",
"role": "http://www.adapthealth.com/role/DisclosureStockholdersEquityCommonStockAwardsDetails",
"shortName": "Stockholders' Equity - Common stock awards (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"p",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_8_1_2020_To_8_31_2020_us-gaap_AwardTypeAxis_ahco_AwardsToNewlyHiredEmployeesMember_2qlBaHbfYU-jvcJLUX8aLw",
"decimals": "0",
"lang": null,
"name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_shares_on3vbUZds0eWVBfJ2b3mgw",
"xsiNil": "false"
}
},
"R59": {
"firstAnchor": {
"ancestors": [
"span",
"p",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_4_1_2020_To_4_30_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_RmRkJB7qskC7zJBmkGgnsw",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_shares_on3vbUZds0eWVBfJ2b3mgw",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "41004 - Disclosure - Stockholders' Equity - Options activity and assumptions (Details)",
"role": "http://www.adapthealth.com/role/DisclosureStockholdersEquityOptionsActivityAndAssumptionsDetails",
"shortName": "Stockholders' Equity - Options activity and assumptions (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"p",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_4_1_2020_To_4_30_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_RmRkJB7qskC7zJBmkGgnsw",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_shares_on3vbUZds0eWVBfJ2b3mgw",
"xsiNil": "false"
}
},
"R6": {
"firstAnchor": {
"ancestors": [
"p",
"td",
"tr",
"table",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "As_Of_12_31_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_MemberUnitsMember_F_ghz9wo5U6LcQnVUmhAXg",
"decimals": "-3",
"first": true,
"lang": null,
"name": "us-gaap:LimitedLiabilityCompanyLlcMembersEquityIncludingPortionAttributableToNoncontrollingInterest",
"reportCount": 1,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
},
"groupType": "statement",
"isDefault": "false",
"longName": "00400 - Statement - Consolidated Statements of Changes in Stockholders' Equity (Deficit) / Members' Equity (Deficit)",
"role": "http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit",
"shortName": "Consolidated Statements of Changes in Stockholders' Equity (Deficit) / Members' Equity (Deficit)",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"p",
"td",
"tr",
"table",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2019_To_3_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_MemberUnitsMember_vI9deR292kmRgR5bgKVMRw",
"decimals": "-3",
"lang": null,
"name": "us-gaap:PartnersCapitalAccountSaleOfUnits",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
}
},
"R60": {
"firstAnchor": {
"ancestors": [
"p",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_7_1_2020_To_9_30_2020_10Ws9DDMzUuX9PRHtI-KKg",
"decimals": "-5",
"first": true,
"lang": null,
"name": "us-gaap:AllocatedShareBasedCompensationExpense",
"reportCount": 1,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "41005 - Disclosure - Stockholders' Equity - Restricted stock (Details)",
"role": "http://www.adapthealth.com/role/DisclosureStockholdersEquityRestrictedStockDetails",
"shortName": "Stockholders' Equity - Restricted stock (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"p",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_3_1_2020_To_3_31_2020_srt_TitleOfIndividualAxis_ahco_SingleEmployeeMember_Hm-Dx62yOEWVxGPAmftQzQ",
"decimals": "INF",
"lang": null,
"name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_pure_VC1uswUYU0eGHyM_VZ2Wkg",
"xsiNil": "false"
}
},
"R61": {
"firstAnchor": {
"ancestors": [
"p",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_6_1_2019_To_6_30_2019_us-gaap_PlanNameAxis_ahco_StockIncentivePlan2019Member_ViuCM9oOI02wOetRTkUEpw",
"decimals": "-5",
"first": true,
"lang": null,
"name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "41006 - Disclosure - Stockholders' Equity - Incentive Units (Details)",
"role": "http://www.adapthealth.com/role/DisclosureStockholdersEquityIncentiveUnitsDetails",
"shortName": "Stockholders' Equity - Incentive Units (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"p",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_6_1_2019_To_6_30_2019_us-gaap_PlanNameAxis_ahco_StockIncentivePlan2019Member_ViuCM9oOI02wOetRTkUEpw",
"decimals": "-5",
"first": true,
"lang": null,
"name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
}
},
"R62": {
"firstAnchor": {
"ancestors": [
"p",
"td",
"tr",
"table",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_7_1_2020_To_9_30_2020_10Ws9DDMzUuX9PRHtI-KKg",
"decimals": "-3",
"first": true,
"lang": null,
"name": "us-gaap:NetIncomeLoss",
"reportCount": 1,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "41101 - Disclosure - Earnings Per Share (Details)",
"role": "http://www.adapthealth.com/role/DisclosureEarningsPerShareDetails",
"shortName": "Earnings Per Share (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"p",
"td",
"tr",
"table",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": "-3",
"lang": null,
"name": "us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
}
},
"R63": {
"firstAnchor": {
"ancestors": [
"p",
"td",
"tr",
"table",
"ix:continuation",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "As_Of_9_30_2020_JIO9M6IRxEGEtUbp64Edvw",
"decimals": "-3",
"first": true,
"lang": null,
"name": "us-gaap:CapitalLeasesFutureMinimumPaymentsNextRollingTwelveMonths",
"reportCount": 1,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "41201 - Disclosure - Leases - Capital leases (Details)",
"role": "http://www.adapthealth.com/role/DisclosureLeasesCapitalLeasesDetails",
"shortName": "Leases - Capital leases (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"p",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "As_Of_12_31_2019_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_AssetsHeldUnderCapitalLeasesMember_ucaOp0PimESEWSrBqdeMlw",
"decimals": "-5",
"lang": null,
"name": "us-gaap:CapitalLeasedAssetsGross",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
}
},
"R64": {
"firstAnchor": {
"ancestors": [
"p",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "As_Of_9_30_2020_JIO9M6IRxEGEtUbp64Edvw",
"decimals": "-5",
"first": true,
"lang": null,
"name": "ahco:DeferredRent",
"reportCount": 1,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "41202 - Disclosure - Leases - Operating (Details)",
"role": "http://www.adapthealth.com/role/DisclosureLeasesOperatingDetails",
"shortName": "Leases - Operating (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"p",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "As_Of_12_31_2019_0sidqbPCzkGz-F_XBgLRsQ",
"decimals": "-5",
"lang": null,
"name": "ahco:DeferredRent",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
}
},
"R65": {
"firstAnchor": {
"ancestors": [
"p",
"td",
"tr",
"table",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_7_1_2020_To_9_30_2020_10Ws9DDMzUuX9PRHtI-KKg",
"decimals": "-3",
"first": true,
"lang": null,
"name": "us-gaap:IncomeTaxExpenseBenefit",
"reportCount": 1,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "41301 - Disclosure - Income Taxes (Details)",
"role": "http://www.adapthealth.com/role/DisclosureIncomeTaxesDetails",
"shortName": "Income Taxes (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"p",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": "2",
"lang": null,
"name": "ahco:TaxReceivableAgreementPercentageSavingsPayable",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_pure_VC1uswUYU0eGHyM_VZ2Wkg",
"xsiNil": "false"
}
},
"R66": {
"firstAnchor": {
"ancestors": [
"p",
"us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "As_Of_9_30_2020_JIO9M6IRxEGEtUbp64Edvw",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:LossContingencyAccrualAtCarryingValue",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "41401 - Disclosure - Commitments and Contingencies (Details)",
"role": "http://www.adapthealth.com/role/DisclosureCommitmentsAndContingenciesDetails",
"shortName": "Commitments and Contingencies (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"p",
"us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "As_Of_9_30_2020_JIO9M6IRxEGEtUbp64Edvw",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:LossContingencyAccrualAtCarryingValue",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
}
},
"R67": {
"firstAnchor": {
"ancestors": [
"p",
"us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "As_Of_9_30_2020_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_InvestorMember_uWkWhBZovEeYTmLs7LyhsQ",
"decimals": "-5",
"first": true,
"lang": null,
"name": "us-gaap:NotesPayableRelatedPartiesNoncurrent",
"reportCount": 1,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "41501 - Disclosure - Related Party Transactions (Details)",
"role": "http://www.adapthealth.com/role/DisclosureRelatedPartyTransactionsDetails",
"shortName": "Related Party Transactions (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"p",
"us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ahco_VendorTwoMember_QI74OYYf802f1RmvZVmnoA",
"decimals": "INF",
"lang": null,
"name": "ahco:NumberOfExecutives",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_item_6gFMeo371kGNxhD3abrurQ",
"xsiNil": "false"
}
},
"R68": {
"firstAnchor": {
"ancestors": [
"p",
"us-gaap:SubsequentEventsTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "As_Of_10_1_2020_us-gaap_BusinessAcquisitionAxis_ahco_PinnacleMedicalSolutionsInc.Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_VWpwoFOSKkS15Y3pD5bYew",
"decimals": "INF",
"first": true,
"lang": null,
"name": "us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_pure_VC1uswUYU0eGHyM_VZ2Wkg",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "41601 - Disclosure - Subsequent Events - Financing and Acquisitions (Details)",
"role": "http://www.adapthealth.com/role/DisclosureSubsequentEventsFinancingAndAcquisitionsDetails",
"shortName": "Subsequent Events - Financing and Acquisitions (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"p",
"us-gaap:SubsequentEventsTextBlock",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "As_Of_10_1_2020_us-gaap_BusinessAcquisitionAxis_ahco_PinnacleMedicalSolutionsInc.Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_VWpwoFOSKkS15Y3pD5bYew",
"decimals": "INF",
"first": true,
"lang": null,
"name": "us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_pure_VC1uswUYU0eGHyM_VZ2Wkg",
"xsiNil": "false"
}
},
"R7": {
"firstAnchor": {
"ancestors": [
"p",
"td",
"tr",
"table",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2019_To_3_31_2019_l2Q7ViOIMUS_pDMzZLf1aQ",
"decimals": "-3",
"first": true,
"lang": null,
"name": "us-gaap:PaymentsOfStockIssuanceCosts",
"reportCount": 1,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
},
"groupType": "statement",
"isDefault": "false",
"longName": "00405 - Statement - Consolidated Statements Of Changes in Stockholders' Equity (Deficit) (Parenthetical)",
"role": "http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitParenthetical",
"shortName": "Consolidated Statements Of Changes in Stockholders' Equity (Deficit) (Parenthetical)",
"subGroupType": "parenthetical",
"uniqueAnchor": null
},
"R8": {
"firstAnchor": {
"ancestors": [
"p",
"td",
"tr",
"table",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": "-3",
"first": true,
"lang": null,
"name": "us-gaap:ProfitLoss",
"reportCount": 1,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
},
"groupType": "statement",
"isDefault": "false",
"longName": "00500 - Statement - Consolidated Statements of Cash Flows",
"role": "http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows",
"shortName": "Consolidated Statements of Cash Flows",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"p",
"td",
"tr",
"table",
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": "-3",
"lang": null,
"name": "us-gaap:Depreciation",
"reportCount": 1,
"unique": true,
"unitRef": "Unit_Standard_USD_dmLALgCATkOI-PnJz58u8g",
"xsiNil": "false"
}
},
"R9": {
"firstAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "10101 - Disclosure - General Information",
"role": "http://www.adapthealth.com/role/DisclosureGeneralInformation",
"shortName": "General Information",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"div",
"div",
"body",
"html"
],
"baseRef": "ahco-20200930x10q.htm",
"contextRef": "Duration_1_1_2020_To_9_30_2020_rp9HacM_-EGkMEpx6IScJA",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
}
},
"segmentCount": 103,
"tag": {
"ahco_ActivstyleInc.Member": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Information pertaining to ActivStyle, Inc.",
"label": "Activstyle Inc. [Member]",
"terseLabel": "ActivStyle, Inc. [Member]"
}
}
},
"localname": "ActivstyleInc.Member",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails"
],
"xbrltype": "domainItemType"
},
"ahco_AdaptHealthHoldingsLlcMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Represents information relating to AdaptHealth Holdings LLC.",
"label": "Adapt Health Holdings Llc [Member]",
"terseLabel": "Adapt Health Holdings LLC"
}
}
},
"localname": "AdaptHealthHoldingsLlcMember",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsBusinessCombinationDetails",
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails"
],
"xbrltype": "domainItemType"
},
"ahco_AdjustmentsToAdditionalPaidInCapitalPutCallAgreement": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of increase (decrease) in additional paid in capital related to put/call agreement.",
"label": "Adjustments To Additional Paid In Capital, Put/Call Agreement",
"terseLabel": "Equity activity resulting from the Put/Call Agreement"
}
}
},
"localname": "AdjustmentsToAdditionalPaidInCapitalPutCallAgreement",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit"
],
"xbrltype": "monetaryItemType"
},
"ahco_AdjustmentsToAdditionalPaidInCapitalTaxReceivableAgreement": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of increase in additional paid in capital (APIC) resulting from Tax Receivable Agreement.",
"label": "Adjustments to Additional Paid in Capital, Tax Receivable Agreement",
"terseLabel": "Equity activity resulting from Tax Receivable Agreement"
}
}
},
"localname": "AdjustmentsToAdditionalPaidInCapitalTaxReceivableAgreement",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit"
],
"xbrltype": "monetaryItemType"
},
"ahco_AdvancedHomeCareIncMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Information pertaining to Advanced Home Care, Inc.",
"label": "Advanced Home Care Inc [Member]",
"terseLabel": "Advanced Home Care Inc [Member]"
}
}
},
"localname": "AdvancedHomeCareIncMember",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails"
],
"xbrltype": "domainItemType"
},
"ahco_AgreementTerm": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The period of time for which the agreement is in effect.",
"label": "Agreement Term"
}
}
},
"localname": "AgreementTerm",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureCommitmentsAndContingenciesDetails"
],
"xbrltype": "durationItemType"
},
"ahco_AutoNotesMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Represents Auto loans.",
"label": "Auto Notes [Member]",
"terseLabel": "Other"
}
}
},
"localname": "AutoNotesMember",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtDetails"
],
"xbrltype": "domainItemType"
},
"ahco_AwardsToNewlyHiredEmployeesMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Information pertaining to awards to newly hired employees.",
"label": "Awards To Newly Hired Employees [Member]",
"terseLabel": "Awards To Newly Hired Employees [Member]"
}
}
},
"localname": "AwardsToNewlyHiredEmployeesMember",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityCommonStockAwardsDetails"
],
"xbrltype": "domainItemType"
},
"ahco_BusinessCombinationContingentConsideration": {
"auth_ref": [
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails": {
"order": 2.0,
"parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The portion of total consideration attributable to contingent consideration.",
"label": "Business Combination, Contingent Consideration",
"terseLabel": "Contingent consideration"
}
}
},
"localname": "BusinessCombinationContingentConsideration",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails",
"http://www.adapthealth.com/role/DisclosureSubsequentEventsFinancingAndAcquisitionsDetails"
],
"xbrltype": "monetaryItemType"
},
"ahco_BusinessCombinationContingentConsiderationLiabilityOtherActivity": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Increase (decrease) in contingent consideration liability attributable to activity other than additions, payments or changes in fair value.",
"label": "Business Combination Contingent Consideration Liability Other Activity",
"terseLabel": "Other activity"
}
}
},
"localname": "BusinessCombinationContingentConsiderationLiabilityOtherActivity",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureFairValueContingentConsiderationDetails"
],
"xbrltype": "monetaryItemType"
},
"ahco_BusinessCombinationContingentConsiderationSharesAuthorizedPerInstallment": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The number of shares authorized to be distributed, per annual installment, to former owners of the acquiree as earn-out consideration if certain hurdles are met.",
"label": "Business Combination Contingent Consideration, Shares Authorized Per Installment",
"terseLabel": "Earn-out consideration, shares per annual installment"
}
}
},
"localname": "BusinessCombinationContingentConsiderationSharesAuthorizedPerInstallment",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails"
],
"xbrltype": "sharesItemType"
},
"ahco_BusinessCombinationContingentConsiderationStockPriceHurdleFirstMeasurementDate": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Earn-out consideration is to be paid in the form of Class A Common Stock, if the average price of the Company's Class A Common Stock for the month of December prior to the first measurement date equals or exceeds this amount.",
"label": "Business Combination Contingent Consideration Stock Price Hurdle First Measurement Date",
"terseLabel": "First stock price hurdle (in dollars per share)"
}
}
},
"localname": "BusinessCombinationContingentConsiderationStockPriceHurdleFirstMeasurementDate",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails"
],
"xbrltype": "perShareItemType"
},
"ahco_BusinessCombinationContingentConsiderationStockPriceHurdleSecondMeasurementDate": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Earn-out consideration is to be paid in the form of Class A Common Stock, if the average price of the Company's Class A Common Stock for the month of December prior to the second measurement date equals or exceeds this amount.",
"label": "Business Combination Contingent Consideration Stock Price Hurdle Second Measurement Date",
"terseLabel": "Second stock price hurdle (in dollars per share)"
}
}
},
"localname": "BusinessCombinationContingentConsiderationStockPriceHurdleSecondMeasurementDate",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails"
],
"xbrltype": "perShareItemType"
},
"ahco_BusinessCombinationContingentConsiderationStockPriceHurdleThirdMeasurementDate": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Earn-out consideration is to be paid in the form of Class A Common Stock, if the average price of the Company's Class A Common Stock for the month of December prior to the third measurement date equals or exceeds this amount.",
"label": "Business Combination Contingent Consideration Stock Price Hurdle Third Measurement Date",
"terseLabel": "Third stock price hurdle (in dollars per share)"
}
}
},
"localname": "BusinessCombinationContingentConsiderationStockPriceHurdleThirdMeasurementDate",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails"
],
"xbrltype": "perShareItemType"
},
"ahco_BusinessCombinationContingentConsiderationTotalSharesAuthorized": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The number of total shares authorized to be distributed to former owners of the acquiree as earn-out consideration if certain hurdles are met.",
"label": "Business Combination, Contingent Consideration, Total Shares Authorized",
"terseLabel": "Earn-out consideration, total shares"
}
}
},
"localname": "BusinessCombinationContingentConsiderationTotalSharesAuthorized",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails"
],
"xbrltype": "sharesItemType"
},
"ahco_BusinessCombinationEscrowPayment": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The amount of escrow payments under business combination.",
"label": "Business Combination, Escrow Payment",
"terseLabel": "Escrow payment"
}
}
},
"localname": "BusinessCombinationEscrowPayment",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails",
"http://www.adapthealth.com/role/DisclosureSubsequentEventsFinancingAndAcquisitionsDetails"
],
"xbrltype": "monetaryItemType"
},
"ahco_CaresActProviderReliefFunds": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The amount of provider relief funds sought or received during the period as provided in the CARES Act.",
"label": "CARES Act Provider Relief Funds",
"terseLabel": "Receipt of provider relief funds, CARES Act"
}
}
},
"localname": "CaresActProviderReliefFunds",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureRevenueRecognitionAndAccountsReceivableDetails"
],
"xbrltype": "monetaryItemType"
},
"ahco_CaresActRecoupableAdvancePayment": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The amount of recoupable advance payment sought or received during the period as provided in the CARES Act.",
"label": "CARES Act Recoupable Advance Payment",
"terseLabel": "Recoupable Advance Payment, CARES Act"
}
}
},
"localname": "CaresActRecoupableAdvancePayment",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureRevenueRecognitionAndAccountsReceivableDetails"
],
"xbrltype": "monetaryItemType"
},
"ahco_CaresActRecoupableFunds": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The total CARES Act recoupable funds, comprised of advance payment and provider relief.",
"label": "CARES Act Recoupable Funds",
"terseLabel": "Total funds, CARES Act"
}
}
},
"localname": "CaresActRecoupableFunds",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureRevenueRecognitionAndAccountsReceivableDetails"
],
"xbrltype": "monetaryItemType"
},
"ahco_CashlessExerciseOfWarrantsShares": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The number of shares issued for cashless exercise of warrants during the period.",
"label": "Cashless Exercise Of Warrants Shares",
"terseLabel": "Shares issued in cashless exercise of warrants (in shares)",
"verboseLabel": "Shares issued for warrants exercised"
}
}
},
"localname": "CashlessExerciseOfWarrantsShares",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit"
],
"xbrltype": "sharesItemType"
},
"ahco_CashlessExerciseOfWarrantsValue": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Non cash value of exercise of warrants.",
"label": "Cashless Exercise Of Warrants, Value",
"terseLabel": "Cashless exercise of warrants"
}
}
},
"localname": "CashlessExerciseOfWarrantsValue",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit"
],
"xbrltype": "monetaryItemType"
},
"ahco_ContingentConsiderationCurrentMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Contingent consideration in a business combination that is classified as current.",
"label": "Contingent Consideration Current [Member]",
"terseLabel": "Acquisition-related contingent consideration obligations-short term"
}
}
},
"localname": "ContingentConsiderationCurrentMember",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureFairValueOfAssetsAndLiabilitiesValuationOfFinancialAssetsAndLiabilitiesDetails"
],
"xbrltype": "domainItemType"
},
"ahco_ContingentConsiderationLiabilityAdditions": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The amount of additions to contingent consideration liability due to acquisitions during the period.",
"label": "Contingent Consideration Liability, Additions",
"terseLabel": "Additions"
}
}
},
"localname": "ContingentConsiderationLiabilityAdditions",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureFairValueContingentConsiderationDetails"
],
"xbrltype": "monetaryItemType"
},
"ahco_ContingentConsiderationNoncurrentMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Contingent consideration in a business combination that is classified as noncurrent.",
"label": "Contingent Consideration Noncurrent [Member]",
"terseLabel": "Acquisition-related contingent consideration obligations-long term"
}
}
},
"localname": "ContingentConsiderationNoncurrentMember",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureFairValueOfAssetsAndLiabilitiesValuationOfFinancialAssetsAndLiabilitiesDetails"
],
"xbrltype": "domainItemType"
},
"ahco_ConversionOfPreferredStockForCommonStockDuringPeriodInShares": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The number of shares of preferred stock converted into common stock during the period.",
"label": "Conversion Of Preferred Stock For Common Stock During Period, In Shares",
"terseLabel": "Conversion of Series A Preferred Stock to Class A Common Stock (in shares)"
}
}
},
"localname": "ConversionOfPreferredStockForCommonStockDuringPeriodInShares",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit"
],
"xbrltype": "sharesItemType"
},
"ahco_ConversionOfPreferredStockIntoPreferredStockOfAnotherSeriesDuringPeriodInShares": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The number of shares of preferred stock converted into preferred stock of another series during the period.",
"label": "Conversion Of Preferred Stock Into Preferred Stock Of Another Series During The Period, In Shares",
"terseLabel": "Conversion of Series B-2 Preferred Stock to Series B-1 Preferred Stock (in shares)"
}
}
},
"localname": "ConversionOfPreferredStockIntoPreferredStockOfAnotherSeriesDuringPeriodInShares",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit"
],
"xbrltype": "sharesItemType"
},
"ahco_CreditAgreementMaturingJuly2025Member": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Information pertaining to Credit Agreement maturing in July 2025.",
"label": "Credit Agreement Maturing July2025 [Member]",
"terseLabel": "Credit Agreement Maturing July 2025 [Member]"
}
}
},
"localname": "CreditAgreementMaturingJuly2025Member",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtDetails",
"http://www.adapthealth.com/role/DisclosureDebtLongTermDebtDetails"
],
"xbrltype": "domainItemType"
},
"ahco_CreditFacilityMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Information pertaining to debt under the credit facility.",
"label": "Credit Facility [Member]",
"terseLabel": "Credit Facility [Member]"
}
}
},
"localname": "CreditFacilityMember",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtDetails",
"http://www.adapthealth.com/role/DisclosureDebtLongTermDebtDetails"
],
"xbrltype": "domainItemType"
},
"ahco_DebtInstrumentInterestRatePayableInCash": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Represents the interest rate on debt instrument payable in cash.",
"label": "Debt Instrument, Interest Rate Payable In Cash",
"terseLabel": "Interest rate payable in cash"
}
}
},
"localname": "DebtInstrumentInterestRatePayableInCash",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails"
],
"xbrltype": "percentItemType"
},
"ahco_DebtInstrumentInterestRatePayableInKind": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Represents the interest rate on debt instrument payable in kind.",
"label": "Debt Instrument, Interest Rate Payable In Kind",
"terseLabel": "Interest rate payable in kind"
}
}
},
"localname": "DebtInstrumentInterestRatePayableInKind",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails"
],
"xbrltype": "percentItemType"
},
"ahco_DebtInstrumentPrepaymentPenaltyRate": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The rate, as a percent, of the make-whole amount that is due when early payment is made on the debt instrument.",
"label": "Debt Instrument, Prepayment Penalty Rate",
"terseLabel": "Make-whole premium, as a percent"
}
}
},
"localname": "DebtInstrumentPrepaymentPenaltyRate",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails"
],
"xbrltype": "percentItemType"
},
"ahco_DebtInstrumentRedemptionPricePercentageProceedsFromEquityOfferings": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer using proceeds from equity offerings.",
"label": "Debt Instrument Redemption Price Percentage, Proceeds From Equity Offerings"
}
}
},
"localname": "DebtInstrumentRedemptionPricePercentageProceedsFromEquityOfferings",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails"
],
"xbrltype": "percentItemType"
},
"ahco_DeferredRent": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The amount of the difference between rent expense recognized on a straight-line basis and the amount payable, which may include a share of real estate taxes and utility costs and fixed annual increases of minimum rent.",
"label": "Deferred Rent",
"terseLabel": "Deferred rent"
}
}
},
"localname": "DeferredRent",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureLeasesOperatingDetails"
],
"xbrltype": "monetaryItemType"
},
"ahco_DeferredTaxAssetAttributableToTaxReceivableAgreementIncreaseDecrease": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The amount of increase (decrease) during the period in deferred tax asset attributable to tax receivable agreement.",
"label": "Deferred Tax Asset Attributable To Tax Receivable Agreement, Increase (Decrease)",
"terseLabel": "Increase in deferred tax asset"
}
}
},
"localname": "DeferredTaxAssetAttributableToTaxReceivableAgreementIncreaseDecrease",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureIncomeTaxesDetails"
],
"xbrltype": "monetaryItemType"
},
"ahco_DelayedDrawTermLoanMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Represents information pertaining to delayed draw term loan.",
"label": "Delayed Draw Term Loan [Member]",
"terseLabel": "Delayed Draw Term Loan"
}
}
},
"localname": "DelayedDrawTermLoanMember",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtDetails",
"http://www.adapthealth.com/role/DisclosureDebtLongTermDebtDetails"
],
"xbrltype": "domainItemType"
},
"ahco_DepreciationExpenseExcludingPatientEquipmentDepreciation": {
"auth_ref": [
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfOperations": {
"order": 2.0,
"parentTag": "us-gaap_CostsAndExpenses",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives, excluding patient equipment depreciation. Includes production and non-production related depreciation.",
"label": "Depreciation Expense Excluding Patient Equipment Depreciation",
"terseLabel": "Depreciation and amortization, excluding patient equipment depreciation"
}
}
},
"localname": "DepreciationExpenseExcludingPatientEquipmentDepreciation",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfOperations"
],
"xbrltype": "monetaryItemType"
},
"ahco_DiabetesMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Information pertaining to diabetes products and services.",
"label": "Diabetes [Member]",
"terseLabel": "Diabetes [Member]"
}
}
},
"localname": "DiabetesMember",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureRevenueRecognitionAndAccountsReceivableDetails"
],
"xbrltype": "domainItemType"
},
"ahco_GoodwillDisclosureAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "No definition available.",
"label": "Goodwill."
}
}
},
"localname": "GoodwillDisclosureAbstract",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureGoodwillAndIdentifiableIntangibleAssetsTables"
],
"xbrltype": "stringItemType"
},
"ahco_GouldsDiscountMedicalLLCMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Represents information pertaining to Gould's Discount Medical, LLC.",
"label": "Goulds Discount Medical L L C [Member]",
"terseLabel": "Gould's"
}
}
},
"localname": "GouldsDiscountMedicalLLCMember",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails"
],
"xbrltype": "domainItemType"
},
"ahco_GovernmentPayorMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Represents government payor.",
"label": "Government Payor [Member]",
"terseLabel": "Government payor"
}
}
},
"localname": "GovernmentPayorMember",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureRevenueRecognitionAndAccountsReceivableDetails"
],
"xbrltype": "domainItemType"
},
"ahco_HealthCareHomeMedicalEquipmentMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Information pertaining to home medical equipment products and services.",
"label": "Health Care Home Medical Equipment [Member]",
"terseLabel": "HME"
}
}
},
"localname": "HealthCareHomeMedicalEquipmentMember",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureRevenueRecognitionAndAccountsReceivableDetails"
],
"xbrltype": "domainItemType"
},
"ahco_HealthCareRespiratoryServicesMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Information pertaining to respiratory services.",
"label": "Health Care Respiratory Services [Member]",
"terseLabel": "Respiratory"
}
}
},
"localname": "HealthCareRespiratoryServicesMember",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureRevenueRecognitionAndAccountsReceivableDetails"
],
"xbrltype": "domainItemType"
},
"ahco_HealthCareSleepTherapyEquipmentSuppliesAndRelatedServicesMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Information pertaining to sleep therapy products and services.",
"label": "Health Care Sleep Therapy Equipment Supplies And Related Services [Member]",
"terseLabel": "Sleep"
}
}
},
"localname": "HealthCareSleepTherapyEquipmentSuppliesAndRelatedServicesMember",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureRevenueRecognitionAndAccountsReceivableDetails"
],
"xbrltype": "domainItemType"
},
"ahco_InitialTermLoanMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Information pertaining to the initial term loan (also called the credit facility term loan).",
"label": "Initial Term Loan [Member]",
"terseLabel": "Initial/credit facility term loan"
}
}
},
"localname": "InitialTermLoanMember",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtDetails",
"http://www.adapthealth.com/role/DisclosureDebtLongTermDebtDetails"
],
"xbrltype": "domainItemType"
},
"ahco_InsurancePayorMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Information pertaining to insurance payor.",
"label": "Insurance Payor [Member]",
"terseLabel": "Insurance Payor [Member]"
}
}
},
"localname": "InsurancePayorMember",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureRevenueRecognitionAndAccountsReceivableDetails"
],
"xbrltype": "domainItemType"
},
"ahco_InterestRateSwapLongTermMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Forward based contracts, classified as non-current, in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
"label": "Interest Rate Swap Long Term [Member]",
"terseLabel": "Interest Rate Swap Long-term [Member]"
}
}
},
"localname": "InterestRateSwapLongTermMember",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureFairValueOfAssetsAndLiabilitiesValuationOfFinancialAssetsAndLiabilitiesDetails"
],
"xbrltype": "domainItemType"
},
"ahco_InterestRateSwapShortTermMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Forward based contracts, classified as current, in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
"label": "Interest Rate Swap Short Term [Member]",
"terseLabel": "Interest Rate Swap Short-term [Member]"
}
}
},
"localname": "InterestRateSwapShortTermMember",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureFairValueOfAssetsAndLiabilitiesValuationOfFinancialAssetsAndLiabilitiesDetails"
],
"xbrltype": "domainItemType"
},
"ahco_LiabilityForPaymentsUnderTaxReceivableAgreement": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The amount of the liability for payments under the tax receivable agreement that have been recognized and recorded in other long-term liabilities.",
"label": "Liability For Payments Under Tax Receivable Agreement",
"terseLabel": "Liability related to TRA"
}
}
},
"localname": "LiabilityForPaymentsUnderTaxReceivableAgreement",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureIncomeTaxesDetails"
],
"xbrltype": "monetaryItemType"
},
"ahco_LiabilityForPaymentsUnderTaxReceivableAgreementIncreaseDueToSharesExchanged": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The increase in the liability for payments under the tax receivable agreement during the period due to additional share exchanges, with a corresponding reduction in additional paid in capital.",
"label": "Liability For Payments Under Tax Receivable Agreement, Increase Due To Shares Exchanged",
"terseLabel": "Increase in liability due to additional exchanges"
}
}
},
"localname": "LiabilityForPaymentsUnderTaxReceivableAgreementIncreaseDueToSharesExchanged",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureIncomeTaxesDetails"
],
"xbrltype": "monetaryItemType"
},
"ahco_MakeWholePremiumFirstPeriodMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "First specified period during which a make-whole premium applies for prepayments of debt. The make-whole premium is equal to a percentage of the total amount of outstanding principal and accrued interest through the date of such prepayment.",
"label": "Make Whole Premium First Period [Member]",
"terseLabel": "Make-whole Premium, First Period [Member]"
}
}
},
"localname": "MakeWholePremiumFirstPeriodMember",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails"
],
"xbrltype": "domainItemType"
},
"ahco_MakeWholePremiumSecondPeriodMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Second specified period during which a make-whole premium applies for prepayments of debt. The make-whole premium is equal to a percentage of the total amount of outstanding principal and accrued interest through the date of such prepayment.",
"label": "Make Whole Premium Second Period [Member]",
"terseLabel": "Make-whole Premium, Second Period [Member]"
}
}
},
"localname": "MakeWholePremiumSecondPeriodMember",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails"
],
"xbrltype": "domainItemType"
},
"ahco_MakeWholePremiumThirdPeriodMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Third specified period during which a make-whole premium applies for prepayments of debt. The make-whole premium is equal to a percentage of the total amount of outstanding principal and accrued interest through the date of such prepayment.",
"label": "Make Whole Premium Third Period [Member]",
"terseLabel": "Make-whole Premium, Third Period [Member]"
}
}
},
"localname": "MakeWholePremiumThirdPeriodMember",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails"
],
"xbrltype": "domainItemType"
},
"ahco_NonEmployeeBoardMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Person serving as non-employee board member.",
"label": "Non Employee Board [Member]",
"terseLabel": "Non-employee board members"
}
}
},
"localname": "NonEmployeeBoardMember",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityRestrictedStockDetails"
],
"xbrltype": "domainItemType"
},
"ahco_NumberOfExecutives": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The number of executives involved.",
"label": "Number Of Executives",
"terseLabel": "Number of executives"
}
}
},
"localname": "NumberOfExecutives",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureRelatedPartyTransactionsDetails"
],
"xbrltype": "integerItemType"
},
"ahco_NumberOfSharesPotentiallyPutOrCalled": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The number of shares potentially put or called per the Put/Call Option and Consent Agreement.",
"label": "Number Of Shares Potentially Put Or Called",
"terseLabel": "Number of shares under Put/Call Option and Consent Agreement"
}
}
},
"localname": "NumberOfSharesPotentiallyPutOrCalled",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails"
],
"xbrltype": "sharesItemType"
},
"ahco_NumberOfSubsidiariesParticipatingInAgreement": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The number of subsidiaries participating in the agreement.",
"label": "Number Of Subsidiaries Participating In Agreement",
"terseLabel": "Number of subsidiaries"
}
}
},
"localname": "NumberOfSubsidiariesParticipatingInAgreement",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureCommitmentsAndContingenciesDetails"
],
"xbrltype": "integerItemType"
},
"ahco_NumberOfTradingDays": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The number of trading days considered in the arrangement.",
"label": "Number Of Trading Days",
"terseLabel": "Number of trading days"
}
}
},
"localname": "NumberOfTradingDays",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityRestrictedStockDetails"
],
"xbrltype": "durationItemType"
},
"ahco_OwnershipInterestNumberOfVotesPerShare": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The number of votes per share of ownership interest in the entity.",
"label": "Ownership Interest, Number Of Votes Per Share",
"terseLabel": "Number of votes per share"
}
}
},
"localname": "OwnershipInterestNumberOfVotesPerShare",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsBusinessCombinationDetails"
],
"xbrltype": "integerItemType"
},
"ahco_PatientCareSolutionsPcsMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Information pertaining to Patient Care Solutions (PCS), a former subsidiary of McKesson Corporation.",
"label": "Patient Care Solutions Pcs [Member]",
"terseLabel": "Patient Care Solutions (PCS) [Member]"
}
}
},
"localname": "PatientCareSolutionsPcsMember",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails"
],
"xbrltype": "domainItemType"
},
"ahco_PatientMedicalEquipmentMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "This member stands for patient medical equipment.",
"label": "Patient Medical Equipment [Member]",
"terseLabel": "Patient medical equipment"
}
}
},
"localname": "PatientMedicalEquipmentMember",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureEquipmentAndOtherFixedAssetsDetails"
],
"xbrltype": "domainItemType"
},
"ahco_PatientPayorMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Represents patient payor.",
"label": "Patient Payor [Member]",
"terseLabel": "Patient payor"
}
}
},
"localname": "PatientPayorMember",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureRevenueRecognitionAndAccountsReceivableDetails"
],
"xbrltype": "domainItemType"
},
"ahco_PaymentForContingentConsiderationLiability": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cash outflow after business combination to settle contingent consideration liability exceeding amount recognized at acquisition date. Includes amounts classified as operating and finance activities.",
"label": "Payment For Contingent Consideration Liability",
"negatedLabel": "Payments"
}
}
},
"localname": "PaymentForContingentConsiderationLiability",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureFairValueContingentConsiderationDetails"
],
"xbrltype": "monetaryItemType"
},
"ahco_PaymentOfDeferredPurchasePriceInAcquisition": {
"auth_ref": [
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows": {
"order": 13.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The cash outflow for the payment of deferred purchase price related to an acquisition.",
"label": "Payment Of Deferred Purchase Price In Acquisition",
"negatedLabel": "Payment of deferred purchase price in connection with an acquisition"
}
}
},
"localname": "PaymentOfDeferredPurchasePriceInAcquisition",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"ahco_PeriodStartingOnClosingDateAndEndingOnSeventhAnniversaryMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Represents the period starting on the closing date and ending on the seventh anniversary.",
"label": "Period Starting On Closing Date And Ending On Seventh Anniversary [Member]",
"terseLabel": "Period starting on the closing date and ending on the seventh anniversary"
}
}
},
"localname": "PeriodStartingOnClosingDateAndEndingOnSeventhAnniversaryMember",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails"
],
"xbrltype": "domainItemType"
},
"ahco_PeriodStartingOnDayAfterSeventhAnniversaryOfClosingDateAndEndingOnMaturityDateMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Represents the period starting on the day after the seventh anniversary of the closing date and ending on the maturity date.",
"label": "Period Starting On Day After Seventh Anniversary Of Closing Date And Ending On Maturity Date [Member]",
"terseLabel": "Period starting on the day after the seventh anniversary of the closing date and ending on the maturity date"
}
}
},
"localname": "PeriodStartingOnDayAfterSeventhAnniversaryOfClosingDateAndEndingOnMaturityDateMember",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails"
],
"xbrltype": "domainItemType"
},
"ahco_PinnacleMedicalSolutionsInc.Member": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Information pertaining to Pinnacle Medical Solutions, Inc.",
"label": "Pinnacle Medical Solutions Inc. [Member]",
"terseLabel": "Pinnacle Medical Solutions, Inc. [Member]"
}
}
},
"localname": "PinnacleMedicalSolutionsInc.Member",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSubsequentEventsFinancingAndAcquisitionsDetails"
],
"xbrltype": "domainItemType"
},
"ahco_PreferredClassB1Member": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Outstanding nonredeemable preferred class B-1 stock or outstanding preferred class B-1 stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
"label": "Preferred Class B1 [Member]",
"terseLabel": "Series B-1 Preferred Stock"
}
}
},
"localname": "PreferredClassB1Member",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails"
],
"xbrltype": "domainItemType"
},
"ahco_PreferredClassB2Member": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Outstanding nonredeemable preferred class B-2 stock or outstanding preferred class B-2 stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
"label": "Preferred Class B2 [Member]",
"terseLabel": "Series B-2 Preferred Stock"
}
}
},
"localname": "PreferredClassB2Member",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails"
],
"xbrltype": "domainItemType"
},
"ahco_PreferredStockConversionMaximumPercentageOfOutstandingCommonStock": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Preferred stock may not be converted into common stock if, following such conversion, the number of share of common stock exceeds this percentage of the outstanding common stock.",
"label": "Preferred Stock Conversion, Maximum Percentage Of Outstanding Common Stock",
"terseLabel": "Preferred stock conversion, ceiling as a percent of outstanding common stock"
}
}
},
"localname": "PreferredStockConversionMaximumPercentageOfOutstandingCommonStock",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails"
],
"xbrltype": "pureItemType"
},
"ahco_PromissoryNoteFromMembersInterestMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Information pertaining to the promissory note issued to investor for members' interest.",
"label": "Promissory Note From Members Interest [Member]",
"terseLabel": "Promissory Note From Members Interest [Member]"
}
}
},
"localname": "PromissoryNoteFromMembersInterestMember",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails"
],
"xbrltype": "domainItemType"
},
"ahco_PromissoryNoteWithInvestorMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Information pertaining to the promissory note issued to investor at recapitalization.",
"label": "Promissory Note With Investor [Member]",
"terseLabel": "Promissory Note With Investor [Member]"
}
}
},
"localname": "PromissoryNoteWithInvestorMember",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails"
],
"xbrltype": "domainItemType"
},
"ahco_PublicOfferingMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "An offering of the entity's stock for sale to the public at a time subsequent to the initial public offering.",
"label": "Public Offering [Member]",
"terseLabel": "Public Offering [Member]"
}
}
},
"localname": "PublicOfferingMember",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitParenthetical"
],
"xbrltype": "domainItemType"
},
"ahco_PublicWarrantsNumberRedeemed": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The number of public warrants redeemed for shares of the entity's stock during the period.",
"label": "Public Warrants, Number Exercised",
"terseLabel": "Public warrants, number redeemed"
}
}
},
"localname": "PublicWarrantsNumberRedeemed",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails"
],
"xbrltype": "sharesItemType"
},
"ahco_PutCallOptionAndConsentAgreementNumberOfSharesComprisingConsiderationUnit": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The number of shares of stock comprising a Consideration Unit per the terms of the Put/Call Option and Consent Agreement.",
"label": "Put Call Option And Consent Agreement, Number Of Shares Comprising Consideration Unit",
"terseLabel": "Number of shares in Consideration Unit"
}
}
},
"localname": "PutCallOptionAndConsentAgreementNumberOfSharesComprisingConsiderationUnit",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails"
],
"xbrltype": "sharesItemType"
},
"ahco_RetentionProgramAwardsMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Information pertaining to awards made under a retention program.",
"label": "Retention Program Awards [Member]",
"terseLabel": "Retention Program Awards [Member]"
}
}
},
"localname": "RetentionProgramAwardsMember",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityCommonStockAwardsDetails"
],
"xbrltype": "domainItemType"
},
"ahco_RevolverLetterOfCreditSublimitMaturingJuly2025.Member": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Information pertaining to the revolver letter of credit sublimit, maturing July 2025.",
"label": "Revolver Letter Of Credit Sublimit Maturing July2025. [Member]",
"terseLabel": "Revolver Letter Of Credit Sublimit Maturing July 2025. [Member]"
}
}
},
"localname": "RevolverLetterOfCreditSublimitMaturingJuly2025.Member",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtDetails",
"http://www.adapthealth.com/role/DisclosureDebtLongTermDebtDetails"
],
"xbrltype": "domainItemType"
},
"ahco_RevolvingCreditLoansMaturingJuly2025Member": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Information pertaining to revolving credit loans maturing in July 2025.",
"label": "Revolving Credit Loans Maturing July2025 [Member]",
"terseLabel": "Revolving Credit Loans Maturing July 2025 [Member]"
}
}
},
"localname": "RevolvingCreditLoansMaturingJuly2025Member",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtDetails",
"http://www.adapthealth.com/role/DisclosureDebtLongTermDebtDetails"
],
"xbrltype": "domainItemType"
},
"ahco_ScheduleOfBusinessAcquisitionConsiderationTableTextBlock": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular presentation of consideration paid in the business acquisition.",
"label": "Schedule Of Business Acquisition Consideration [Table Text Block]",
"terseLabel": "Summary of consideration"
}
}
},
"localname": "ScheduleOfBusinessAcquisitionConsiderationTableTextBlock",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsTables"
],
"xbrltype": "textBlockItemType"
},
"ahco_ScheduleOfUsefulLivesOfIdentifiableIntangibleAssetsTableTextBlock": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular presentation of useful lives, at acquisition, of identifiable finite-lived intangible assets.",
"label": "Schedule Of Useful Lives Of Identifiable Intangible Assets [Table Text Block]",
"terseLabel": "Schedule of useful lives of acquired intangible assets"
}
}
},
"localname": "ScheduleOfUsefulLivesOfIdentifiableIntangibleAssetsTableTextBlock",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureGeneralInformationTables"
],
"xbrltype": "textBlockItemType"
},
"ahco_SeniorNotes6.125PercentDue2028Member": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Information pertaining to Senior Notes 6.125%, due in 2028.",
"label": "Senior Notes6.125 Percent Due2028 [Member]",
"terseLabel": "Senior Notes 6.125 Percent Due 2028 [Member]"
}
}
},
"localname": "SeniorNotes6.125PercentDue2028Member",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtDetails",
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails"
],
"xbrltype": "domainItemType"
},
"ahco_ShareholderSOfAdaptHealthHoldingsLlcMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Represents information relating to Shareholders of Adapt Health Holdings LLC",
"label": "Shareholder S Of Adapt Health Holdings Llc [Member]",
"terseLabel": "Shareholders of Adapt Health Holdings LLC"
}
}
},
"localname": "ShareholderSOfAdaptHealthHoldingsLlcMember",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsBusinessCombinationDetails"
],
"xbrltype": "domainItemType"
},
"ahco_SharesCallAgreementPrice": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The price at which shares are called under the Put/Call Option and Consent Agreement.",
"label": "Shares Call Agreement, Price",
"terseLabel": "Sales price (in dollars per share)"
}
}
},
"localname": "SharesCallAgreementPrice",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails"
],
"xbrltype": "perShareItemType"
},
"ahco_SharesIssuedDuringPeriodCommonSharesExchangedForPreferredShares": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Number of shares of stock issued (redeemed) during the period in an exchange of common stock for preferred stock.",
"label": "Shares Issued During Period Common Shares Exchanged For Preferred Shares",
"terseLabel": "Exchange of Class A Common Stock for Series B-1 Preferred Stock (in shares)"
}
}
},
"localname": "SharesIssuedDuringPeriodCommonSharesExchangedForPreferredShares",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit"
],
"xbrltype": "sharesItemType"
},
"ahco_SharesIssuedDuringPeriodPreferredSharesExchangedForCommonShares": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Number of shares of stock issued (redeemed) during the period in an exchange of preferred stock for common stock.",
"label": "Shares Issued During Period Preferred Shares Exchanged For Common Shares",
"terseLabel": "Exchange of Series A Preferred Stock for Class A Common Stock (in shares)"
}
}
},
"localname": "SharesIssuedDuringPeriodPreferredSharesExchangedForCommonShares",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails"
],
"xbrltype": "sharesItemType"
},
"ahco_SharesIssuedDuringPeriodPreferredSharesExchangedForPreferredStock": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Number of shares of stock issued (redeemed) during the period in an exchange of preferred stock for preferred stock.",
"label": "Shares Issued During Period Preferred Shares Exchanged For Preferred Stock",
"terseLabel": "Exchange of Series B-2 Preferred Stock for Series B-1 Preferred Stock (in shares)"
}
}
},
"localname": "SharesIssuedDuringPeriodPreferredSharesExchangedForPreferredStock",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails"
],
"xbrltype": "sharesItemType"
},
"ahco_SharesIssuedDuringPeriodSharesSharesExchanged": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Number of stock issued during the period for exchange of common stock into different class.",
"label": "Shares Issued During Period, Shares, Shares Exchanged",
"terseLabel": "Exchange of Class B Common Stock for Class A Common Stock (in shares)"
}
}
},
"localname": "SharesIssuedDuringPeriodSharesSharesExchanged",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit"
],
"xbrltype": "sharesItemType"
},
"ahco_SharesIssuedDuringPeriodValueCommonSharesExchangedForPreferredShares": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Equity impact of the value of stock issued (redeemed) during the period in an exchange of common for preferred stock.",
"label": "Shares Issued During Period Value Common Shares Exchanged For Preferred Shares",
"terseLabel": "Exchange of Class A Common Stock for Series B-1 Preferred Stock"
}
}
},
"localname": "SharesIssuedDuringPeriodValueCommonSharesExchangedForPreferredShares",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit"
],
"xbrltype": "monetaryItemType"
},
"ahco_SharesIssuedDuringPeriodValueSharesExchanged": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Equity impact of the value of stock issued during the period for exchange of common stock into different class.",
"label": "Shares Issued During Period, Value, Shares Exchanged",
"terseLabel": "Exchange of Class B Common Stock for Class A Common Stock"
}
}
},
"localname": "SharesIssuedDuringPeriodValueSharesExchanged",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit"
],
"xbrltype": "monetaryItemType"
},
"ahco_SharesPutAgreementMinimumFixedPrice": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The minimum fixed price of shares subject to put under the Put/Call Option and Consent Agreement.",
"label": "Shares Put Agreement, Minimum Fixed Price",
"terseLabel": "Minimum fixed purchase price (in dollars per share)"
}
}
},
"localname": "SharesPutAgreementMinimumFixedPrice",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails"
],
"xbrltype": "perShareItemType"
},
"ahco_SharesPutAgreementMinimumVariablePrice": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The minimum price, as a percentage of the 30-day volume weighted average price per share, of shares subject to put under the Put/Call Option and Consent Agreement.",
"label": "Shares Put Agreement Minimum Variable Price",
"terseLabel": "Minimum variable price, as percent of weighted average price"
}
}
},
"localname": "SharesPutAgreementMinimumVariablePrice",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails"
],
"xbrltype": "percentItemType"
},
"ahco_SignificantAcquisitionsIn2019Member": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Represents information about Significant Acquisitions In 2019.",
"label": "Significant Acquisitions In2019 [Member]",
"terseLabel": "Significant acquisitions in 2019"
}
}
},
"localname": "SignificantAcquisitionsIn2019Member",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails",
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsTables"
],
"xbrltype": "domainItemType"
},
"ahco_SignificantAcquisitionsIn2020Member": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Information pertaining to significant acquisitions during 2020.",
"label": "Significant Acquisitions In2020 [Member]",
"terseLabel": "Significant Acquisitions In 2020 [Member]"
}
}
},
"localname": "SignificantAcquisitionsIn2020Member",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails",
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsTables"
],
"xbrltype": "domainItemType"
},
"ahco_SignificantTransactionsAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "n/a",
"label": "Significant Transactions [Abstract]"
}
}
},
"localname": "SignificantTransactionsAbstract",
"nsuri": "http://www.adapthealth.com/20200930",
"xbrltype": "stringItemType"
},
"ahco_SignificantTransactionsTextBlock": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The disclosure of significant transactions during the period.",
"label": "Significant Transactions [Text Block]",
"terseLabel": "Significant Transactions"
}
}
},
"localname": "SignificantTransactionsTextBlock",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactions"
],
"xbrltype": "textBlockItemType"
},
"ahco_SingleEmployeeMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Information pertaining to a single employee to whom was granted a share-based compensation award.",
"label": "Single Employee [Member]",
"terseLabel": "Single Employee [Member]"
}
}
},
"localname": "SingleEmployeeMember",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityRestrictedStockDetails"
],
"xbrltype": "domainItemType"
},
"ahco_SleepmedTherapiesIncMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Represents information pertaining to SleepMed Therapies, Inc.",
"label": "Sleepmed Therapies Inc [Member]",
"terseLabel": "SleepMed"
}
}
},
"localname": "SleepmedTherapiesIncMember",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails"
],
"xbrltype": "domainItemType"
},
"ahco_SolaraMedicalSuppliesLlcMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Information pertaining to Solara Medical Supplies, LLC.",
"label": "Solara Medical Supplies Llc [Member]",
"terseLabel": "Solara Medical Supplies, LLC [Member]"
}
}
},
"localname": "SolaraMedicalSuppliesLlcMember",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails"
],
"xbrltype": "domainItemType"
},
"ahco_StockIncentivePlan2019Member": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Represents element information pertaining to Stock Incentive Plan 2019.",
"label": "Stock Incentive Plan2019 [Member]",
"terseLabel": "2019 Incentive Plan"
}
}
},
"localname": "StockIncentivePlan2019Member",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityEquityBasedCompensationDetails",
"http://www.adapthealth.com/role/DisclosureStockholdersEquityIncentiveUnitsDetails"
],
"xbrltype": "domainItemType"
},
"ahco_SummaryOfResultsOfBusinessAcquiredTableTextBlock": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of results of business acquired during the period.",
"label": "Summary Of Results Of Business Acquired [Table Text Block]",
"terseLabel": "Summary of results of business acquired"
}
}
},
"localname": "SummaryOfResultsOfBusinessAcquiredTableTextBlock",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsTables"
],
"xbrltype": "textBlockItemType"
},
"ahco_SuppliesToHomeMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Information pertaining to supplies to home products and services.",
"label": "Supplies To Home [Member]",
"terseLabel": "Supplies to the home"
}
}
},
"localname": "SuppliesToHomeMember",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureRevenueRecognitionAndAccountsReceivableDetails"
],
"xbrltype": "domainItemType"
},
"ahco_TaxReceivableAgreementPercentageSavingsPayable": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The percentage of net cash savings, if any, in U.S. federal, state and local income tax that is payable under the tax receivable agreement.",
"label": "Tax Receivable Agreement Percentage Savings Payable",
"terseLabel": "Tax Receivable Agreement, payout percentage"
}
}
},
"localname": "TaxReceivableAgreementPercentageSavingsPayable",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureIncomeTaxesDetails"
],
"xbrltype": "percentItemType"
},
"ahco_TermLoanMaturingJuly2025Member": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Information pertaining to term loan maturing July 2025.",
"label": "Term Loan Maturing July2025 [Member]",
"terseLabel": "Term Loan Maturing July 2025 [Member]"
}
}
},
"localname": "TermLoanMaturingJuly2025Member",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtDetails",
"http://www.adapthealth.com/role/DisclosureDebtLongTermDebtDetails"
],
"xbrltype": "domainItemType"
},
"ahco_TwelveMonthLondonInterBankOfferedRateMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Represents the information pertaining to twelve-month London inter bank offered rate.",
"label": "Twelve Month London Inter Bank Offered Rate [Member]",
"terseLabel": "Twelve-month LIBOR"
}
}
},
"localname": "TwelveMonthLondonInterBankOfferedRateMember",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails"
],
"xbrltype": "domainItemType"
},
"ahco_VariousEmployeesMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Information pertaining to a group of employees to whom was granted a share-based compensation award.",
"label": "Various Employees [Member]",
"terseLabel": "Various Employees [Member]"
}
}
},
"localname": "VariousEmployeesMember",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityRestrictedStockDetails"
],
"xbrltype": "domainItemType"
},
"ahco_VendorTwoMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Represents the information pertaining to vendor two.",
"label": "Vendor Two [Member]",
"terseLabel": "Vendor two"
}
}
},
"localname": "VendorTwoMember",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureRelatedPartyTransactionsDetails"
],
"xbrltype": "domainItemType"
},
"ahco_WarrantCashlessExerciseShareEquivalentOfExercisePrice": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The number of shares deemed surrendered in lieu of exercise price in cashless exercise of warrant.",
"label": "Warrant Cashless Exercise, Share Equivalent Of Exercise Price"
}
}
},
"localname": "WarrantCashlessExerciseShareEquivalentOfExercisePrice",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails"
],
"xbrltype": "sharesItemType"
},
"ahco_WarrantCashlessExerciseSharePriceFactor": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The average last sale price of common stock for ten trading days ending on the third trading day of the redemption notice, used as a factor to determine the share equivalent of the exercise price in the cashless exercise of warrants.",
"label": "Warrant Cashless Exercise, Share Price Factor"
}
}
},
"localname": "WarrantCashlessExerciseSharePriceFactor",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails"
],
"xbrltype": "perShareItemType"
},
"ahco_WarrantRedemptionPrice": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The amount per warrant at which they are redeemed by the issuer.",
"label": "Warrant Redemption Price"
}
}
},
"localname": "WarrantRedemptionPrice",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails"
],
"xbrltype": "perShareItemType"
},
"ahco_WarrantRedemptionStockPriceTrigger": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Price of the entity's common stock which would be required to be attained for the redemption feature of the warrants to become effective.",
"label": "Warrant Redemption, Stock Price Trigger"
}
}
},
"localname": "WarrantRedemptionStockPriceTrigger",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails"
],
"xbrltype": "perShareItemType"
},
"ahco_WarrantRedemptionThresholdConsecutiveTradingDays": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Threshold period of specified consecutive trading days within which common stock price must exceed threshold price for specified number of trading days to trigger redemption feature.",
"label": "Warrant Redemption, Threshold Consecutive Trading Days"
}
}
},
"localname": "WarrantRedemptionThresholdConsecutiveTradingDays",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails"
],
"xbrltype": "integerItemType"
},
"ahco_WarrantRedemptionThresholdTradingDays": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Threshold number of specified trading days that common stock price must exceed threshold within a specified consecutive trading period to trigger redemption feature.",
"label": "Warrant Redemption, Threshold Trading Days"
}
}
},
"localname": "WarrantRedemptionThresholdTradingDays",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails"
],
"xbrltype": "integerItemType"
},
"ahco_WarrantsExercisedForCashNumberOfWarrants": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The number of warrants exercised for cash during the period.",
"label": "Warrants Exercised For Cash, Number Of Warrants",
"terseLabel": "Warrants exercised for cash, number exercised"
}
}
},
"localname": "WarrantsExercisedForCashNumberOfWarrants",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails"
],
"xbrltype": "sharesItemType"
},
"ahco_WarrantsExercisedInCashlessTransactionNumberOfWarrants": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The number of warrants exercised in a cashless transaction.",
"label": "Warrants Exercised In Cashless Transaction, Number Of Warrants",
"terseLabel": "Warrants exercised in cashless transaction, number exercised"
}
}
},
"localname": "WarrantsExercisedInCashlessTransactionNumberOfWarrants",
"nsuri": "http://www.adapthealth.com/20200930",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails"
],
"xbrltype": "sharesItemType"
},
"dei_AmendmentFlag": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
"label": "Amendment Flag"
}
}
},
"localname": "AmendmentFlag",
"nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "booleanItemType"
},
"dei_CityAreaCode": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Area code of city",
"label": "City Area Code"
}
}
},
"localname": "CityAreaCode",
"nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "normalizedStringItemType"
},
"dei_CoverAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Cover page.",
"label": "Document and Entity Information"
}
}
},
"localname": "CoverAbstract",
"nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
"xbrltype": "stringItemType"
},
"dei_CurrentFiscalYearEndDate": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "End date of current fiscal year in the format --MM-DD.",
"label": "Current Fiscal Year End Date"
}
}
},
"localname": "CurrentFiscalYearEndDate",
"nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "gMonthDayItemType"
},
"dei_DocumentFiscalPeriodFocus": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
"label": "Document Fiscal Period Focus"
}
}
},
"localname": "DocumentFiscalPeriodFocus",
"nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "fiscalPeriodItemType"
},
"dei_DocumentFiscalYearFocus": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
"label": "Document Fiscal Year Focus"
}
}
},
"localname": "DocumentFiscalYearFocus",
"nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "gYearItemType"
},
"dei_DocumentInformationLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Document Information [Line Items]"
}
}
},
"localname": "DocumentInformationLineItems",
"nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "stringItemType"
},
"dei_DocumentInformationTable": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
"label": "Document Information [Table]"
}
}
},
"localname": "DocumentInformationTable",
"nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "stringItemType"
},
"dei_DocumentPeriodEndDate": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
"label": "Document Period End Date"
}
}
},
"localname": "DocumentPeriodEndDate",
"nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "dateItemType"
},
"dei_DocumentQuarterlyReport": {
"auth_ref": [
"r531"
],
"lang": {
"en-US": {
"role": {
"documentation": "Boolean flag that is true only for a form used as an quarterly report.",
"label": "Document Quarterly Report"
}
}
},
"localname": "DocumentQuarterlyReport",
"nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "booleanItemType"
},
"dei_DocumentTransitionReport": {
"auth_ref": [
"r532"
],
"lang": {
"en-US": {
"role": {
"documentation": "Boolean flag that is true only for a form used as a transition report.",
"label": "Document Transition Report"
}
}
},
"localname": "DocumentTransitionReport",
"nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "booleanItemType"
},
"dei_DocumentType": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
"label": "Document Type"
}
}
},
"localname": "DocumentType",
"nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "submissionTypeItemType"
},
"dei_EntityAddressAddressLine1": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Address Line 1 such as Attn, Building Name, Street Name",
"label": "Entity Address, Address Line One"
}
}
},
"localname": "EntityAddressAddressLine1",
"nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "normalizedStringItemType"
},
"dei_EntityAddressAddressLine2": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Address Line 2 such as Street or Suite number",
"label": "Entity Address, Address Line Two"
}
}
},
"localname": "EntityAddressAddressLine2",
"nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "normalizedStringItemType"
},
"dei_EntityAddressCityOrTown": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Name of the City or Town",
"label": "Entity Address, City or Town"
}
}
},
"localname": "EntityAddressCityOrTown",
"nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "normalizedStringItemType"
},
"dei_EntityAddressPostalZipCode": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Code for the postal or zip code",
"label": "Entity Address, Postal Zip Code"
}
}
},
"localname": "EntityAddressPostalZipCode",
"nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "normalizedStringItemType"
},
"dei_EntityAddressStateOrProvince": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Name of the state or province.",
"label": "Entity Address, State or Province"
}
}
},
"localname": "EntityAddressStateOrProvince",
"nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "stateOrProvinceItemType"
},
"dei_EntityCentralIndexKey": {
"auth_ref": [
"r533"
],
"lang": {
"en-US": {
"role": {
"documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
"label": "Entity Central Index Key"
}
}
},
"localname": "EntityCentralIndexKey",
"nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "centralIndexKeyItemType"
},
"dei_EntityCommonStockSharesOutstanding": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
"label": "Entity Common Stock, Shares Outstanding",
"terseLabel": "Entity Common Stock, Shares Outstanding"
}
}
},
"localname": "EntityCommonStockSharesOutstanding",
"nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "sharesItemType"
},
"dei_EntityCurrentReportingStatus": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
"label": "Entity Current Reporting Status"
}
}
},
"localname": "EntityCurrentReportingStatus",
"nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "yesNoItemType"
},
"dei_EntityDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
"label": "Entity [Domain]",
"terseLabel": "Entity [Domain]"
}
}
},
"localname": "EntityDomain",
"nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsBusinessCombinationDetails"
],
"xbrltype": "domainItemType"
},
"dei_EntityEmergingGrowthCompany": {
"auth_ref": [
"r533"
],
"lang": {
"en-US": {
"role": {
"documentation": "Indicate if registrant meets the emerging growth company criteria.",
"label": "Entity Emerging Growth Company"
}
}
},
"localname": "EntityEmergingGrowthCompany",
"nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "booleanItemType"
},
"dei_EntityExTransitionPeriod": {
"auth_ref": [
"r535"
],
"lang": {
"en-US": {
"role": {
"documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
"label": "Entity Ex Transition Period"
}
}
},
"localname": "EntityExTransitionPeriod",
"nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "booleanItemType"
},
"dei_EntityFileNumber": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
"label": "Entity File Number"
}
}
},
"localname": "EntityFileNumber",
"nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "fileNumberItemType"
},
"dei_EntityFilerCategory": {
"auth_ref": [
"r533"
],
"lang": {
"en-US": {
"role": {
"documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
"label": "Entity Filer Category"
}
}
},
"localname": "EntityFilerCategory",
"nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "filerCategoryItemType"
},
"dei_EntityIncorporationStateCountryCode": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Two-character EDGAR code representing the state or country of incorporation.",
"label": "Entity Incorporation, State or Country Code"
}
}
},
"localname": "EntityIncorporationStateCountryCode",
"nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "edgarStateCountryItemType"
},
"dei_EntityInteractiveDataCurrent": {
"auth_ref": [
"r534"
],
"lang": {
"en-US": {
"role": {
"documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
"label": "Entity Interactive Data Current"
}
}
},
"localname": "EntityInteractiveDataCurrent",
"nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "yesNoItemType"
},
"dei_EntityRegistrantName": {
"auth_ref": [
"r533"
],
"lang": {
"en-US": {
"role": {
"documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
"label": "Entity Registrant Name"
}
}
},
"localname": "EntityRegistrantName",
"nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "normalizedStringItemType"
},
"dei_EntityShellCompany": {
"auth_ref": [
"r533"
],
"lang": {
"en-US": {
"role": {
"documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
"label": "Entity Shell Company"
}
}
},
"localname": "EntityShellCompany",
"nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "booleanItemType"
},
"dei_EntitySmallBusiness": {
"auth_ref": [
"r533"
],
"lang": {
"en-US": {
"role": {
"documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
"label": "Entity Small Business"
}
}
},
"localname": "EntitySmallBusiness",
"nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "booleanItemType"
},
"dei_EntityTaxIdentificationNumber": {
"auth_ref": [
"r533"
],
"lang": {
"en-US": {
"role": {
"documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
"label": "Entity Tax Identification Number"
}
}
},
"localname": "EntityTaxIdentificationNumber",
"nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "employerIdItemType"
},
"dei_LegalEntityAxis": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The set of legal entities associated with a report.",
"label": "Legal Entity [Axis]"
}
}
},
"localname": "LegalEntityAxis",
"nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsBusinessCombinationDetails"
],
"xbrltype": "stringItemType"
},
"dei_LocalPhoneNumber": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Local phone number for entity.",
"label": "Local Phone Number"
}
}
},
"localname": "LocalPhoneNumber",
"nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "normalizedStringItemType"
},
"dei_Security12bTitle": {
"auth_ref": [
"r529"
],
"lang": {
"en-US": {
"role": {
"documentation": "Title of a 12(b) registered security.",
"label": "Title of 12(b) Security"
}
}
},
"localname": "Security12bTitle",
"nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "securityTitleItemType"
},
"dei_SecurityExchangeName": {
"auth_ref": [
"r530"
],
"lang": {
"en-US": {
"role": {
"documentation": "Name of the Exchange on which a security is registered.",
"label": "Security Exchange Name"
}
}
},
"localname": "SecurityExchangeName",
"nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "edgarExchangeCodeItemType"
},
"dei_TradingSymbol": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Trading symbol of an instrument as listed on an exchange.",
"label": "Trading Symbol"
}
}
},
"localname": "TradingSymbol",
"nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DocumentDocumentAndEntityInformation"
],
"xbrltype": "tradingSymbolItemType"
},
"srt_MajorCustomersAxis": {
"auth_ref": [
"r188",
"r259",
"r264",
"r518"
],
"lang": {
"en-US": {
"role": {
"label": "Customer [Axis]"
}
}
},
"localname": "MajorCustomersAxis",
"nsuri": "http://fasb.org/srt/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureRevenueRecognitionAndAccountsReceivableDetails"
],
"xbrltype": "stringItemType"
},
"srt_MaximumMember": {
"auth_ref": [
"r281",
"r284",
"r455",
"r456",
"r457",
"r458",
"r459",
"r460",
"r461",
"r516",
"r519"
],
"lang": {
"en-US": {
"role": {
"label": "Maximum [Member]",
"terseLabel": "Maximum"
}
}
},
"localname": "MaximumMember",
"nsuri": "http://fasb.org/srt/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtLongTermDebtDetails",
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails",
"http://www.adapthealth.com/role/DisclosureGeneralInformationDetails",
"http://www.adapthealth.com/role/DisclosureLeasesCapitalLeasesDetails"
],
"xbrltype": "domainItemType"
},
"srt_MinimumMember": {
"auth_ref": [
"r281",
"r284",
"r455",
"r456",
"r457",
"r458",
"r459",
"r460",
"r461",
"r516",
"r519"
],
"lang": {
"en-US": {
"role": {
"label": "Minimum [Member]",
"terseLabel": "Minimum"
}
}
},
"localname": "MinimumMember",
"nsuri": "http://fasb.org/srt/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtLongTermDebtDetails",
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails",
"http://www.adapthealth.com/role/DisclosureGeneralInformationDetails"
],
"xbrltype": "domainItemType"
},
"srt_NameOfMajorCustomerDomain": {
"auth_ref": [
"r188",
"r259",
"r264",
"r518"
],
"lang": {
"en-US": {
"role": {
"label": "Name Of Major Customer [Domain]",
"terseLabel": "Customer [Domain]"
}
}
},
"localname": "NameOfMajorCustomerDomain",
"nsuri": "http://fasb.org/srt/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureRevenueRecognitionAndAccountsReceivableDetails"
],
"xbrltype": "domainItemType"
},
"srt_OwnershipAxis": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Ownership [Axis]"
}
}
},
"localname": "OwnershipAxis",
"nsuri": "http://fasb.org/srt/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsBusinessCombinationDetails"
],
"xbrltype": "stringItemType"
},
"srt_OwnershipDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Ownership [Domain]",
"terseLabel": "Ownership [Domain]"
}
}
},
"localname": "OwnershipDomain",
"nsuri": "http://fasb.org/srt/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsBusinessCombinationDetails"
],
"xbrltype": "domainItemType"
},
"srt_ProductOrServiceAxis": {
"auth_ref": [
"r186",
"r259",
"r262",
"r462",
"r515",
"r517"
],
"lang": {
"en-US": {
"role": {
"label": "Product and Service [Axis]"
}
}
},
"localname": "ProductOrServiceAxis",
"nsuri": "http://fasb.org/srt/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureRevenueRecognitionAndAccountsReceivableDetails"
],
"xbrltype": "stringItemType"
},
"srt_ProductsAndServicesDomain": {
"auth_ref": [
"r186",
"r259",
"r262",
"r462",
"r515",
"r517"
],
"lang": {
"en-US": {
"role": {
"label": "Products And Services [Domain]",
"terseLabel": "Product and Service [Domain]"
}
}
},
"localname": "ProductsAndServicesDomain",
"nsuri": "http://fasb.org/srt/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureRevenueRecognitionAndAccountsReceivableDetails"
],
"xbrltype": "domainItemType"
},
"srt_RangeAxis": {
"auth_ref": [
"r270",
"r281",
"r284",
"r455",
"r456",
"r457",
"r458",
"r459",
"r460",
"r461",
"r516",
"r519"
],
"lang": {
"en-US": {
"role": {
"label": "Range [Axis]"
}
}
},
"localname": "RangeAxis",
"nsuri": "http://fasb.org/srt/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtLongTermDebtDetails",
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails",
"http://www.adapthealth.com/role/DisclosureGeneralInformationDetails",
"http://www.adapthealth.com/role/DisclosureLeasesCapitalLeasesDetails"
],
"xbrltype": "stringItemType"
},
"srt_RangeMember": {
"auth_ref": [
"r270",
"r281",
"r284",
"r455",
"r456",
"r457",
"r458",
"r459",
"r460",
"r461",
"r516",
"r519"
],
"lang": {
"en-US": {
"role": {
"label": "Range [Member]",
"terseLabel": "Range [Domain]"
}
}
},
"localname": "RangeMember",
"nsuri": "http://fasb.org/srt/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtLongTermDebtDetails",
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails",
"http://www.adapthealth.com/role/DisclosureGeneralInformationDetails",
"http://www.adapthealth.com/role/DisclosureLeasesCapitalLeasesDetails"
],
"xbrltype": "domainItemType"
},
"srt_ScenarioUnspecifiedDomain": {
"auth_ref": [
"r282"
],
"lang": {
"en-US": {
"role": {
"label": "Scenario Unspecified [Domain]",
"terseLabel": "Scenario, Unspecified [Domain]"
}
}
},
"localname": "ScenarioUnspecifiedDomain",
"nsuri": "http://fasb.org/srt/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails"
],
"xbrltype": "domainItemType"
},
"srt_StatementScenarioAxis": {
"auth_ref": [
"r226",
"r282",
"r450"
],
"lang": {
"en-US": {
"role": {
"label": "Scenario [Axis]"
}
}
},
"localname": "StatementScenarioAxis",
"nsuri": "http://fasb.org/srt/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails"
],
"xbrltype": "stringItemType"
},
"srt_TitleOfIndividualAxis": {
"auth_ref": [
"r189",
"r444"
],
"lang": {
"en-US": {
"role": {
"label": "Title of Individual [Axis]"
}
}
},
"localname": "TitleOfIndividualAxis",
"nsuri": "http://fasb.org/srt/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityRestrictedStockDetails"
],
"xbrltype": "stringItemType"
},
"srt_TitleOfIndividualWithRelationshipToEntityDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Title Of Individual With Relationship To Entity [Domain]",
"terseLabel": "Title of Individual [Domain]"
}
}
},
"localname": "TitleOfIndividualWithRelationshipToEntityDomain",
"nsuri": "http://fasb.org/srt/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityRestrictedStockDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_AccountingPoliciesAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Summary of Significant Accounting Policies"
}
}
},
"localname": "AccountingPoliciesAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureGeneralInformationPolicies"
],
"xbrltype": "stringItemType"
},
"us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.",
"label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]",
"terseLabel": "Accounts Payable and Accrued Expenses"
}
}
},
"localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureAccountsPayableAndAccruedExpenses"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
"auth_ref": [
"r31"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets": {
"order": 1.0,
"parentTag": "us-gaap_LiabilitiesCurrent",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
"label": "Accounts Payable and Accrued Liabilities, Current",
"terseLabel": "Accounts payable and accrued expenses",
"verboseLabel": "Accounts payable and accrued expenses"
}
}
},
"localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureAccountsPayableAndAccruedExpensesDetails",
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Accounts Payable and Accrued Expenses"
}
}
},
"localname": "AccountsPayableAndAccruedLiabilitiesCurrentAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.",
"label": "Accounts Payable and Other Accrued Liabilities, Current",
"terseLabel": "Other"
}
}
},
"localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureAccountsPayableAndAccruedExpensesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AccountsPayableCurrent": {
"auth_ref": [
"r29"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
"label": "Accounts Payable, Current",
"terseLabel": "Accounts payable"
}
}
},
"localname": "AccountsPayableCurrent",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureAccountsPayableAndAccruedExpensesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AccountsReceivableNetCurrent": {
"auth_ref": [
"r2",
"r17",
"r190",
"r191"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets": {
"order": 1.0,
"parentTag": "us-gaap_AssetsCurrent",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
"label": "Accounts Receivable, Net, Current",
"terseLabel": "Accounts receivable"
}
}
},
"localname": "AccountsReceivableNetCurrent",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
"auth_ref": [
"r27",
"r218"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureEquipmentAndOtherFixedAssetsDetails": {
"order": 1.0,
"parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
"label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
"negatedLabel": "Less accumulated depreciation"
}
}
},
"localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureEquipmentAndOtherFixedAssetsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
"auth_ref": [
"r20",
"r50",
"r51",
"r52",
"r501",
"r524",
"r525"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets": {
"order": 1.0,
"parentTag": "us-gaap_StockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
"label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
"terseLabel": "Accumulated other comprehensive income"
}
}
},
"localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AdditionalPaidInCapital": {
"auth_ref": [
"r18",
"r312"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets": {
"order": 2.0,
"parentTag": "us-gaap_StockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.",
"label": "Additional Paid in Capital",
"terseLabel": "Additional paid-in capital"
}
}
},
"localname": "AdditionalPaidInCapital",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AdditionalPaidInCapitalMember": {
"auth_ref": [
"r107",
"r108",
"r109",
"r309",
"r310",
"r311"
],
"lang": {
"en-US": {
"role": {
"documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
"label": "Additional Paid In Capital [Member]",
"terseLabel": "Additional paid-in capital"
}
}
},
"localname": "AdditionalPaidInCapitalMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit"
],
"xbrltype": "domainItemType"
},
"us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of other increase (decrease) in additional paid in capital (APIC).",
"label": "Adjustments to Additional Paid in Capital, Other",
"terseLabel": "Equity activity resulting from the impact of other changes in ownership and deferred taxes"
}
}
},
"localname": "AdjustmentsToAdditionalPaidInCapitalOther",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
"terseLabel": "Adjustments to reconcile net (loss) income to net cash provided by operating activities:"
}
}
},
"localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "stringItemType"
},
"us-gaap_AllocatedShareBasedCompensationExpense": {
"auth_ref": [
"r287",
"r305",
"r314"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
"label": "Allocated Share-based Compensation Expense",
"terseLabel": "Equity-based compensation expense"
}
}
},
"localname": "AllocatedShareBasedCompensationExpense",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityCommonStockAwardsDetails",
"http://www.adapthealth.com/role/DisclosureStockholdersEquityEquityBasedCompensationDetails",
"http://www.adapthealth.com/role/DisclosureStockholdersEquityRestrictedStockDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AmortizationOfDebtDiscountPremium": {
"auth_ref": [
"r72",
"r89",
"r424"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows": {
"order": 9.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.",
"label": "Amortization of Debt Discount (Premium)",
"terseLabel": "Amortization of bond discount"
}
}
},
"localname": "AmortizationOfDebtDiscountPremium",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AmortizationOfFinancingCosts": {
"auth_ref": [
"r68",
"r89",
"r426"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows": {
"order": 11.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of amortization expense attributable to debt issuance costs.",
"label": "Amortization of Debt Issuance Costs",
"verboseLabel": "Amortization of deferred financing costs"
}
}
},
"localname": "AmortizationOfFinancingCosts",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AmortizationOfIntangibleAssets": {
"auth_ref": [
"r89",
"r206",
"r212"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows": {
"order": 8.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
"label": "Amortization of Intangible Assets",
"terseLabel": "Amortization of intangible assets"
}
}
},
"localname": "AmortizationOfIntangibleAssets",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureGoodwillAndIdentifiableIntangibleAssetsIntangibleAssetsDetails",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember": {
"auth_ref": [
"r49",
"r52",
"r53",
"r374"
],
"lang": {
"en-US": {
"role": {
"documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, including the portion attributable to the noncontrolling interest. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
"label": "Aoci Including Portion Attributable To Noncontrolling Interest [Member]",
"terseLabel": "Accumulated other comprehensive income"
}
}
},
"localname": "AociIncludingPortionAttributableToNoncontrollingInterestMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit"
],
"xbrltype": "domainItemType"
},
"us-gaap_Assets": {
"auth_ref": [
"r100",
"r169",
"r178",
"r184",
"r195",
"r368",
"r375",
"r414",
"r479",
"r499"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
"label": "Assets",
"totalLabel": "Total Assets"
}
}
},
"localname": "Assets",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AssetsAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Assets [Abstract]",
"terseLabel": "Assets"
}
}
},
"localname": "AssetsAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets"
],
"xbrltype": "stringItemType"
},
"us-gaap_AssetsCurrent": {
"auth_ref": [
"r3",
"r4",
"r45",
"r100",
"r195",
"r368",
"r375",
"r414"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets": {
"order": 1.0,
"parentTag": "us-gaap_Assets",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
"label": "Assets, Current",
"totalLabel": "Total current assets"
}
}
},
"localname": "AssetsCurrent",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AssetsCurrentAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Assets, Current [Abstract]",
"terseLabel": "Current assets:"
}
}
},
"localname": "AssetsCurrentAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets"
],
"xbrltype": "stringItemType"
},
"us-gaap_AssetsFairValueDisclosure": {
"auth_ref": [
"r402"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
"label": "Assets, Fair Value Disclosure",
"terseLabel": "Total assets measured at fair value"
}
}
},
"localname": "AssetsFairValueDisclosure",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureFairValueOfAssetsAndLiabilitiesValuationOfFinancialAssetsAndLiabilitiesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AssetsFairValueDisclosureAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Assets, Fair Value Disclosure [Abstract]",
"terseLabel": "Assets"
}
}
},
"localname": "AssetsFairValueDisclosureAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureFairValueOfAssetsAndLiabilitiesValuationOfFinancialAssetsAndLiabilitiesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_AssetsHeldUnderCapitalLeasesMember": {
"auth_ref": [
"r436"
],
"lang": {
"en-US": {
"role": {
"documentation": "Long lived property, plant or equipment assets held by a lessee through a capital lease arrangement.",
"label": "Assets Held Under Capital Leases [Member]",
"terseLabel": "Equipment under capital leases"
}
}
},
"localname": "AssetsHeldUnderCapitalLeasesMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureLeasesCapitalLeasesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_AwardTypeAxis": {
"auth_ref": [
"r288",
"r308"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by type of award under share-based payment arrangement.",
"label": "Award Type [Axis]"
}
}
},
"localname": "AwardTypeAxis",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityCommonStockAwardsDetails",
"http://www.adapthealth.com/role/DisclosureStockholdersEquityOptionsActivityAndAssumptionsDetails",
"http://www.adapthealth.com/role/DisclosureStockholdersEquityRestrictedStockDetails",
"http://www.adapthealth.com/role/DisclosureStockholdersEquityTables"
],
"xbrltype": "stringItemType"
},
"us-gaap_BalanceSheetLocationAxis": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by location on balance sheet (statement of financial position).",
"label": "Balance Sheet Location [Axis]"
}
}
},
"localname": "BalanceSheetLocationAxis",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesFinancialInstrumentsDetails",
"http://www.adapthealth.com/role/DisclosureFairValueContingentConsiderationDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_BalanceSheetLocationDomain": {
"auth_ref": [
"r385",
"r390"
],
"lang": {
"en-US": {
"role": {
"documentation": "Location in the balance sheet (statement of financial position).",
"label": "Balance Sheet Location [Domain]",
"terseLabel": "Balance Sheet Location [Domain]"
}
}
},
"localname": "BalanceSheetLocationDomain",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesFinancialInstrumentsDetails",
"http://www.adapthealth.com/role/DisclosureFairValueContingentConsiderationDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
"label": "Basis of Accounting, Policy [Policy Text Block]",
"terseLabel": "Basis of Presentation"
}
}
},
"localname": "BasisOfAccountingPolicyPolicyTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureGeneralInformationPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_BusinessAcquisitionAcquireeDomain": {
"auth_ref": [
"r280",
"r283"
],
"lang": {
"en-US": {
"role": {
"documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
"label": "Business Acquisition Acquiree [Domain]",
"terseLabel": "Business Acquisition, Acquiree [Domain]"
}
}
},
"localname": "BusinessAcquisitionAcquireeDomain",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails",
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsTables",
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails",
"http://www.adapthealth.com/role/DisclosureSubsequentEventsFinancingAndAcquisitionsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_BusinessAcquisitionAxis": {
"auth_ref": [
"r280",
"r283",
"r341",
"r342"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by business combination or series of individually immaterial business combinations.",
"label": "Business Acquisition [Axis]"
}
}
},
"localname": "BusinessAcquisitionAxis",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails",
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsTables",
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails",
"http://www.adapthealth.com/role/DisclosureSubsequentEventsFinancingAndAcquisitionsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_BusinessAcquisitionContingentConsiderationLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Business Acquisition, Contingent Consideration [Line Items]"
}
}
},
"localname": "BusinessAcquisitionContingentConsiderationLineItems",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureFairValueContingentConsiderationDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Business Acquisition, Equity Interests Issued or Issuable [Line Items]"
}
}
},
"localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsBusinessCombinationDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_BusinessAcquisitionLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Business Acquisition"
}
}
},
"localname": "BusinessAcquisitionLineItems",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails",
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsTables",
"http://www.adapthealth.com/role/DisclosureStockholdersEquityTables"
],
"xbrltype": "stringItemType"
},
"us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
"auth_ref": [
"r337"
],
"lang": {
"en-US": {
"role": {
"documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
"label": "Business Acquisition, Percentage of Voting Interests Acquired",
"terseLabel": "Interest acquired, as a percent"
}
}
},
"localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails",
"http://www.adapthealth.com/role/DisclosureSubsequentEventsFinancingAndAcquisitionsDetails"
],
"xbrltype": "percentItemType"
},
"us-gaap_BusinessAcquisitionProFormaInformationAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Business Acquisition, Pro Forma Information [Abstract]",
"terseLabel": "Pro-forma financial information:"
}
}
},
"localname": "BusinessAcquisitionProFormaInformationAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsProFormaFinancialInformationAndResultsOfBusinessAcquiredDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
"auth_ref": [
"r339",
"r340"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.",
"label": "Schedule of proforma net revenue and operating income"
}
}
},
"localname": "BusinessAcquisitionProFormaInformationTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax": {
"auth_ref": [
"r339",
"r340"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount after tax of pro forma income from continuing operations as if the business combination had been completed at the beginning of a period.",
"label": "Business Acquisition, Pro Forma Income (Loss) from Continuing Operations, Net of Tax",
"terseLabel": "Pro-forma operating income"
}
}
},
"localname": "BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsProFormaFinancialInformationAndResultsOfBusinessAcquiredDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessAcquisitionsProFormaRevenue": {
"auth_ref": [
"r339",
"r340"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
"label": "Business Acquisition, Pro Forma Revenue",
"terseLabel": "Pro-forma net revenue"
}
}
},
"localname": "BusinessAcquisitionsProFormaRevenue",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsProFormaFinancialInformationAndResultsOfBusinessAcquiredDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationConsiderationTransferred1": {
"auth_ref": [
"r351",
"r352",
"r354"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
"label": "Total Merger Consideration",
"totalLabel": "Total consideration"
}
}
},
"localname": "BusinessCombinationConsiderationTransferred1",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": {
"auth_ref": [
"r351",
"r352"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails": {
"order": 1.0,
"parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.",
"label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable",
"terseLabel": "Equity consideration issued in connection with acquisitions"
}
}
},
"localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombinationAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination [Abstract]"
}
}
},
"localname": "BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombinationAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": {
"auth_ref": [
"r349",
"r351",
"r352",
"r357"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails": {
"order": 3.0,
"parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.",
"label": "Business Combination, Consideration Transferred, Liabilities Incurred",
"terseLabel": "Liability incurred",
"verboseLabel": "Seller note issued in connection with an acquisition"
}
}
},
"localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationConsiderationTransferredOther1": {
"auth_ref": [
"r356"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails": {
"order": 4.0,
"parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of tangible or intangible assets, including a business or subsidiary of the acquirer transferred by the entity to the former owners of the acquiree. Excludes cash.",
"label": "Business Combination, Consideration Transferred, Other",
"terseLabel": "Contingent purchase price in connection with acquisitions",
"verboseLabel": "Deferred payments"
}
}
},
"localname": "BusinessCombinationConsiderationTransferredOther1",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
"auth_ref": [
"r88",
"r361"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
"label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
"negatedLabel": "Gain"
}
}
},
"localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureFairValueContingentConsiderationDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueLow": {
"auth_ref": [
"r362"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows": {
"order": 6.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "This element represents the amount of any change recognized during the period in the low-end of the estimated range of outcomes (undiscounted) of a liability assumed in a business combination arising from an item of contingent consideration.",
"label": "Business Combination, Contingent Consideration Arrangements, Change in Range of Outcomes, Contingent Consideration, Liability, Value, Low",
"negatedLabel": "Change in fair value of contingent consideration"
}
}
},
"localname": "BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueLow",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationContingentConsiderationLiability": {
"auth_ref": [
"r350",
"r353",
"r359"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
"label": "Business Combination, Contingent Consideration, Liability",
"periodEndLabel": "Contingent consideration liability at end of period",
"periodStartLabel": "Contingent consideration liability at beginning of period"
}
}
},
"localname": "BusinessCombinationContingentConsiderationLiability",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureFairValueContingentConsiderationDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized": {
"auth_ref": [
"r345"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The amount, measured at acquisition-date fair value, of all liabilities assumed that arise from contingencies and were recognized by the entity.",
"label": "Business Combination, Liabilities Arising from Contingencies, Amount Recognized",
"terseLabel": "Potential contingent payment"
}
}
},
"localname": "BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual": {
"auth_ref": [
"r338"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "This element represents the amount of earnings or loss of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.",
"label": "Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual",
"terseLabel": "Operating income (loss) since acquisition date"
}
}
},
"localname": "BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsProFormaFinancialInformationAndResultsOfBusinessAcquiredDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual": {
"auth_ref": [
"r338"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "This element represents the amount of revenue of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.",
"label": "Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual",
"terseLabel": "Net revenue since acquisition date"
}
}
},
"localname": "BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsProFormaFinancialInformationAndResultsOfBusinessAcquiredDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod": {
"auth_ref": [
"r346"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of increase (decrease) in income that would have been recognized in previous periods if the adjustments to provisional amounts were recognized as of the acquisition date.",
"label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustments Related to Previous Period",
"negatedLabel": "Payment of working capital adjustment from 2018 acquisitions"
}
}
},
"localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation": {
"auth_ref": [
"r344"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails": {
"order": 12.0,
"parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of lease obligation assumed in business combination.",
"label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Capital Lease Obligation",
"negatedLabel": "Capital lease obligations"
}
}
},
"localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
"auth_ref": [
"r344"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails": {
"order": 1.0,
"parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
"label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
"terseLabel": "Cash"
}
}
},
"localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": {
"auth_ref": [
"r344"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails": {
"order": 5.0,
"parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.",
"label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other",
"verboseLabel": "Net assets - working capital"
}
}
},
"localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
"auth_ref": [
"r344"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails": {
"order": 4.0,
"parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
"label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets",
"terseLabel": "Prepaid and other current assets"
}
}
},
"localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
"auth_ref": [
"r344"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails": {
"order": 2.0,
"parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
"label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
"terseLabel": "Accounts receivable"
}
}
},
"localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
"auth_ref": [
"r344"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails": {
"order": 10.0,
"parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
"label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable And Accrued Expenses",
"negatedLabel": "Accounts payable and accrued expenses"
}
}
},
"localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue": {
"auth_ref": [
"r344"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails": {
"order": 11.0,
"parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.",
"label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue",
"negatedLabel": "Contract liabilities"
}
}
},
"localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": {
"auth_ref": [
"r344"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails": {
"order": 6.0,
"parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
"label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other",
"negatedLabel": "Net liabilities - working capital"
}
}
},
"localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
"auth_ref": [
"r344"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails": {
"order": 7.0,
"parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
"label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
"terseLabel": "Intangible assets"
}
}
},
"localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
"auth_ref": [
"r343",
"r344"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails": {
"order": 3.0,
"parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The amount of inventory recognized as of the acquisition date.",
"label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
"terseLabel": "Inventory"
}
}
},
"localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": {
"auth_ref": [
"r344"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails": {
"order": 13.0,
"parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
"label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other",
"negatedLabel": "Other long-term liabilities"
}
}
},
"localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
"auth_ref": [
"r343",
"r344"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails": {
"order": 8.0,
"parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
"label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
"terseLabel": "Equipment and other fixed assets"
}
}
},
"localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
"auth_ref": [
"r344"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
"label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
"totalLabel": "Net assets acquired"
}
}
},
"localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net [Abstract]",
"terseLabel": "Estimated fair values of net assets acquired"
}
}
},
"localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
"auth_ref": [
"r93",
"r94",
"r95"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
"label": "Capital Expenditures Incurred but Not yet Paid",
"terseLabel": "Unpaid equipment and other fixed asset purchases at end of year"
}
}
},
"localname": "CapitalExpendituresIncurredButNotYetPaid",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CapitalLeaseObligationsCurrent": {
"auth_ref": [
"r11",
"r434",
"r437"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureCapitalLeaseObligationsFutureAnnualMinimumPaymentsDetailsCalc2": {
"order": 1.0,
"parentTag": "us-gaap_CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments",
"weight": 1.0
},
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets": {
"order": 2.0,
"parentTag": "us-gaap_LiabilitiesCurrent",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of capital lease obligation due within one year or the normal operating cycle, if longer.",
"label": "Capital Lease Obligations, Current",
"negatedLabel": "Current portion",
"terseLabel": "Current portion of capital lease obligations"
}
}
},
"localname": "CapitalLeaseObligationsCurrent",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureLeasesCapitalLeasesDetails",
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CapitalLeaseObligationsIncurred": {
"auth_ref": [
"r93",
"r94"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of increase in lease obligation from new lease.",
"label": "Capital Lease Obligations Incurred",
"terseLabel": "Equipment acquired under capital lease obligations"
}
}
},
"localname": "CapitalLeaseObligationsIncurred",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CapitalLeaseObligationsNoncurrent": {
"auth_ref": [
"r36",
"r434",
"r437"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureCapitalLeaseObligationsFutureAnnualMinimumPaymentsDetailsCalc2": {
"order": 2.0,
"parentTag": "us-gaap_CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal, through the balance sheet date and due to be paid more than one year (or one operating cycle, if longer) after the balance sheet date.",
"label": "Capital Lease Obligations, Noncurrent",
"totalLabel": "Noncurrent"
}
}
},
"localname": "CapitalLeaseObligationsNoncurrent",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureLeasesCapitalLeasesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CapitalLeasedAssetsGross": {
"auth_ref": [
"r433"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount before accumulated depreciation of leased physical assets used in the normal conduct of business to produce goods and services.",
"label": "Capital Leased Assets, Gross",
"terseLabel": "Cost of equipment under capital leases"
}
}
},
"localname": "CapitalLeasedAssetsGross",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureLeasesCapitalLeasesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CapitalLeasedAssetsLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Capital Leased Assets [Line Items]"
}
}
},
"localname": "CapitalLeasedAssetsLineItems",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureLeasesCapitalLeasesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_CapitalLeasesBalanceSheetAssetsByMajorClassNetLesseeBalanceSheetAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Capital Leases, Balance Sheet, Assets by Major Class, Net [Abstract]",
"terseLabel": "Equipment under capital leases"
}
}
},
"localname": "CapitalLeasesBalanceSheetAssetsByMajorClassNetLesseeBalanceSheetAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureLeasesCapitalLeasesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_CapitalLeasesFutureMinimumPaymentsDue": {
"auth_ref": [
"r437"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureLeasesCapitalLeasesDetails": {
"order": 1.0,
"parentTag": "us-gaap_CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of minimum lease payments for capital leases.",
"label": "Capital Leases, Future Minimum Payments Due",
"totalLabel": "Total"
}
}
},
"localname": "CapitalLeasesFutureMinimumPaymentsDue",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureLeasesCapitalLeasesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CapitalLeasesFutureMinimumPaymentsDueInRollingYearTwo": {
"auth_ref": [
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureLeasesCapitalLeasesDetails": {
"order": 1.0,
"parentTag": "us-gaap_CapitalLeasesFutureMinimumPaymentsDue",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of minimum lease payments for capital leases due in the second rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
"label": "Capital Leases, Future Minimum Payments, Due in Rolling Year Two",
"terseLabel": "2022"
}
}
},
"localname": "CapitalLeasesFutureMinimumPaymentsDueInRollingYearTwo",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureLeasesCapitalLeasesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CapitalLeasesFutureMinimumPaymentsDueRollingMaturityAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Capital Leases, Future Minimum Payments Due, Rolling Maturity [Abstract]"
}
}
},
"localname": "CapitalLeasesFutureMinimumPaymentsDueRollingMaturityAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureLeasesCapitalLeasesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments": {
"auth_ref": [
"r437"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureLeasesCapitalLeasesDetails": {
"order": 2.0,
"parentTag": "us-gaap_CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount necessary to reduce net minimum lease payments to present value for capital leases.",
"label": "Capital Leases, Future Minimum Payments, Interest Included in Payments",
"negatedLabel": "Less amount representing interest"
}
}
},
"localname": "CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureLeasesCapitalLeasesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CapitalLeasesFutureMinimumPaymentsNextRollingTwelveMonths": {
"auth_ref": [
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureLeasesCapitalLeasesDetails": {
"order": 2.0,
"parentTag": "us-gaap_CapitalLeasesFutureMinimumPaymentsDue",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of minimum lease payments for capital leases due in the next rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
"label": "Capital Leases, Future Minimum Payments, Next Rolling Twelve Months",
"terseLabel": "2021"
}
}
},
"localname": "CapitalLeasesFutureMinimumPaymentsNextRollingTwelveMonths",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureLeasesCapitalLeasesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments": {
"auth_ref": [
"r437"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureCapitalLeaseObligationsFutureAnnualMinimumPaymentsDetailsCalc2": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
},
"http://www.adapthealth.com/role/DisclosureLeasesCapitalLeasesDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Present value of minimum lease payments for capital leases net of executory costs, including amounts paid by the lessee to the lessor for insurance, maintenance and taxes.",
"label": "Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments",
"terseLabel": "Capital lease obligations"
}
}
},
"localname": "CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureLeasesCapitalLeasesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CapitalLeasesIncomeStatementInterestExpense": {
"auth_ref": [
"r435"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The financing charge for leasing arrangements meeting the criteria for capitalization.",
"label": "Capital Leases, Income Statement, Interest Expense",
"terseLabel": "Interest expense related to capital leases"
}
}
},
"localname": "CapitalLeasesIncomeStatementInterestExpense",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureLeasesCapitalLeasesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation": {
"auth_ref": [
"r428",
"r433"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The total charge for the use of long-lived depreciable assets subject to a lease meeting the criteria for capitalization.",
"label": "Capital Leases, Lessee Balance Sheet, Assets by Major Class, Accumulated Depreciation",
"terseLabel": "Accumulated depreciation of equipment under capital leases"
}
}
},
"localname": "CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureLeasesCapitalLeasesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
"auth_ref": [
"r85",
"r91",
"r96"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets": {
"order": 2.0,
"parentTag": "us-gaap_AssetsCurrent",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
"label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
"periodEndLabel": "Cash and cash equivalents - end of the period",
"periodStartLabel": "Cash and cash equivalents - beginning of the period",
"terseLabel": "Cash and cash equivalents"
}
}
},
"localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
"auth_ref": [
"r85",
"r415"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
"label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
"totalLabel": "Net increase (decrease) in cash and cash equivalents"
}
}
},
"localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1": {
"auth_ref": [
"r399"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of the increase (decrease) in fair value of the hedged item in a fair value hedge recognized in the income statement.",
"label": "Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge",
"terseLabel": "Change in fair value of interest rate swaps, inclusive of reclassification adjustment"
}
}
},
"localname": "ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ClassOfStockDomain": {
"auth_ref": [
"r98",
"r100",
"r124",
"r129",
"r137",
"r141",
"r145",
"r153",
"r154",
"r155",
"r195",
"r414"
],
"lang": {
"en-US": {
"role": {
"documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
"label": "Class Of Stock [Domain]",
"terseLabel": "Class of Stock [Domain]"
}
}
},
"localname": "ClassOfStockDomain",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsBusinessCombinationDetails",
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails",
"http://www.adapthealth.com/role/DisclosureSubsequentEventsFinancingAndAcquisitionsDetails",
"http://www.adapthealth.com/role/DocumentDocumentAndEntityInformation",
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets",
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheetsParenthetical",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit"
],
"xbrltype": "domainItemType"
},
"us-gaap_ClassOfStockLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Class of Stock [Line Items]"
}
}
},
"localname": "ClassOfStockLineItems",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
"auth_ref": [
"r238"
],
"lang": {
"en-US": {
"role": {
"documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
"label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
"verboseLabel": "Warrant exercisable price"
}
}
},
"localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails"
],
"xbrltype": "perShareItemType"
},
"us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.",
"label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right",
"terseLabel": "Common stock for each warrant exercised"
}
}
},
"localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_ClassOfWarrantOrRightOutstanding": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Number of warrants or rights outstanding.",
"label": "Class of Warrant or Right, Outstanding",
"terseLabel": "Warrants outstanding"
}
}
},
"localname": "ClassOfWarrantOrRightOutstanding",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_CommitmentsAndContingencies": {
"auth_ref": [
"r39",
"r225",
"r484",
"r506"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
"label": "Commitments and Contingencies",
"terseLabel": "Commitments and contingencies (note 14)"
}
}
},
"localname": "CommitmentsAndContingencies",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Commitments and Contingencies."
}
}
},
"localname": "CommitmentsAndContingenciesDisclosureAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
"auth_ref": [
"r222",
"r223",
"r224",
"r227"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for commitments and contingencies.",
"label": "Commitments and Contingencies Disclosure [Text Block]",
"terseLabel": "Commitments and Contingencies"
}
}
},
"localname": "CommitmentsAndContingenciesDisclosureTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureCommitmentsAndContingencies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_CommonClassAMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Classification of common stock representing ownership interest in a corporation.",
"label": "Common Class A [Member]",
"terseLabel": "Class A Common Stock"
}
}
},
"localname": "CommonClassAMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsBusinessCombinationDetails",
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails",
"http://www.adapthealth.com/role/DisclosureSubsequentEventsFinancingAndAcquisitionsDetails",
"http://www.adapthealth.com/role/DocumentDocumentAndEntityInformation",
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets",
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheetsParenthetical",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit"
],
"xbrltype": "domainItemType"
},
"us-gaap_CommonClassBMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.",
"label": "Common Class B [Member]",
"terseLabel": "Class B Common Stock"
}
}
},
"localname": "CommonClassBMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsBusinessCombinationDetails",
"http://www.adapthealth.com/role/DocumentDocumentAndEntityInformation",
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets",
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheetsParenthetical",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit"
],
"xbrltype": "domainItemType"
},
"us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
"auth_ref": [
"r41"
],
"lang": {
"en-US": {
"role": {
"documentation": "Aggregate number of common shares reserved for future issuance.",
"label": "Common Stock, Capital Shares Reserved for Future Issuance",
"terseLabel": "Stock available for issuance"
}
}
},
"localname": "CommonStockCapitalSharesReservedForFutureIssuance",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityEquityBasedCompensationDetails",
"http://www.adapthealth.com/role/DisclosureSubsequentEventsFinancingAndAcquisitionsDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_CommonStockMember": {
"auth_ref": [
"r107",
"r108"
],
"lang": {
"en-US": {
"role": {
"documentation": "Stock that is subordinate to all other stock of the issuer.",
"label": "Common Stock [Member]",
"terseLabel": "Common Stock"
}
}
},
"localname": "CommonStockMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit"
],
"xbrltype": "domainItemType"
},
"us-gaap_CommonStockParOrStatedValuePerShare": {
"auth_ref": [
"r16"
],
"lang": {
"en-US": {
"role": {
"documentation": "Face amount or stated value per share of common stock.",
"label": "Common Stock, Par or Stated Value Per Share",
"terseLabel": "Common stock, par value (in dollars per share)"
}
}
},
"localname": "CommonStockParOrStatedValuePerShare",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheetsParenthetical"
],
"xbrltype": "perShareItemType"
},
"us-gaap_CommonStockSharesAuthorized": {
"auth_ref": [
"r16"
],
"lang": {
"en-US": {
"role": {
"documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
"label": "Common Stock, Shares Authorized",
"terseLabel": "Common stock, shares authorized (in shares)"
}
}
},
"localname": "CommonStockSharesAuthorized",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheetsParenthetical"
],
"xbrltype": "sharesItemType"
},
"us-gaap_CommonStockSharesIssued": {
"auth_ref": [
"r16"
],
"lang": {
"en-US": {
"role": {
"documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
"label": "Common Stock, Shares, Issued",
"terseLabel": "Common stock, shares issued (in shares)"
}
}
},
"localname": "CommonStockSharesIssued",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheetsParenthetical"
],
"xbrltype": "sharesItemType"
},
"us-gaap_CommonStockSharesOutstanding": {
"auth_ref": [
"r16",
"r237"
],
"lang": {
"en-US": {
"role": {
"documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
"label": "Common Stock, Shares, Outstanding",
"terseLabel": "Common stock, shares outstanding (in shares)"
}
}
},
"localname": "CommonStockSharesOutstanding",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheetsParenthetical"
],
"xbrltype": "sharesItemType"
},
"us-gaap_CommonStockValue": {
"auth_ref": [
"r16"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets": {
"order": 3.0,
"parentTag": "us-gaap_StockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
"label": "Common Stock, Value, Issued",
"terseLabel": "Common stock"
}
}
},
"localname": "CommonStockValue",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ComprehensiveIncomeNetOfTax": {
"auth_ref": [
"r55",
"r57",
"r58",
"r65",
"r491",
"r511"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfComprehensiveIncomeLoss": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
"label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
"totalLabel": "Comprehensive income (loss) attributable to AdaptHealth Corp."
}
}
},
"localname": "ComprehensiveIncomeNetOfTax",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfComprehensiveIncomeLoss"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
"auth_ref": [
"r55",
"r57",
"r64",
"r366",
"r367",
"r379",
"r490",
"r510"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfComprehensiveIncomeLoss": {
"order": 1.0,
"parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
"label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
"terseLabel": "Net income attributable to noncontrolling interests"
}
}
},
"localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfComprehensiveIncomeLoss"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
"auth_ref": [
"r55",
"r57",
"r63",
"r365",
"r379",
"r489",
"r509"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfComprehensiveIncomeLoss": {
"order": 2.0,
"parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
"label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
"totalLabel": "Comprehensive income (loss)"
}
}
},
"localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfComprehensiveIncomeLoss"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ConcentrationRiskCreditRisk": {
"auth_ref": [
"r158",
"r497"
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of accounting policy for credit risk.",
"label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
"terseLabel": "Concentration of Credit Risk"
}
}
},
"localname": "ConcentrationRiskCreditRisk",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureGeneralInformationPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ConsolidationPolicyTextBlock": {
"auth_ref": [
"r97",
"r370"
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
"label": "Consolidation, Policy [Policy Text Block]",
"terseLabel": "Basis of Consolidation"
}
}
},
"localname": "ConsolidationPolicyTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureGeneralInformationPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ContractBasedIntangibleAssetsMember": {
"auth_ref": [
"r347"
],
"lang": {
"en-US": {
"role": {
"documentation": "Right received from contract, including, but not limited to, advertising contract, broadcast rights, franchise agreement, lease agreement, licensing agreement, and use rights.",
"label": "Contract Based Intangible Assets [Member]",
"terseLabel": "Payor contracts"
}
}
},
"localname": "ContractBasedIntangibleAssetsMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureGeneralInformationDetails",
"http://www.adapthealth.com/role/DisclosureGoodwillAndIdentifiableIntangibleAssetsIntangibleAssetsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_ContractWithCustomerLiabilityCurrent": {
"auth_ref": [
"r248",
"r249",
"r260"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets": {
"order": 3.0,
"parentTag": "us-gaap_LiabilitiesCurrent",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
"label": "Contract with Customer, Liability, Current",
"terseLabel": "Contract liabilities"
}
}
},
"localname": "ContractWithCustomerLiabilityCurrent",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": {
"auth_ref": [
"r14",
"r15",
"r238",
"r241"
],
"lang": {
"en-US": {
"role": {
"documentation": "Number of shares issued for each share of convertible preferred stock that is converted.",
"label": "Convertible Preferred Stock, Shares Issued upon Conversion",
"terseLabel": "Shares of common stock received in conversion for each share of preferred stock"
}
}
},
"localname": "ConvertiblePreferredStockSharesIssuedUponConversion",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_CostOfGoodsAndServicesSold": {
"auth_ref": [
"r70",
"r462"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfOperations": {
"order": 1.0,
"parentTag": "us-gaap_CostsAndExpenses",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
"label": "Cost of Goods and Services Sold",
"terseLabel": "Cost of net revenue"
}
}
},
"localname": "CostOfGoodsAndServicesSold",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfOperations"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CostOfRevenueAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Cost of Revenue [Abstract]",
"terseLabel": "Costs and expenses:"
}
}
},
"localname": "CostOfRevenueAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfOperations"
],
"xbrltype": "stringItemType"
},
"us-gaap_CostOfSalesMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Primary financial statement caption encompassing cost of sales.",
"label": "Cost Of Sales [Member]",
"terseLabel": "Cost of Sales [Member]"
}
}
},
"localname": "CostOfSalesMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityEquityBasedCompensationDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_CostsAndExpenses": {
"auth_ref": [
"r69"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfOperations": {
"order": 1.0,
"parentTag": "us-gaap_OperatingIncomeLoss",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Total costs of sales and operating expenses for the period.",
"label": "Costs and Expenses",
"totalLabel": "Total costs and expenses"
}
}
},
"localname": "CostsAndExpenses",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfOperations"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DebtDisclosureAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Debt"
}
}
},
"localname": "DebtDisclosureAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_DebtDisclosureTextBlock": {
"auth_ref": [
"r233"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
"label": "Debt Disclosure [Text Block]",
"terseLabel": "Debt"
}
}
},
"localname": "DebtDisclosureTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebt"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_DebtInstrumentAxis": {
"auth_ref": [
"r11",
"r12",
"r13",
"r480",
"r481",
"r498"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
"label": "Debt Instrument [Axis]"
}
}
},
"localname": "DebtInstrumentAxis",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtDetails",
"http://www.adapthealth.com/role/DisclosureDebtLongTermDebtDetails",
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
"label": "Debt Instrument, Basis Spread on Variable Rate",
"verboseLabel": "Rate margin (as a percent)"
}
}
},
"localname": "DebtInstrumentBasisSpreadOnVariableRate1",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtLongTermDebtDetails",
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails"
],
"xbrltype": "percentItemType"
},
"us-gaap_DebtInstrumentCarryingAmount": {
"auth_ref": [
"r13",
"r229",
"r481",
"r498"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureDebtDetailsCalc2": {
"order": 3.0,
"parentTag": "us-gaap_LongTermDebt",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
"label": "Long-term Debt, Gross",
"terseLabel": "Debt, Gross",
"verboseLabel": "Debt balance outstanding"
}
}
},
"localname": "DebtInstrumentCarryingAmount",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtDetails",
"http://www.adapthealth.com/role/DisclosureDebtLongTermDebtDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DebtInstrumentFaceAmount": {
"auth_ref": [
"r425",
"r427"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Face (par) amount of debt instrument at time of issuance.",
"label": "Debt Instrument, Face Amount",
"terseLabel": "Face amount"
}
}
},
"localname": "DebtInstrumentFaceAmount",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtLongTermDebtDetails",
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DebtInstrumentInterestRateStatedPercentage": {
"auth_ref": [
"r35"
],
"lang": {
"en-US": {
"role": {
"documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
"label": "Debt Instrument, Interest Rate, Stated Percentage",
"terseLabel": "Debt Interest rate"
}
}
},
"localname": "DebtInstrumentInterestRateStatedPercentage",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails"
],
"xbrltype": "percentItemType"
},
"us-gaap_DebtInstrumentLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Debt Instrument [Line Items]"
}
}
},
"localname": "DebtInstrumentLineItems",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtDetails",
"http://www.adapthealth.com/role/DisclosureDebtLongTermDebtDetails",
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_DebtInstrumentNameDomain": {
"auth_ref": [
"r36"
],
"lang": {
"en-US": {
"role": {
"documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
"label": "Debt Instrument Name [Domain]",
"terseLabel": "Debt Instrument, Name [Domain]"
}
}
},
"localname": "DebtInstrumentNameDomain",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtDetails",
"http://www.adapthealth.com/role/DisclosureDebtLongTermDebtDetails",
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_DebtInstrumentRedemptionPeriodAxis": {
"auth_ref": [
"r495"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
"label": "Debt Instrument, Redemption, Period [Axis]"
}
}
},
"localname": "DebtInstrumentRedemptionPeriodAxis",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_DebtInstrumentRedemptionPeriodDomain": {
"auth_ref": [
"r495"
],
"lang": {
"en-US": {
"role": {
"documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
"label": "Debt Instrument Redemption Period [Domain]",
"terseLabel": "Debt Instrument, Redemption, Period [Domain]"
}
}
},
"localname": "DebtInstrumentRedemptionPeriodDomain",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_DebtInstrumentRedemptionPeriodFiveMember": {
"auth_ref": [
"r495"
],
"lang": {
"en-US": {
"role": {
"documentation": "Period five representing fifth most current period of debt redemption features under terms of the debt agreement.",
"label": "Debt Instrument Redemption Period Five [Member]",
"terseLabel": "Redemption Period Five and thereafter"
}
}
},
"localname": "DebtInstrumentRedemptionPeriodFiveMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_DebtInstrumentRedemptionPeriodFourMember": {
"auth_ref": [
"r495"
],
"lang": {
"en-US": {
"role": {
"documentation": "Period four representing fourth most current period of debt redemption features under terms of the debt agreement.",
"label": "Debt Instrument Redemption Period Four [Member]",
"terseLabel": "Redemption Period Four"
}
}
},
"localname": "DebtInstrumentRedemptionPeriodFourMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_DebtInstrumentRedemptionPeriodOneMember": {
"auth_ref": [
"r495"
],
"lang": {
"en-US": {
"role": {
"documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement.",
"label": "Debt Instrument Redemption Period One [Member]",
"terseLabel": "Redemption Period One"
}
}
},
"localname": "DebtInstrumentRedemptionPeriodOneMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_DebtInstrumentRedemptionPeriodThreeMember": {
"auth_ref": [
"r495"
],
"lang": {
"en-US": {
"role": {
"documentation": "Period three representing third most current period of debt redemption features under terms of the debt agreement.",
"label": "Debt Instrument Redemption Period Three [Member]",
"terseLabel": "Redemption Period Three"
}
}
},
"localname": "DebtInstrumentRedemptionPeriodThreeMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_DebtInstrumentRedemptionPeriodTwoMember": {
"auth_ref": [
"r495"
],
"lang": {
"en-US": {
"role": {
"documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement.",
"label": "Debt Instrument Redemption Period Two [Member]",
"terseLabel": "Redemption Period Two"
}
}
},
"localname": "DebtInstrumentRedemptionPeriodTwoMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_DebtInstrumentRedemptionPricePercentage": {
"auth_ref": [
"r495"
],
"lang": {
"en-US": {
"role": {
"documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.",
"label": "Debt Instrument, Redemption Price, Percentage"
}
}
},
"localname": "DebtInstrumentRedemptionPricePercentage",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails"
],
"xbrltype": "percentItemType"
},
"us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Percentage of principal amount of debt redeemed.",
"label": "Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed"
}
}
},
"localname": "DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails"
],
"xbrltype": "percentItemType"
},
"us-gaap_DebtInstrumentTable": {
"auth_ref": [
"r36",
"r103",
"r238",
"r242",
"r243",
"r244",
"r424",
"r425",
"r427",
"r496"
],
"lang": {
"en-US": {
"role": {
"documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
"label": "Schedule of Long-term Debt Instruments [Table]"
}
}
},
"localname": "DebtInstrumentTable",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtDetails",
"http://www.adapthealth.com/role/DisclosureDebtLongTermDebtDetails",
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_DebtInstrumentUnamortizedDiscount": {
"auth_ref": [
"r424",
"r427"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureDebtDetailsCalc2": {
"order": 1.0,
"parentTag": "us-gaap_LongTermDebt",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, after accumulated amortization, of debt discount.",
"label": "Debt Instrument, Unamortized Discount",
"negatedLabel": "Unamortized discount on senior unsecured notes"
}
}
},
"localname": "DebtInstrumentUnamortizedDiscount",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtDetails",
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DeferredFinanceCostsNet": {
"auth_ref": [
"r28",
"r426"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureDebtDetailsCalc2": {
"order": 2.0,
"parentTag": "us-gaap_LongTermDebt",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
"label": "Debt Issuance Costs, Net",
"negatedTerseLabel": "Unamortized deferred financing fees"
}
}
},
"localname": "DeferredFinanceCostsNet",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtDetails",
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DeferredIncomeTaxAssetsNet": {
"auth_ref": [
"r317",
"r318"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets": {
"order": 2.0,
"parentTag": "us-gaap_Assets",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
"label": "Deferred Income Tax Assets, Net",
"terseLabel": "Deferred tax assets"
}
}
},
"localname": "DeferredIncomeTaxAssetsNet",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DeferredIncomeTaxExpenseBenefit": {
"auth_ref": [
"r89",
"r101",
"r324",
"r329",
"r330",
"r331"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows": {
"order": 4.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
"label": "Deferred Income Tax Expense (Benefit)",
"terseLabel": "Deferred income tax (benefit) expense"
}
}
},
"localname": "DeferredIncomeTaxExpenseBenefit",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_Depreciation": {
"auth_ref": [
"r89",
"r216"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows": {
"order": 2.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
"label": "Depreciation",
"verboseLabel": "Depreciation and amortization, including patient equipment depreciation"
}
}
},
"localname": "Depreciation",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Derivative Assets (Liabilities), at Fair Value, Net, by Balance Sheet Classification [Abstract]",
"terseLabel": "Derivative financial instruments"
}
}
},
"localname": "DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesFinancialInstrumentsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_DerivativeContractTypeDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
"label": "Derivative Contract Type [Domain]",
"terseLabel": "Derivative Contract [Domain]"
}
}
},
"localname": "DerivativeContractTypeDomain",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesFinancialInstrumentsDetails",
"http://www.adapthealth.com/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesNotDesignatedDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_DerivativeGainLossOnDerivativeNet": {
"auth_ref": [
"r387"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
"label": "Derivative, Gain (Loss) on Derivative, Net",
"terseLabel": "Amount of Gain or (Loss) Recognized in OCI on Derivative"
}
}
},
"localname": "DerivativeGainLossOnDerivativeNet",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesEffectOnAccumulatedOtherComprehensiveIncomeDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DerivativeInstrumentRiskAxis": {
"auth_ref": [
"r386",
"r389",
"r392",
"r396"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by type of derivative contract.",
"label": "Derivative Instrument [Axis]"
}
}
},
"localname": "DerivativeInstrumentRiskAxis",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesFinancialInstrumentsDetails",
"http://www.adapthealth.com/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesNotDesignatedDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Derivative Instruments and Hedging Activities"
}
}
},
"localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
"auth_ref": [
"r401"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
"label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
"terseLabel": "Derivative Instruments and Hedging Activities"
}
}
},
"localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDerivativeInstrumentsAndHedgingActivities"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]"
}
}
},
"localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesFinancialInstrumentsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of information about derivatives and hedging activities.",
"label": "Derivative Instruments and Hedging Activities Disclosures [Table]"
}
}
},
"localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesFinancialInstrumentsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
"auth_ref": [
"r384",
"r386",
"r392",
"r396",
"r397",
"r398",
"r400"
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
"label": "Derivative Instruments, Gain (Loss) [Table]"
}
}
},
"localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesNotDesignatedDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_DerivativeInstrumentsGainLossLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Derivative Instruments, Gain (Loss) [Line Items]"
}
}
},
"localname": "DerivativeInstrumentsGainLossLineItems",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesNotDesignatedDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": {
"auth_ref": [
"r391",
"r393"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.",
"label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net",
"verboseLabel": "Amount of Gain or (Loss) Recognized in Income on Derivative"
}
}
},
"localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesNotDesignatedDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DerivativeLiabilities": {
"auth_ref": [
"r46",
"r47",
"r413"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
"label": "Derivative Assets (Liabilities), at Fair Value, Net",
"negatedLabel": "Fair Value Liability"
}
}
},
"localname": "DerivativeLiabilities",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesFinancialInstrumentsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DerivativeLiabilityNotionalAmount": {
"auth_ref": [
"r381",
"r382",
"r383"
],
"lang": {
"en-US": {
"role": {
"documentation": "Nominal or face amount used to calculate payments on the derivative liability.",
"label": "Derivative Liability, Notional Amount",
"verboseLabel": "Notional amount"
}
}
},
"localname": "DerivativeLiabilityNotionalAmount",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesFinancialInstrumentsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DesignatedAsHedgingInstrumentMember": {
"auth_ref": [
"r384"
],
"lang": {
"en-US": {
"role": {
"documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
"label": "Designated As Hedging Instrument [Member]",
"terseLabel": "Derivatives designated as hedging instruments"
}
}
},
"localname": "DesignatedAsHedgingInstrumentMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesFinancialInstrumentsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_DisaggregationOfRevenueLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Disaggregation of Revenue [Line Items]",
"terseLabel": "Revenue Recognition"
}
}
},
"localname": "DisaggregationOfRevenueLineItems",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureRevenueRecognitionAndAccountsReceivableDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_DisaggregationOfRevenueTable": {
"auth_ref": [
"r259",
"r262",
"r263",
"r264",
"r265",
"r266",
"r267",
"r268"
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
"label": "Disaggregation of Revenue [Table]"
}
}
},
"localname": "DisaggregationOfRevenueTable",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureRevenueRecognitionAndAccountsReceivableDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_DisaggregationOfRevenueTableTextBlock": {
"auth_ref": [
"r259"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
"label": "Disaggregation of Revenue [Table Text Block]",
"terseLabel": "Schedule of composition of net revenues by payor type and core service lines"
}
}
},
"localname": "DisaggregationOfRevenueTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureRevenueRecognitionAndAccountsReceivableTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsPaid": {
"auth_ref": [
"r245"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows": {
"order": 11.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cash distribution paid to unit-holder of limited liability company (LLC).",
"label": "Distribution Made to Limited Liability Company (LLC) Member, Cash Distributions Paid",
"negatedLabel": "Distributions to members"
}
}
},
"localname": "DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsPaid",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_EarningsPerShareAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Earnings per share"
}
}
},
"localname": "EarningsPerShareAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_EarningsPerShareBasic": {
"auth_ref": [
"r66",
"r112",
"r113",
"r114",
"r115",
"r116",
"r121",
"r124",
"r141",
"r144",
"r145",
"r149",
"r150",
"r492",
"r512"
],
"lang": {
"en-US": {
"role": {
"documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
"label": "Earnings Per Share, Basic"
}
}
},
"localname": "EarningsPerShareBasic",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureEarningsPerShareDetails"
],
"xbrltype": "perShareItemType"
},
"us-gaap_EarningsPerShareBasicAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Earnings Per Share, Basic [Abstract]"
}
}
},
"localname": "EarningsPerShareBasicAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureEarningsPerShareDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Earnings Per Share, Basic and Diluted [Abstract]",
"terseLabel": "Net income (loss) per common share:"
}
}
},
"localname": "EarningsPerShareBasicAndDilutedAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureEarningsPerShareDetails",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfOperations"
],
"xbrltype": "stringItemType"
},
"us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract]",
"terseLabel": "Weighted average shares outstanding for net income (loss) attributable to AdaptHealth Corp.:",
"verboseLabel": "Denominator:"
}
}
},
"localname": "EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfOperations"
],
"xbrltype": "stringItemType"
},
"us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Earnings Per Share, Basic, Other Disclosures [Abstract]",
"terseLabel": "Denominator:"
}
}
},
"localname": "EarningsPerShareBasicOtherDisclosuresAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureEarningsPerShareDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_EarningsPerShareDiluted": {
"auth_ref": [
"r66",
"r112",
"r113",
"r114",
"r115",
"r116",
"r124",
"r141",
"r144",
"r145",
"r149",
"r150",
"r492",
"r512"
],
"lang": {
"en-US": {
"role": {
"documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
"label": "Earnings Per Share, Diluted",
"terseLabel": "Diluted"
}
}
},
"localname": "EarningsPerShareDiluted",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureEarningsPerShareDetails",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfOperations"
],
"xbrltype": "perShareItemType"
},
"us-gaap_EarningsPerShareDilutedAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Earnings Per Share, Diluted [Abstract]"
}
}
},
"localname": "EarningsPerShareDilutedAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureEarningsPerShareDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_EarningsPerShareTextBlock": {
"auth_ref": [
"r146",
"r147",
"r148",
"r151"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for earnings per share.",
"label": "Earnings Per Share [Text Block]",
"verboseLabel": "Earnings Per Share"
}
}
},
"localname": "EarningsPerShareTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureEarningsPerShare"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_EmployeeRelatedLiabilitiesCurrent": {
"auth_ref": [
"r33"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
"label": "Employee-related Liabilities, Current",
"terseLabel": "Employee related accruals"
}
}
},
"localname": "EmployeeRelatedLiabilitiesCurrent",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureAccountsPayableAndAccruedExpensesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount": {
"auth_ref": [
"r306"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cost capitalized for award under share-based payment arrangement.",
"label": "Share-based Payment Arrangement, Amount Capitalized",
"terseLabel": "Compensation cost, portion to be recognized over service period"
}
}
},
"localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityRestrictedStockDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
"auth_ref": [
"r307"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
"label": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized",
"verboseLabel": "Unrecognized compensation expense"
}
}
},
"localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityEquityBasedCompensationDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
"auth_ref": [
"r307"
],
"lang": {
"en-US": {
"role": {
"documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
"label": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition",
"terseLabel": "Recognition period"
}
}
},
"localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityEquityBasedCompensationDetails"
],
"xbrltype": "durationItemType"
},
"us-gaap_EmployeeStockOptionMember": {
"auth_ref": [
"r304"
],
"lang": {
"en-US": {
"role": {
"documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
"label": "Employee Stock Option [Member]",
"terseLabel": "Options"
}
}
},
"localname": "EmployeeStockOptionMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityOptionsActivityAndAssumptionsDetails",
"http://www.adapthealth.com/role/DisclosureStockholdersEquityTables"
],
"xbrltype": "domainItemType"
},
"us-gaap_EquityAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Stockholders' Equity"
}
}
},
"localname": "EquityAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_EquityComponentDomain": {
"auth_ref": [
"r107",
"r108",
"r109",
"r111",
"r117",
"r119",
"r152",
"r196",
"r237",
"r245",
"r309",
"r310",
"r311",
"r325",
"r326",
"r416",
"r417",
"r418",
"r419",
"r420",
"r421",
"r520",
"r521",
"r522"
],
"lang": {
"en-US": {
"role": {
"documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
"label": "Equity Component [Domain]",
"terseLabel": "Equity Component [Domain]"
}
}
},
"localname": "EquityComponentDomain",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit"
],
"xbrltype": "domainItemType"
},
"us-gaap_EquityMethodInvestmentOwnershipPercentage": {
"auth_ref": [
"r194"
],
"lang": {
"en-US": {
"role": {
"documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
"label": "Equity Method Investment, Ownership Percentage",
"terseLabel": "Ownership interest, as a percent"
}
}
},
"localname": "EquityMethodInvestmentOwnershipPercentage",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureRelatedPartyTransactionsDetails"
],
"xbrltype": "percentItemType"
},
"us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
}
}
},
"localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureFairValueOfAssetsAndLiabilitiesNonFinancialAssetsMeasuredOnNonRecurringBasisDetails",
"http://www.adapthealth.com/role/DisclosureFairValueOfAssetsAndLiabilitiesValuationOfFinancialAssetsAndLiabilitiesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
"auth_ref": [
"r402",
"r403",
"r404",
"r411"
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
"label": "Fair Value, Recurring and Nonrecurring [Table]"
}
}
},
"localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureFairValueOfAssetsAndLiabilitiesNonFinancialAssetsMeasuredOnNonRecurringBasisDetails",
"http://www.adapthealth.com/role/DisclosureFairValueOfAssetsAndLiabilitiesValuationOfFinancialAssetsAndLiabilitiesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock": {
"auth_ref": [
"r402",
"r403",
"r405"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of assets and liabilities by class, including financial instruments measured at fair value that are classified in shareholders' equity, if any, that are measured at fair value on a nonrecurring basis in periods after initial recognition (for example, impaired assets). Disclosures may include, but are not limited to: (a) the fair value measurements recorded and the reasons for the measurements and (b) the level within the fair value hierarchy in which the fair value measurements are categorized in their entirety (levels 1, 2, 3).",
"label": "Fair Value Measurements, Nonrecurring [Table Text Block]",
"terseLabel": "Summary of non-financial assets measured on a non-recurring basis"
}
}
},
"localname": "FairValueAssetsMeasuredOnNonrecurringBasisTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureFairValueOfAssetsAndLiabilitiesTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
"auth_ref": [
"r408"
],
"lang": {
"en-US": {
"role": {
"documentation": "Class of asset.",
"label": "Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation By Asset Class [Domain]",
"terseLabel": "Asset Class [Domain]"
}
}
},
"localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureFairValueOfAssetsAndLiabilitiesValuationOfFinancialAssetsAndLiabilitiesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_FairValueByAssetClassAxis": {
"auth_ref": [
"r402",
"r411"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by class of asset.",
"label": "Asset Class [Axis]"
}
}
},
"localname": "FairValueByAssetClassAxis",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureFairValueOfAssetsAndLiabilitiesValuationOfFinancialAssetsAndLiabilitiesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_FairValueByFairValueHierarchyLevelAxis": {
"auth_ref": [
"r271",
"r272",
"r273",
"r274",
"r275",
"r276",
"r277",
"r279",
"r403",
"r452",
"r453",
"r454"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
"label": "Fair Value Hierarchy and NAV [Axis]"
}
}
},
"localname": "FairValueByFairValueHierarchyLevelAxis",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureFairValueContingentConsiderationDetails",
"http://www.adapthealth.com/role/DisclosureFairValueOfAssetsAndLiabilitiesNonFinancialAssetsMeasuredOnNonRecurringBasisDetails",
"http://www.adapthealth.com/role/DisclosureFairValueOfAssetsAndLiabilitiesValuationOfFinancialAssetsAndLiabilitiesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_FairValueByLiabilityClassAxis": {
"auth_ref": [
"r410",
"r411"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by class of liability.",
"label": "Liability Class [Axis]"
}
}
},
"localname": "FairValueByLiabilityClassAxis",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureFairValueOfAssetsAndLiabilitiesValuationOfFinancialAssetsAndLiabilitiesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_FairValueByMeasurementFrequencyAxis": {
"auth_ref": [
"r402",
"r403",
"r406",
"r407",
"r412"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by measurement frequency.",
"label": "Measurement Frequency [Axis]"
}
}
},
"localname": "FairValueByMeasurementFrequencyAxis",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureFairValueOfAssetsAndLiabilitiesNonFinancialAssetsMeasuredOnNonRecurringBasisDetails",
"http://www.adapthealth.com/role/DisclosureFairValueOfAssetsAndLiabilitiesValuationOfFinancialAssetsAndLiabilitiesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_FairValueDisclosuresAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Fair Value of Assets and Liabilities"
}
}
},
"localname": "FairValueDisclosuresAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_FairValueDisclosuresTextBlock": {
"auth_ref": [
"r410"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
"label": "Fair Value Disclosures [Text Block]",
"terseLabel": "Fair Value of Assets and Liabilities"
}
}
},
"localname": "FairValueDisclosuresTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureFairValueOfAssetsAndLiabilities"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_FairValueInputsLevel1Member": {
"auth_ref": [
"r271",
"r272",
"r277",
"r279",
"r403",
"r452"
],
"lang": {
"en-US": {
"role": {
"documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
"label": "Fair Value Inputs Level1 [Member]",
"terseLabel": "Level 1"
}
}
},
"localname": "FairValueInputsLevel1Member",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureFairValueOfAssetsAndLiabilitiesValuationOfFinancialAssetsAndLiabilitiesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_FairValueInputsLevel2Member": {
"auth_ref": [
"r271",
"r272",
"r277",
"r279",
"r403",
"r453"
],
"lang": {
"en-US": {
"role": {
"documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
"label": "Fair Value Inputs Level2 [Member]",
"terseLabel": "Level 2"
}
}
},
"localname": "FairValueInputsLevel2Member",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureFairValueOfAssetsAndLiabilitiesValuationOfFinancialAssetsAndLiabilitiesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_FairValueInputsLevel3Member": {
"auth_ref": [
"r271",
"r272",
"r273",
"r274",
"r275",
"r276",
"r277",
"r279",
"r403",
"r454"
],
"lang": {
"en-US": {
"role": {
"documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
"label": "Fair Value Inputs Level3 [Member]",
"terseLabel": "Level 3"
}
}
},
"localname": "FairValueInputsLevel3Member",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureFairValueContingentConsiderationDetails",
"http://www.adapthealth.com/role/DisclosureFairValueOfAssetsAndLiabilitiesNonFinancialAssetsMeasuredOnNonRecurringBasisDetails",
"http://www.adapthealth.com/role/DisclosureFairValueOfAssetsAndLiabilitiesValuationOfFinancialAssetsAndLiabilitiesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
"auth_ref": [
"r408"
],
"lang": {
"en-US": {
"role": {
"documentation": "Represents classes of liabilities measured and disclosed at fair value.",
"label": "Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation By Liability Class [Domain]",
"terseLabel": "Fair Value by Liability Class [Domain]"
}
}
},
"localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureFairValueOfAssetsAndLiabilitiesValuationOfFinancialAssetsAndLiabilitiesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_FairValueMeasurementFrequencyDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Measurement frequency.",
"label": "Fair Value Measurement Frequency [Domain]",
"terseLabel": "Fair Value, Measurement Frequency [Domain]"
}
}
},
"localname": "FairValueMeasurementFrequencyDomain",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureFairValueOfAssetsAndLiabilitiesNonFinancialAssetsMeasuredOnNonRecurringBasisDetails",
"http://www.adapthealth.com/role/DisclosureFairValueOfAssetsAndLiabilitiesValuationOfFinancialAssetsAndLiabilitiesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
"auth_ref": [
"r271",
"r272",
"r273",
"r274",
"r275",
"r276",
"r277",
"r279",
"r452",
"r453",
"r454"
],
"lang": {
"en-US": {
"role": {
"documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
"label": "Fair Value Measurements Fair Value Hierarchy [Domain]",
"terseLabel": "Fair Value Hierarchy and NAV [Domain]"
}
}
},
"localname": "FairValueMeasurementsFairValueHierarchyDomain",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureFairValueContingentConsiderationDetails",
"http://www.adapthealth.com/role/DisclosureFairValueOfAssetsAndLiabilitiesNonFinancialAssetsMeasuredOnNonRecurringBasisDetails",
"http://www.adapthealth.com/role/DisclosureFairValueOfAssetsAndLiabilitiesValuationOfFinancialAssetsAndLiabilitiesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_FairValueMeasurementsNonrecurringMember": {
"auth_ref": [
"r402",
"r403",
"r406",
"r407",
"r409",
"r412"
],
"lang": {
"en-US": {
"role": {
"documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value.",
"label": "Fair Value Measurements Nonrecurring [Member]",
"terseLabel": "Nonrecurring"
}
}
},
"localname": "FairValueMeasurementsNonrecurringMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureFairValueOfAssetsAndLiabilitiesNonFinancialAssetsMeasuredOnNonRecurringBasisDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_FairValueMeasurementsRecurringMember": {
"auth_ref": [
"r410",
"r412"
],
"lang": {
"en-US": {
"role": {
"documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
"label": "Fair Value Measurements Recurring [Member]",
"terseLabel": "Recurring"
}
}
},
"localname": "FairValueMeasurementsRecurringMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureFairValueOfAssetsAndLiabilitiesValuationOfFinancialAssetsAndLiabilitiesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
"label": "Finite-Lived Intangible Asset, Useful Life"
}
}
},
"localname": "FiniteLivedIntangibleAssetUsefulLife",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureGeneralInformationDetails"
],
"xbrltype": "durationItemType"
},
"us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
"auth_ref": [
"r211"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
"label": "Finite-Lived Intangible Assets, Accumulated Amortization"
}
}
},
"localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureGoodwillAndIdentifiableIntangibleAssetsIntangibleAssetsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths": {
"auth_ref": [
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureGoodwillAndIdentifiableIntangibleAssetsIntangibleAssetsDetails": {
"order": 1.0,
"parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the next rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
"label": "Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months",
"terseLabel": "2021"
}
}
},
"localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureGoodwillAndIdentifiableIntangibleAssetsIntangibleAssetsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive": {
"auth_ref": [
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureGoodwillAndIdentifiableIntangibleAssetsIntangibleAssetsDetails": {
"order": 2.0,
"parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized after the fifth rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
"label": "Finite-Lived Intangible Assets, Amortization Expense, Rolling after Year Five",
"terseLabel": "Thereafter"
}
}
},
"localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureGoodwillAndIdentifiableIntangibleAssetsIntangibleAssetsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive": {
"auth_ref": [
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureGoodwillAndIdentifiableIntangibleAssetsIntangibleAssetsDetails": {
"order": 3.0,
"parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the fifth rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
"label": "Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Five",
"terseLabel": "2025"
}
}
},
"localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureGoodwillAndIdentifiableIntangibleAssetsIntangibleAssetsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour": {
"auth_ref": [
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureGoodwillAndIdentifiableIntangibleAssetsIntangibleAssetsDetails": {
"order": 4.0,
"parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the fourth rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
"label": "Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Four",
"terseLabel": "2024"
}
}
},
"localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureGoodwillAndIdentifiableIntangibleAssetsIntangibleAssetsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree": {
"auth_ref": [
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureGoodwillAndIdentifiableIntangibleAssetsIntangibleAssetsDetails": {
"order": 5.0,
"parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the third rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
"label": "Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Three",
"terseLabel": "2023"
}
}
},
"localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureGoodwillAndIdentifiableIntangibleAssetsIntangibleAssetsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo": {
"auth_ref": [
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureGoodwillAndIdentifiableIntangibleAssetsIntangibleAssetsDetails": {
"order": 6.0,
"parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the second rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
"label": "Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Two",
"terseLabel": "2022"
}
}
},
"localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureGoodwillAndIdentifiableIntangibleAssetsIntangibleAssetsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
"auth_ref": [
"r207",
"r208",
"r211",
"r213",
"r463",
"r464"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by major type or class of finite-lived intangible assets.",
"label": "Finite-Lived Intangible Assets by Major Class [Axis]"
}
}
},
"localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureGeneralInformationDetails",
"http://www.adapthealth.com/role/DisclosureGoodwillAndIdentifiableIntangibleAssetsIntangibleAssetsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure": {
"auth_ref": [
"r402"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Fair value portion of assets, excluding financial assets, that lack physical substance, having a limited useful life.",
"label": "Finite-lived Intangible Assets, Fair Value Disclosure"
}
}
},
"localname": "FiniteLivedIntangibleAssetsFairValueDisclosure",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureFairValueOfAssetsAndLiabilitiesNonFinancialAssetsMeasuredOnNonRecurringBasisDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_FiniteLivedIntangibleAssetsLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Finite-Lived Intangible Assets [Line Items]"
}
}
},
"localname": "FiniteLivedIntangibleAssetsLineItems",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureGoodwillAndIdentifiableIntangibleAssetsIntangibleAssetsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
"auth_ref": [
"r207",
"r210"
],
"lang": {
"en-US": {
"role": {
"documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
"label": "Finite Lived Intangible Assets Major Class Name [Domain]",
"terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
}
}
},
"localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureGeneralInformationDetails",
"http://www.adapthealth.com/role/DisclosureGoodwillAndIdentifiableIntangibleAssetsIntangibleAssetsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_FiniteLivedIntangibleAssetsNet": {
"auth_ref": [
"r211",
"r463"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureGoodwillAndIdentifiableIntangibleAssetsIntangibleAssetsDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
"label": "Finite-Lived Intangible Assets, Net",
"totalLabel": "Finite-Lived Intangible Assets, Net, Total"
}
}
},
"localname": "FiniteLivedIntangibleAssetsNet",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureGoodwillAndIdentifiableIntangibleAssetsIntangibleAssetsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_FiniteLivedIntangibleAssetsNetAmortizationExpenseRollingMaturityAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Finite-Lived Intangible Assets, Net, Amortization Expense, Rolling Maturity [Abstract]"
}
}
},
"localname": "FiniteLivedIntangibleAssetsNetAmortizationExpenseRollingMaturityAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureGoodwillAndIdentifiableIntangibleAssetsIntangibleAssetsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": {
"auth_ref": [
"r463"
],
"lang": {
"en-US": {
"role": {
"documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
"label": "Finite-Lived Intangible Assets, Remaining Amortization Period"
}
}
},
"localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureGoodwillAndIdentifiableIntangibleAssetsIntangibleAssetsDetails"
],
"xbrltype": "durationItemType"
},
"us-gaap_GainLossOnSaleOfInvestments": {
"auth_ref": [
"r89"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows": {
"order": 13.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.",
"label": "Gain (Loss) on Sale of Investments",
"negatedLabel": "Gain on sale of investment"
}
}
},
"localname": "GainLossOnSaleOfInvestments",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_GainsLossesOnExtinguishmentOfDebt": {
"auth_ref": [
"r89",
"r231",
"r232"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfOperations": {
"order": 1.0,
"parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
"label": "Gain (Loss) on Extinguishment of Debt",
"negatedLabel": "Loss on extinguishment of debt"
}
}
},
"localname": "GainsLossesOnExtinguishmentOfDebt",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfOperations"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_GeneralAndAdministrativeExpense": {
"auth_ref": [
"r71"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfOperations": {
"order": 3.0,
"parentTag": "us-gaap_CostsAndExpenses",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
"label": "General and Administrative Expense",
"terseLabel": "General and administrative expenses"
}
}
},
"localname": "GeneralAndAdministrativeExpense",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfOperations"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_GeneralAndAdministrativeExpenseMember": {
"auth_ref": [
"r67"
],
"lang": {
"en-US": {
"role": {
"documentation": "Primary financial statement caption encompassing general and administrative expense.",
"label": "General And Administrative Expense [Member]",
"terseLabel": "General and administrative expenses"
}
}
},
"localname": "GeneralAndAdministrativeExpenseMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityEquityBasedCompensationDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_Goodwill": {
"auth_ref": [
"r197",
"r199",
"r478"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails": {
"order": 9.0,
"parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
"weight": 1.0
},
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets": {
"order": 3.0,
"parentTag": "us-gaap_Assets",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
"label": "Goodwill",
"periodEndLabel": "Ending balance",
"periodStartLabel": "Beginning balance",
"terseLabel": "Goodwill"
}
}
},
"localname": "Goodwill",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureGoodwillAndIdentifiableIntangibleAssetsDetails",
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails",
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_GoodwillAcquiredDuringPeriod": {
"auth_ref": [
"r200"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
"label": "Goodwill, Acquired During Period",
"terseLabel": "Acquired goodwill during the period"
}
}
},
"localname": "GoodwillAcquiredDuringPeriod",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureGoodwillAndIdentifiableIntangibleAssetsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Goodwill and Intangible Assets Disclosure [Abstract]"
}
}
},
"localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
"auth_ref": [
"r215"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for goodwill and intangible assets.",
"label": "Goodwill and Intangible Assets Disclosure [Text Block]",
"terseLabel": "Goodwill and Identifiable Intangible Assets"
}
}
},
"localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureGoodwillAndIdentifiableIntangibleAssets"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
"auth_ref": [
"r97",
"r202"
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.",
"label": "Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]",
"terseLabel": "Valuation of Goodwill and Intangible Assets"
}
}
},
"localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureGeneralInformationPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_GoodwillFairValueDisclosure": {
"auth_ref": [
"r402"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Fair value portion of asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
"label": "Goodwill, Fair Value Disclosure",
"terseLabel": "Goodwill (annual impairment assessment)"
}
}
},
"localname": "GoodwillFairValueDisclosure",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureFairValueOfAssetsAndLiabilitiesNonFinancialAssetsMeasuredOnNonRecurringBasisDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_GoodwillImpairmentLoss": {
"auth_ref": [
"r89",
"r198",
"r201",
"r203"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
"label": "Goodwill, Impairment Loss"
}
}
},
"localname": "GoodwillImpairmentLoss",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureGoodwillAndIdentifiableIntangibleAssetsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_GoodwillRollForward": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
"label": "Goodwill [Roll Forward]",
"terseLabel": "Net carrying amount"
}
}
},
"localname": "GoodwillRollForward",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureGoodwillAndIdentifiableIntangibleAssetsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_HealthCareOtherMember": {
"auth_ref": [
"r262"
],
"lang": {
"en-US": {
"role": {
"documentation": "Service provided for maintenance, diagnosis and treatment of physical and mental health, classified as other.",
"label": "Health Care Other [Member]",
"terseLabel": "Other"
}
}
},
"localname": "HealthCareOtherMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureRevenueRecognitionAndAccountsReceivableDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_HedgingDesignationAxis": {
"auth_ref": [
"r384",
"r397"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by designation of purpose of derivative instrument.",
"label": "Hedging Designation [Axis]"
}
}
},
"localname": "HedgingDesignationAxis",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesFinancialInstrumentsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_HedgingDesignationDomain": {
"auth_ref": [
"r384"
],
"lang": {
"en-US": {
"role": {
"documentation": "Designation of purpose of derivative instrument.",
"label": "Hedging Designation [Domain]",
"terseLabel": "Hedging Designation [Domain]"
}
}
},
"localname": "HedgingDesignationDomain",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesFinancialInstrumentsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_ImpairmentOfIntangibleAssetsFinitelived": {
"auth_ref": [
"r89",
"r214"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.",
"label": "Impairment of Intangible Assets, Finite-lived"
}
}
},
"localname": "ImpairmentOfIntangibleAssetsFinitelived",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureGoodwillAndIdentifiableIntangibleAssetsIntangibleAssetsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
"auth_ref": [
"r61",
"r169",
"r177",
"r180",
"r183",
"r185",
"r477",
"r486",
"r494",
"r513"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfOperations": {
"order": 1.0,
"parentTag": "us-gaap_ProfitLoss",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
"label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
"totalLabel": "Income (loss) before income taxes"
}
}
},
"localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfOperations"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
"auth_ref": [
"r59",
"r66",
"r110",
"r112",
"r113",
"r114",
"r115",
"r124",
"r141",
"r144",
"r485",
"r487",
"r492",
"r507"
],
"lang": {
"en-US": {
"role": {
"documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.",
"label": "Income (Loss) from Continuing Operations, Per Basic Share",
"terseLabel": "Basic"
}
}
},
"localname": "IncomeLossFromContinuingOperationsPerBasicShare",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfOperations"
],
"xbrltype": "perShareItemType"
},
"us-gaap_IncomeStatementAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Consolidated Statements of Income (Loss)"
}
}
},
"localname": "IncomeStatementAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_IncomeStatementLocationAxis": {
"auth_ref": [
"r220"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by location in the income statement.",
"label": "Income Statement Location [Axis]"
}
}
},
"localname": "IncomeStatementLocationAxis",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesNotDesignatedDetails",
"http://www.adapthealth.com/role/DisclosureStockholdersEquityEquityBasedCompensationDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_IncomeStatementLocationDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Location in the income statement.",
"label": "Income Statement Location [Domain]",
"terseLabel": "Income Statement Location [Domain]"
}
}
},
"localname": "IncomeStatementLocationDomain",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesNotDesignatedDetails",
"http://www.adapthealth.com/role/DisclosureStockholdersEquityEquityBasedCompensationDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_IncomeTaxDisclosureAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Income Taxes"
}
}
},
"localname": "IncomeTaxDisclosureAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_IncomeTaxDisclosureTextBlock": {
"auth_ref": [
"r320",
"r322",
"r323",
"r327",
"r332",
"r334",
"r335",
"r336"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
"label": "Income Tax Disclosure [Text Block]",
"terseLabel": "Income Taxes"
}
}
},
"localname": "IncomeTaxDisclosureTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureIncomeTaxes"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_IncomeTaxExpenseBenefit": {
"auth_ref": [
"r101",
"r118",
"r119",
"r168",
"r319",
"r328",
"r333",
"r514"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfOperations": {
"order": 2.0,
"parentTag": "us-gaap_ProfitLoss",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
"label": "Income Tax Expense (Benefit)",
"verboseLabel": "Income tax (benefit) expense"
}
}
},
"localname": "IncomeTaxExpenseBenefit",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureIncomeTaxesDetails",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfOperations"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncomeTaxesPaidNet": {
"auth_ref": [
"r92"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
"label": "Income Taxes Paid, Net",
"terseLabel": "Cash paid for income taxes"
}
}
},
"localname": "IncomeTaxesPaidNet",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
"auth_ref": [
"r88"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows": {
"order": 17.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
"label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
"terseLabel": "Accounts payable and accrued expenses and other current liabilities"
}
}
},
"localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncreaseDecreaseInAccountsReceivable": {
"auth_ref": [
"r88"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows": {
"order": 14.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
"label": "Increase (Decrease) in Accounts Receivable",
"negatedLabel": "Accounts receivable"
}
}
},
"localname": "IncreaseDecreaseInAccountsReceivable",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncreaseDecreaseInInventories": {
"auth_ref": [
"r88"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows": {
"order": 15.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
"label": "Increase (Decrease) in Inventories",
"negatedLabel": "Inventory"
}
}
},
"localname": "IncreaseDecreaseInInventories",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Increase (Decrease) in Operating Capital [Abstract]",
"terseLabel": "Changes in operating assets and liabilities, net of effects from acquisitions:"
}
}
},
"localname": "IncreaseDecreaseInOperatingCapitalAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "stringItemType"
},
"us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
"auth_ref": [
"r88"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows": {
"order": 16.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
"label": "Increase (Decrease) in Prepaid Expense and Other Assets",
"negatedLabel": "Prepaid and other assets"
}
}
},
"localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants": {
"auth_ref": [
"r125",
"r126",
"r127",
"r145"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureEarningsPerShareDetails": {
"order": 2.0,
"parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
"weight": 1.0
}
},
"lang": {
"en-US": {
"role": {
"documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.",
"label": "Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants",
"terseLabel": "Add: Warrants"
}
}
},
"localname": "IncrementalCommonSharesAttributableToCallOptionsAndWarrants",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureEarningsPerShareDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares": {
"auth_ref": [
"r126",
"r127",
"r130",
"r131",
"r132",
"r133",
"r134",
"r135",
"r136",
"r145"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureEarningsPerShareDetails": {
"order": 1.0,
"parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
"weight": 1.0
}
},
"lang": {
"en-US": {
"role": {
"documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of contingently issuable shares. Contingently issuable shares are those shares that are issuable for little or no cash contingent on certain conditions being met.",
"label": "Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares",
"terseLabel": "Add: Contingent Consideration Shares"
}
}
},
"localname": "IncrementalCommonSharesAttributableToContingentlyIssuableShares",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureEarningsPerShareDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
"auth_ref": [
"r125",
"r126",
"r128",
"r145"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureEarningsPerShareDetails": {
"order": 3.0,
"parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
"weight": 1.0
}
},
"lang": {
"en-US": {
"role": {
"documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
"label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
"terseLabel": "Add: Unvested restricted stock"
}
}
},
"localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureEarningsPerShareDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_IntangibleAssetsNetExcludingGoodwill": {
"auth_ref": [
"r205",
"r209"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets": {
"order": 4.0,
"parentTag": "us-gaap_Assets",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
"label": "Intangible Assets, Net (Excluding Goodwill)",
"terseLabel": "Identifiable intangible assets, net"
}
}
},
"localname": "IntangibleAssetsNetExcludingGoodwill",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_InterestExpense": {
"auth_ref": [
"r60",
"r167",
"r423",
"r426",
"r493"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfOperations": {
"order": 2.0,
"parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
"label": "Interest Expense",
"terseLabel": "Interest expense, net"
}
}
},
"localname": "InterestExpense",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfOperations"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_InterestExpenseMember": {
"auth_ref": [
"r395"
],
"lang": {
"en-US": {
"role": {
"documentation": "Primary financial statement caption encompassing interest expense.",
"label": "Interest Expense [Member]",
"terseLabel": "Interest expense"
}
}
},
"localname": "InterestExpenseMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesNotDesignatedDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_InterestPaidNet": {
"auth_ref": [
"r82",
"r86",
"r92"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
"label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
"terseLabel": "Cash paid for interest"
}
}
},
"localname": "InterestPaidNet",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_InterestPayableCurrent": {
"auth_ref": [
"r7",
"r8",
"r33"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
"label": "Interest Payable, Current",
"terseLabel": "Accrued interest"
}
}
},
"localname": "InterestPayableCurrent",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureAccountsPayableAndAccruedExpensesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_InterestRateSwapMember": {
"auth_ref": [
"r394"
],
"lang": {
"en-US": {
"role": {
"documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
"label": "Interest Rate Swap [Member]",
"terseLabel": "Interest rate swap agreements"
}
}
},
"localname": "InterestRateSwapMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesFinancialInstrumentsDetails",
"http://www.adapthealth.com/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesNotDesignatedDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_InventoryNet": {
"auth_ref": [
"r1",
"r44"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets": {
"order": 3.0,
"parentTag": "us-gaap_AssetsCurrent",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
"label": "Inventory, Net",
"terseLabel": "Inventory"
}
}
},
"localname": "InventoryNet",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_InvestorMember": {
"auth_ref": [
"r441",
"r442"
],
"lang": {
"en-US": {
"role": {
"documentation": "Business entity or individual that puts money, by purchase or expenditure, in something offering potential profitable returns, such as interest income or appreciation in value.",
"label": "Investor [Member]",
"terseLabel": "Investor"
}
}
},
"localname": "InvestorMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureRelatedPartyTransactionsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_LeaseAndRentalExpense": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
"label": "Operating Leases, Rent Expense",
"terseLabel": "Rent expense"
}
}
},
"localname": "LeaseAndRentalExpense",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureLeasesOperatingDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LeasesOfLesseeDisclosureTextBlock": {
"auth_ref": [
"r438"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for lessee entity's leasing arrangements including, but not limited to, all of the following: (a.) The basis on which contingent rental payments are determined, (b.) The existence and terms of renewal or purchase options and escalation clauses, (c.) Restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing.",
"label": "Leases of Lessee Disclosure [Text Block]",
"terseLabel": "Lease Commitments"
}
}
},
"localname": "LeasesOfLesseeDisclosureTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureLeases"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_LeasesOperatingAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Lease Commitments"
}
}
},
"localname": "LeasesOperatingAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_Liabilities": {
"auth_ref": [
"r32",
"r100",
"r179",
"r195",
"r369",
"r375",
"r376",
"r414"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets": {
"order": 2.0,
"parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
"label": "Liabilities",
"totalLabel": "Total Liabilities"
}
}
},
"localname": "Liabilities",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LiabilitiesAndStockholdersEquity": {
"auth_ref": [
"r23",
"r100",
"r195",
"r414",
"r483",
"r504"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
"label": "Liabilities and Equity",
"totalLabel": "Total Liabilities and Stockholders' Equity (Deficit)"
}
}
},
"localname": "LiabilitiesAndStockholdersEquity",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Liabilities and Equity [Abstract]",
"terseLabel": "Liabilities and Stockholders' Equity (Deficit)"
}
}
},
"localname": "LiabilitiesAndStockholdersEquityAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets"
],
"xbrltype": "stringItemType"
},
"us-gaap_LiabilitiesCurrent": {
"auth_ref": [
"r34",
"r100",
"r195",
"r369",
"r375",
"r376",
"r414"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets": {
"order": 1.0,
"parentTag": "us-gaap_Liabilities",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
"label": "Liabilities, Current",
"totalLabel": "Total current liabilities"
}
}
},
"localname": "LiabilitiesCurrent",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LiabilitiesCurrentAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Liabilities, Current [Abstract]",
"terseLabel": "Current liabilities:"
}
}
},
"localname": "LiabilitiesCurrentAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets"
],
"xbrltype": "stringItemType"
},
"us-gaap_LiabilitiesFairValueDisclosure": {
"auth_ref": [
"r402"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Fair value of financial and nonfinancial obligations.",
"label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
"terseLabel": "Total liabilities measured at fair value"
}
}
},
"localname": "LiabilitiesFairValueDisclosure",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureFairValueOfAssetsAndLiabilitiesValuationOfFinancialAssetsAndLiabilitiesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LiabilitiesFairValueDisclosureAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Liabilities, Fair Value Disclosure [Abstract]",
"terseLabel": "Liabilities"
}
}
},
"localname": "LiabilitiesFairValueDisclosureAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureFairValueOfAssetsAndLiabilitiesValuationOfFinancialAssetsAndLiabilitiesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_LimitedLiabilityCompanyLLCMembersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Limited Liability Company (LLC) Members' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
"terseLabel": "Members' Equity (Deficit)"
}
}
},
"localname": "LimitedLiabilityCompanyLLCMembersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit"
],
"xbrltype": "stringItemType"
},
"us-gaap_LimitedLiabilityCompanyLlcMembersEquityIncludingPortionAttributableToNoncontrollingInterest": {
"auth_ref": [
"r152",
"r245"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of ownership interest in a limited liability company (LLC), including portions attributable to both the parent and noncontrolling interests.",
"label": "Limited Liability Company (LLC) Members' Equity, Including Portion Attributable to Noncontrolling Interest",
"periodEndLabel": "Members equity, Ending Balance",
"periodStartLabel": "Members equity, Beginning Balance"
}
}
},
"localname": "LimitedLiabilityCompanyLlcMembersEquityIncludingPortionAttributableToNoncontrollingInterest",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LineOfCredit": {
"auth_ref": [
"r13",
"r481",
"r498"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
"label": "Long-term Line of Credit",
"terseLabel": "Revolver balance"
}
}
},
"localname": "LineOfCredit",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtLongTermDebtDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LineOfCreditFacilityCommitmentFeePercentage": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.",
"label": "Line of Credit Facility, Commitment Fee Percentage",
"terseLabel": "Commitment fee (as a percent)"
}
}
},
"localname": "LineOfCreditFacilityCommitmentFeePercentage",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtLongTermDebtDetails"
],
"xbrltype": "percentItemType"
},
"us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd": {
"auth_ref": [
"r30"
],
"lang": {
"en-US": {
"role": {
"documentation": "The effective interest rate at the end of the reporting period.",
"label": "Line of Credit Facility, Interest Rate at Period End",
"terseLabel": "Credit facility Interest rate"
}
}
},
"localname": "LineOfCreditFacilityInterestRateAtPeriodEnd",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtLongTermDebtDetails"
],
"xbrltype": "percentItemType"
},
"us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
"auth_ref": [
"r30"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
"label": "Line of Credit Facility, Maximum Borrowing Capacity",
"terseLabel": "Borrowing capacity"
}
}
},
"localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtDetails",
"http://www.adapthealth.com/role/DisclosureDebtLongTermDebtDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal": {
"auth_ref": [
"r30"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of the required periodic payment applied to principal.",
"label": "Line of Credit Facility, Periodic Payment, Principal",
"terseLabel": "Quarterly principal repayments"
}
}
},
"localname": "LineOfCreditFacilityPeriodicPaymentPrincipal",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtLongTermDebtDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
"auth_ref": [
"r30"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
"label": "Line of Credit Facility, Remaining Borrowing Capacity",
"terseLabel": "Remaining maximum borrowings available"
}
}
},
"localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtLongTermDebtDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LongTermDebt": {
"auth_ref": [
"r13",
"r230",
"r481",
"r500"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureDebtDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
},
"http://www.adapthealth.com/role/DisclosureDebtDetailsCalc2": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
"label": "Long-term Debt",
"totalLabel": "Debt, Net"
}
}
},
"localname": "LongTermDebt",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LongTermDebtCurrent": {
"auth_ref": [
"r31"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureDebtDetails": {
"order": 2.0,
"parentTag": "us-gaap_LongTermDebt",
"weight": 1.0
},
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets": {
"order": 4.0,
"parentTag": "us-gaap_LiabilitiesCurrent",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
"label": "Long-term Debt, Current Maturities",
"negatedLabel": "Current portion",
"terseLabel": "Current portion of long-term debt"
}
}
},
"localname": "LongTermDebtCurrent",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtDetails",
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LongTermDebtNoncurrent": {
"auth_ref": [
"r36"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureDebtDetails": {
"order": 1.0,
"parentTag": "us-gaap_LongTermDebt",
"weight": 1.0
},
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets": {
"order": 2.0,
"parentTag": "us-gaap_Liabilities",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
"label": "Long-term Debt, Excluding Current Maturities",
"terseLabel": "Long-term debt, less current portion",
"verboseLabel": "Long-term portion"
}
}
},
"localname": "LongTermDebtNoncurrent",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtDetails",
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LossContingencyAccrualAtCarryingValue": {
"auth_ref": [
"r225"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of loss contingency liability.",
"label": "Loss Contingency Accrual",
"terseLabel": "Accrual related to lawsuits, claims, investigations and proceedings"
}
}
},
"localname": "LossContingencyAccrualAtCarryingValue",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureCommitmentsAndContingenciesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_MemberUnitsMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Ownership interest in limited liability company (LLC).",
"label": "Member Units [Member]",
"terseLabel": "Members interest"
}
}
},
"localname": "MemberUnitsMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit"
],
"xbrltype": "domainItemType"
},
"us-gaap_MinorityInterest": {
"auth_ref": [
"r43",
"r100",
"r195",
"r414",
"r482",
"r503"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets": {
"order": 1.0,
"parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
"label": "Stockholders' Equity Attributable to Noncontrolling Interest",
"terseLabel": "Noncontrolling interest in subsidiaries"
}
}
},
"localname": "MinorityInterest",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
"auth_ref": [
"r245"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
"label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
"negatedLabel": "Distributions to noncontrolling interest"
}
}
},
"localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.",
"label": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners",
"terseLabel": "Noncontrolling interest, as a percent"
}
}
},
"localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsBusinessCombinationDetails"
],
"xbrltype": "percentItemType"
},
"us-gaap_MinorityInterestOwnershipPercentageByParent": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.",
"label": "Noncontrolling Interest, Ownership Percentage by Parent",
"terseLabel": "Controlling interest, as a percent"
}
}
},
"localname": "MinorityInterestOwnershipPercentageByParent",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsBusinessCombinationDetails"
],
"xbrltype": "percentItemType"
},
"us-gaap_MoneyMarketFundsMember": {
"auth_ref": [
"r271"
],
"lang": {
"en-US": {
"role": {
"documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
"label": "Money Market Funds [Member]",
"terseLabel": "Money market accounts"
}
}
},
"localname": "MoneyMarketFundsMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureFairValueOfAssetsAndLiabilitiesValuationOfFinancialAssetsAndLiabilitiesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_NetCashProvidedByUsedInFinancingActivities": {
"auth_ref": [
"r85"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows": {
"order": 3.0,
"parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
"label": "Net Cash Provided by (Used in) Financing Activities",
"totalLabel": "Net cash provided by financing activities"
}
}
},
"localname": "NetCashProvidedByUsedInFinancingActivities",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
"terseLabel": "Cash flows from financing activities:"
}
}
},
"localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "stringItemType"
},
"us-gaap_NetCashProvidedByUsedInInvestingActivities": {
"auth_ref": [
"r85"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows": {
"order": 2.0,
"parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
"label": "Net Cash Provided by (Used in) Investing Activities",
"totalLabel": "Net cash used in investing activities"
}
}
},
"localname": "NetCashProvidedByUsedInInvestingActivities",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
"terseLabel": "Cash flows from investing activities:"
}
}
},
"localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "stringItemType"
},
"us-gaap_NetCashProvidedByUsedInOperatingActivities": {
"auth_ref": [
"r85",
"r87",
"r90"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows": {
"order": 1.0,
"parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
"weight": 1.0
}
},
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
"label": "Net Cash Provided by (Used in) Operating Activities",
"totalLabel": "Net cash provided by operating activities"
}
}
},
"localname": "NetCashProvidedByUsedInOperatingActivities",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
"terseLabel": "Cash flows from operating activities:"
}
}
},
"localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "stringItemType"
},
"us-gaap_NetIncomeLoss": {
"auth_ref": [
"r0",
"r54",
"r56",
"r62",
"r90",
"r100",
"r110",
"r112",
"r113",
"r114",
"r115",
"r118",
"r119",
"r138",
"r169",
"r177",
"r180",
"r183",
"r185",
"r195",
"r414",
"r488",
"r508"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureEarningsPerShareDetails": {
"order": 1.0,
"parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
"weight": 1.0
},
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfOperations": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
"label": "Net Income (Loss) Attributable to Parent",
"totalLabel": "Net income (loss) attributable to AdaptHealth Corp."
}
}
},
"localname": "NetIncomeLoss",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureEarningsPerShareDetails",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfOperations"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NetIncomeLossAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Net Income (Loss) Attributable to Parent [Abstract]",
"terseLabel": "Numerator:"
}
}
},
"localname": "NetIncomeLossAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureEarningsPerShareDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
"auth_ref": [
"r54",
"r56",
"r118",
"r119",
"r372",
"r378"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureEarningsPerShareDetails": {
"order": 1.0,
"parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted",
"weight": -1.0
},
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfOperations": {
"order": 1.0,
"parentTag": "us-gaap_NetIncomeLoss",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
"label": "Net Income (Loss) Attributable to Noncontrolling Interest",
"terseLabel": "Income (loss) attributable to noncontrolling interest"
}
}
},
"localname": "NetIncomeLossAttributableToNoncontrollingInterest",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfOperations"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
"auth_ref": [
"r112",
"r113",
"r114",
"r115",
"r121",
"r122",
"r140",
"r145",
"r169",
"r177",
"r180",
"r183",
"r185"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureEarningsPerShareDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
"label": "Net Income (Loss) Available to Common Stockholders, Basic"
}
}
},
"localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureEarningsPerShareDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
"auth_ref": [
"r123",
"r140",
"r145"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureEarningsPerShareDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.",
"label": "Net Income (Loss) Available to Common Stockholders, Diluted",
"totalLabel": "Net Income (Loss) Available to Common Stockholders, Diluted, Total"
}
}
},
"localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureEarningsPerShareDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
"label": "New Accounting Pronouncements, Policy [Policy Text Block]",
"terseLabel": "Recent Accounting Pronouncements"
}
}
},
"localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureGeneralInformationPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Noncash Investing and Financing Items [Abstract]",
"terseLabel": "Noncash investing and financing activities:"
}
}
},
"localname": "NoncashInvestingAndFinancingItemsAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "stringItemType"
},
"us-gaap_NoncontrollingInterestMember": {
"auth_ref": [
"r107",
"r108",
"r109",
"r245",
"r363"
],
"lang": {
"en-US": {
"role": {
"documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
"label": "Noncontrolling Interest [Member]",
"terseLabel": "Noncontrolling interests in subsidiaries"
}
}
},
"localname": "NoncontrollingInterestMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit"
],
"xbrltype": "domainItemType"
},
"us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock": {
"auth_ref": [
"r292"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock shares.",
"label": "Nonvested Restricted Stock Shares Activity [Table Text Block]"
}
}
},
"localname": "NonvestedRestrictedStockSharesActivityTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_NotesPayableOtherPayablesMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "A written promise to pay a note to a third party.",
"label": "Notes Payable Other Payables [Member]",
"terseLabel": "New Promissory Note"
}
}
},
"localname": "NotesPayableOtherPayablesMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtDetails",
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_NotesPayableRelatedPartiesNoncurrent": {
"auth_ref": [
"r37",
"r105",
"r442"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The amount for notes payable (written promise to pay), payable to related parties, which are due after one year (or one business cycle).",
"label": "Notes Payable, Related Parties, Noncurrent",
"terseLabel": "Loan from related party"
}
}
},
"localname": "NotesPayableRelatedPartiesNoncurrent",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureRelatedPartyTransactionsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OperatingIncomeLoss": {
"auth_ref": [
"r169",
"r177",
"r180",
"r183",
"r185"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfOperations": {
"order": 3.0,
"parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The net result for the period of deducting operating expenses from operating revenues.",
"label": "Operating Income (Loss)",
"totalLabel": "Operating income"
}
}
},
"localname": "OperatingIncomeLoss",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfOperations"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OperatingLeasesFutureMinimumPaymentsDue": {
"auth_ref": [
"r429",
"r430"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureLeasesOperatingDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.",
"label": "Operating Leases, Future Minimum Payments Due",
"totalLabel": "Lease commitments"
}
}
},
"localname": "OperatingLeasesFutureMinimumPaymentsDue",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureLeasesOperatingDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]",
"terseLabel": "Minimum annual lease commitments under noncancelable leases"
}
}
},
"localname": "OperatingLeasesFutureMinimumPaymentsDueAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureLeasesOperatingDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals": {
"auth_ref": [
"r431"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Contractually required future rental payments receivable on noncancelable subleasing arrangements.",
"label": "Operating Leases, Future Minimum Payments Due, Future Minimum Sublease Rentals",
"terseLabel": "Minimum sublease rentals"
}
}
},
"localname": "OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureLeasesOperatingDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OperatingLeasesFutureMinimumPaymentsDueInRollingAfterYearFive": {
"auth_ref": [
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureLeasesOperatingDetails": {
"order": 1.0,
"parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
"label": "Operating Leases, Future Minimum Payments, Due in Rolling after Year Five",
"terseLabel": "Thereafter"
}
}
},
"localname": "OperatingLeasesFutureMinimumPaymentsDueInRollingAfterYearFive",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureLeasesOperatingDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OperatingLeasesFutureMinimumPaymentsDueInRollingYearFive": {
"auth_ref": [
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureLeasesOperatingDetails": {
"order": 2.0,
"parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
"label": "Operating Leases, Future Minimum Payments, Due in Rolling Year Five",
"terseLabel": "2025"
}
}
},
"localname": "OperatingLeasesFutureMinimumPaymentsDueInRollingYearFive",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureLeasesOperatingDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OperatingLeasesFutureMinimumPaymentsDueInRollingYearFour": {
"auth_ref": [
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureLeasesOperatingDetails": {
"order": 3.0,
"parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
"label": "Operating Leases, Future Minimum Payments, Due in Rolling Year Four",
"terseLabel": "2024"
}
}
},
"localname": "OperatingLeasesFutureMinimumPaymentsDueInRollingYearFour",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureLeasesOperatingDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OperatingLeasesFutureMinimumPaymentsDueInRollingYearThree": {
"auth_ref": [
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureLeasesOperatingDetails": {
"order": 4.0,
"parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
"label": "Operating Leases, Future Minimum Payments, Due in Rolling Year Three",
"terseLabel": "2023"
}
}
},
"localname": "OperatingLeasesFutureMinimumPaymentsDueInRollingYearThree",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureLeasesOperatingDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OperatingLeasesFutureMinimumPaymentsDueInRollingYearTwo": {
"auth_ref": [
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureLeasesOperatingDetails": {
"order": 5.0,
"parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
"label": "Operating Leases, Future Minimum Payments, Due in Rolling Year Two",
"terseLabel": "2022"
}
}
},
"localname": "OperatingLeasesFutureMinimumPaymentsDueInRollingYearTwo",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureLeasesOperatingDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OperatingLeasesFutureMinimumPaymentsDueRollingMaturityAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Operating Leases, Future Minimum Payments Due, Rolling Maturity [Abstract]"
}
}
},
"localname": "OperatingLeasesFutureMinimumPaymentsDueRollingMaturityAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureLeasesOperatingDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_OperatingLeasesFutureMinimumPaymentsNextRollingTwelveMonths": {
"auth_ref": [
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureLeasesOperatingDetails": {
"order": 6.0,
"parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
"label": "Operating Leases, Future Minimum Payments, Next Rolling Twelve Months",
"terseLabel": "2021"
}
}
},
"localname": "OperatingLeasesFutureMinimumPaymentsNextRollingTwelveMonths",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureLeasesOperatingDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "General Information"
}
}
},
"localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": {
"auth_ref": [
"r106",
"r120",
"r164",
"r380"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.",
"label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]",
"terseLabel": "General Information"
}
}
},
"localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureGeneralInformation"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_OtherAssetsNoncurrent": {
"auth_ref": [
"r28"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets": {
"order": 5.0,
"parentTag": "us-gaap_Assets",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of noncurrent assets classified as other.",
"label": "Other Assets, Noncurrent",
"terseLabel": "Other assets"
}
}
},
"localname": "OtherAssetsNoncurrent",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
"auth_ref": [
"r48",
"r50"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfComprehensiveIncomeLoss": {
"order": 2.0,
"parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
"label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
"terseLabel": "Interest rate swap agreements, inclusive of reclassification adjustment"
}
}
},
"localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfComprehensiveIncomeLoss"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
"terseLabel": "Other comprehensive loss:"
}
}
},
"localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfComprehensiveIncomeLoss"
],
"xbrltype": "stringItemType"
},
"us-gaap_OtherCurrentLiabilitiesMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Primary financial statement caption encompassing other current liabilities.",
"label": "Other Current Liabilities [Member]",
"terseLabel": "Other current liabilities"
}
}
},
"localname": "OtherCurrentLiabilitiesMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesFinancialInstrumentsDetails",
"http://www.adapthealth.com/role/DisclosureFairValueContingentConsiderationDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_OtherLiabilitiesCurrent": {
"auth_ref": [
"r5",
"r6",
"r33"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets": {
"order": 5.0,
"parentTag": "us-gaap_LiabilitiesCurrent",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
"label": "Other Liabilities, Current",
"terseLabel": "Other liabilities"
}
}
},
"localname": "OtherLiabilitiesCurrent",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherLiabilitiesNoncurrent": {
"auth_ref": [
"r38"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets": {
"order": 3.0,
"parentTag": "us-gaap_Liabilities",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
"label": "Other Liabilities, Noncurrent",
"terseLabel": "Other long-term liabilities"
}
}
},
"localname": "OtherLiabilitiesNoncurrent",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherNoncurrentLiabilitiesMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
"label": "Other Noncurrent Liabilities [Member]",
"terseLabel": "Other long-term liabilities"
}
}
},
"localname": "OtherNoncurrentLiabilitiesMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesFinancialInstrumentsDetails",
"http://www.adapthealth.com/role/DisclosureFairValueContingentConsiderationDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_OtherSundryLiabilitiesCurrent": {
"auth_ref": [
"r33",
"r228"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.",
"label": "Other Sundry Liabilities, Current",
"terseLabel": "Current tax liability associated with recapitalization"
}
}
},
"localname": "OtherSundryLiabilitiesCurrent",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PaidInKindInterest": {
"auth_ref": [
"r89"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows": {
"order": 10.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method.",
"label": "Paid-in-Kind Interest",
"terseLabel": "Imputed interest expense"
}
}
},
"localname": "PaidInKindInterest",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PartnersCapitalAccountDistributions": {
"auth_ref": [
"r245",
"r246"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Total distributions to each class of partners (i.e., general, limited and preferred partners).",
"label": "Partners' Capital Account, Distributions",
"negatedLabel": "Distributions to members",
"terseLabel": "Distributions to members"
}
}
},
"localname": "PartnersCapitalAccountDistributions",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtLongTermDebtDetails",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PartnersCapitalAccountRedemptions": {
"auth_ref": [
"r245",
"r246"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Total change in each class of partners' capital accounts during the year due to redemptions and adjustments to redemption value. All partners include general, limited and preferred partners.",
"label": "Partners' Capital Account, Redemptions",
"negatedLabel": "Redemption of members' interest",
"terseLabel": "Redemption of members' interest"
}
}
},
"localname": "PartnersCapitalAccountRedemptions",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtLongTermDebtDetails",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PartnersCapitalAccountSaleOfUnits": {
"auth_ref": [
"r245",
"r246"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Total change in each class of partners' capital accounts during the year due to the sale of units. All partners include general, limited and preferred partners.",
"label": "Partners' Capital Account, Sale of Units",
"terseLabel": "Issuance of members' interest, net of offering costs of $837"
}
}
},
"localname": "PartnersCapitalAccountSaleOfUnits",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PartnersCapitalAccountUnitBasedCompensation": {
"auth_ref": [
"r245",
"r246"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of increase (decrease) in partners' capital account for unit-based payment arrangement issued by partnership. Partner includes, but is not limited to, general, limited and preferred partners.",
"label": "Partners' Capital Account, Unit-based Compensation",
"terseLabel": "Equity-based compensation"
}
}
},
"localname": "PartnersCapitalAccountUnitBasedCompensation",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": {
"auth_ref": [
"r80"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows": {
"order": 12.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
"label": "Payment for Contingent Consideration Liability, Financing Activities",
"negatedLabel": "Payment of contingent consideration in connection with acquisition- financing"
}
}
},
"localname": "PaymentForContingentConsiderationLiabilityFinancingActivities",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities": {
"auth_ref": [
"r83"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows": {
"order": 7.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability exceeding amount recognized at acquisition date. Includes, but is not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
"label": "Payment for Contingent Consideration Liability, Operating Activities",
"negatedLabel": "Payment of contingent consideration in connection with acquisition - operating"
}
}
},
"localname": "PaymentForContingentConsiderationLiabilityOperatingActivities",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PaymentsForRepurchaseOfPreferredStockAndPreferenceStock": {
"auth_ref": [
"r77"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows": {
"order": 14.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The cash outflow to reacquire preferred stock during the period.",
"label": "Payments for Repurchase of Preferred Stock and Preference Stock",
"negatedLabel": "Payments for redemption of members' interest"
}
}
},
"localname": "PaymentsForRepurchaseOfPreferredStockAndPreferenceStock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PaymentsOfDebtIssuanceCosts": {
"auth_ref": [
"r79"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
"label": "Payments of Debt Issuance Costs"
}
}
},
"localname": "PaymentsOfDebtIssuanceCosts",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtLongTermDebtDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PaymentsOfFinancingCosts": {
"auth_ref": [
"r81"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows": {
"order": 10.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The cash outflow for loan and debt issuance costs.",
"label": "Payments of Financing Costs",
"negatedLabel": "Payments of deferred financing costs"
}
}
},
"localname": "PaymentsOfFinancingCosts",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PaymentsOfStockIssuanceCosts": {
"auth_ref": [
"r81"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows": {
"order": 9.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
"label": "Payments of Stock Issuance Costs",
"negatedLabel": "Payments for equity issuance costs",
"terseLabel": "Offering costs"
}
}
},
"localname": "PaymentsOfStockIssuanceCosts",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitParenthetical"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PaymentsToAcquireBusinessesGross": {
"auth_ref": [
"r73",
"r355"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails": {
"order": 5.0,
"parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
"label": "Payments to Acquire Businesses, Gross",
"terseLabel": "Cash payment"
}
}
},
"localname": "PaymentsToAcquireBusinessesGross",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails",
"http://www.adapthealth.com/role/DisclosureSubsequentEventsFinancingAndAcquisitionsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
"auth_ref": [
"r73"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows": {
"order": 1.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
"label": "Payments to Acquire Businesses, Net of Cash Acquired",
"negatedLabel": "Payments for business acquisitions, net of cash acquired"
}
}
},
"localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PaymentsToAcquireMarketableSecurities": {
"auth_ref": [
"r193"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows": {
"order": 2.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cash outflow for purchase of marketable security.",
"label": "Payments to Acquire Marketable Securities",
"negatedLabel": "Payments for investments in cost-method companies",
"terseLabel": "Payments to acquire cost method investments"
}
}
},
"localname": "PaymentsToAcquireMarketableSecurities",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsBusinessCombinationDetails",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
"auth_ref": [
"r74"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows": {
"order": 4.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
"label": "Payments to Acquire Property, Plant, and Equipment",
"negatedLabel": "Purchases of equipment and other fixed assets"
}
}
},
"localname": "PaymentsToAcquirePropertyPlantAndEquipment",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PaymentsToMinorityShareholders": {
"auth_ref": [
"r81"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows": {
"order": 4.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.",
"label": "Payments to Noncontrolling Interests",
"negatedLabel": "Distributions to noncontrolling interest"
}
}
},
"localname": "PaymentsToMinorityShareholders",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PerformanceSharesMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Share-based payment arrangement awarded for meeting performance target.",
"label": "Performance Shares [Member]",
"terseLabel": "Vesting based on performance"
}
}
},
"localname": "PerformanceSharesMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityCommonStockAwardsDetails",
"http://www.adapthealth.com/role/DisclosureStockholdersEquityRestrictedStockDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_PlanNameAxis": {
"auth_ref": [
"r288",
"r308"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by plan name for share-based payment arrangement.",
"label": "Plan Name [Axis]"
}
}
},
"localname": "PlanNameAxis",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityEquityBasedCompensationDetails",
"http://www.adapthealth.com/role/DisclosureStockholdersEquityIncentiveUnitsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_PlanNameDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Plan name for share-based payment arrangement.",
"label": "Plan Name [Domain]",
"terseLabel": "Plan Name [Domain]"
}
}
},
"localname": "PlanNameDomain",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityEquityBasedCompensationDetails",
"http://www.adapthealth.com/role/DisclosureStockholdersEquityIncentiveUnitsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_PreferredClassAMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Outstanding nonredeemable preferred class A stock or outstanding convertible preferred class A stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
"label": "Preferred Class A [Member]",
"terseLabel": "Series A Preferred Stock"
}
}
},
"localname": "PreferredClassAMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_PreferredClassBMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Outstanding nonredeemable preferred class B stock or outstanding preferred class B stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
"label": "Preferred Class B [Member]",
"terseLabel": "Series B Preferred Stock"
}
}
},
"localname": "PreferredClassBMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_PreferredStockLiquidationPreference": {
"auth_ref": [
"r15",
"r98",
"r238",
"r239"
],
"lang": {
"en-US": {
"role": {
"documentation": "The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.",
"label": "Preferred Stock, Liquidation Preference Per Share",
"terseLabel": "Preferred stock, liquidation preference (in dollars per share)"
}
}
},
"localname": "PreferredStockLiquidationPreference",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails"
],
"xbrltype": "perShareItemType"
},
"us-gaap_PreferredStockMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.",
"label": "Preferred Stock [Member]",
"terseLabel": "Preferred Stock"
}
}
},
"localname": "PreferredStockMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit"
],
"xbrltype": "domainItemType"
},
"us-gaap_PreferredStockParOrStatedValuePerShare": {
"auth_ref": [
"r15"
],
"lang": {
"en-US": {
"role": {
"documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
"label": "Preferred Stock, Par or Stated Value Per Share",
"terseLabel": "Preferred stock, par value (in dollars per share)"
}
}
},
"localname": "PreferredStockParOrStatedValuePerShare",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails",
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheetsParenthetical"
],
"xbrltype": "perShareItemType"
},
"us-gaap_PreferredStockSharesAuthorized": {
"auth_ref": [
"r15"
],
"lang": {
"en-US": {
"role": {
"documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
"label": "Preferred Stock, Shares Authorized",
"terseLabel": "Preferred stock, shares authorized (in shares)"
}
}
},
"localname": "PreferredStockSharesAuthorized",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheetsParenthetical"
],
"xbrltype": "sharesItemType"
},
"us-gaap_PreferredStockSharesIssued": {
"auth_ref": [
"r15"
],
"lang": {
"en-US": {
"role": {
"documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
"label": "Preferred Stock, Shares Issued",
"terseLabel": "Preferred stock, shares issued (in shares)"
}
}
},
"localname": "PreferredStockSharesIssued",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheetsParenthetical"
],
"xbrltype": "sharesItemType"
},
"us-gaap_PreferredStockSharesOutstanding": {
"auth_ref": [
"r15"
],
"lang": {
"en-US": {
"role": {
"documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
"label": "Preferred Stock, Shares Outstanding",
"terseLabel": "Preferred stock, shares outstanding (in shares)"
}
}
},
"localname": "PreferredStockSharesOutstanding",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheetsParenthetical"
],
"xbrltype": "sharesItemType"
},
"us-gaap_PreferredStockValue": {
"auth_ref": [
"r15"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets": {
"order": 4.0,
"parentTag": "us-gaap_StockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
"label": "Preferred Stock, Value, Issued",
"terseLabel": "Preferred Stock, par value of $0.0001 per share, 5,000,000 shares authorized; 183,560 and 0 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively"
}
}
},
"localname": "PreferredStockValue",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
"auth_ref": [
"r3",
"r24",
"r25"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets": {
"order": 4.0,
"parentTag": "us-gaap_AssetsCurrent",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
"label": "Prepaid Expense and Other Assets, Current",
"terseLabel": "Prepaid and other current assets"
}
}
},
"localname": "PrepaidExpenseAndOtherAssetsCurrent",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PrivatePlacementMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.",
"label": "Private Placement [Member]",
"terseLabel": "Private Placement [Member]"
}
}
},
"localname": "PrivatePlacementMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitParenthetical"
],
"xbrltype": "domainItemType"
},
"us-gaap_ProceedsFromIssuanceOfCommonLimitedPartnersUnits": {
"auth_ref": [
"r75"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows": {
"order": 8.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The cash inflow from the issuance of common limited partners units during the period.",
"label": "Proceeds from Issuance of Common Limited Partners Units",
"terseLabel": "Proceeds from issuance of members' interests"
}
}
},
"localname": "ProceedsFromIssuanceOfCommonLimitedPartnersUnits",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ProceedsFromIssuanceOfCommonStock": {
"auth_ref": [
"r75"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows": {
"order": 15.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The cash inflow from the additional capital contribution to the entity.",
"label": "Proceeds from Issuance of Common Stock",
"terseLabel": "Proceed from issuance of Class A Common Stock"
}
}
},
"localname": "ProceedsFromIssuanceOfCommonStock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ProceedsFromIssuanceOfPrivatePlacement": {
"auth_ref": [
"r75"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows": {
"order": 5.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.",
"label": "Proceeds from Issuance of Private Placement",
"verboseLabel": "Proceeds from the sale of Class A Common Stock and Series A Preferred Stock"
}
}
},
"localname": "ProceedsFromIssuanceOfPrivatePlacement",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ProceedsFromIssuanceOfUnsecuredDebt": {
"auth_ref": [
"r76"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows": {
"order": 6.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The cash inflow from the issuance of long-term debt that is not secured by collateral. Excludes proceeds from tax exempt unsecured debt.",
"label": "Proceeds from Issuance of Unsecured Debt",
"terseLabel": "Proceeds from the issuance of senior unsecured notes, net of related discount"
}
}
},
"localname": "ProceedsFromIssuanceOfUnsecuredDebt",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ProceedsFromLinesOfCredit": {
"auth_ref": [
"r76",
"r104"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows": {
"order": 16.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
"label": "Proceeds from Lines of Credit",
"verboseLabel": "Proceeds from borrowings on long-term debt and lines of credit"
}
}
},
"localname": "ProceedsFromLinesOfCredit",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtLongTermDebtDetails",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ProceedsFromNotesPayable": {
"auth_ref": [
"r76"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows": {
"order": 7.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation.",
"label": "Proceeds from Notes Payable",
"terseLabel": "Proceeds from issuance of promissory note payable"
}
}
},
"localname": "ProceedsFromNotesPayable",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ProceedsFromSaleOfTradingSecuritiesHeldforinvestment": {
"auth_ref": [
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows": {
"order": 3.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The cash inflow associated with the sale of securities classified as trading securities and held for investment purposes. Excludes proceeds from trading securities purchased and held principally for the purpose of selling them in the near term (thus held for only a short period of time).",
"label": "Proceeds from Sale of Debt and Equity Securities, FV-NI, Held-for-investment",
"terseLabel": "Proceeds from sale of investment"
}
}
},
"localname": "ProceedsFromSaleOfTradingSecuritiesHeldforinvestment",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ProceedsFromWarrantExercises": {
"auth_ref": [
"r75"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows": {
"order": 3.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.",
"label": "Proceeds from Warrant Exercises",
"terseLabel": "Proceeds from exercise of warrants"
}
}
},
"localname": "ProceedsFromWarrantExercises",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ProfitLoss": {
"auth_ref": [
"r0",
"r54",
"r56",
"r84",
"r100",
"r110",
"r118",
"r119",
"r169",
"r177",
"r180",
"r183",
"r185",
"r195",
"r365",
"r371",
"r373",
"r378",
"r379",
"r414",
"r494"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureEarningsPerShareDetails": {
"order": 2.0,
"parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted",
"weight": 1.0
},
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows": {
"order": 1.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
},
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfComprehensiveIncomeLoss": {
"order": 1.0,
"parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
"weight": 1.0
},
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfOperations": {
"order": 2.0,
"parentTag": "us-gaap_NetIncomeLoss",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
"label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
"terseLabel": "Net income (loss)",
"totalLabel": "Net income (loss)"
}
}
},
"localname": "ProfitLoss",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfComprehensiveIncomeLoss",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfOperations"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PropertyPlantAndEquipmentAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Equipment and Other Fixed Assets"
}
}
},
"localname": "PropertyPlantAndEquipmentAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
"auth_ref": [
"r27",
"r219"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
"label": "Property, Plant and Equipment, Type [Axis]"
}
}
},
"localname": "PropertyPlantAndEquipmentByTypeAxis",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureEquipmentAndOtherFixedAssetsDetails",
"http://www.adapthealth.com/role/DisclosureLeasesCapitalLeasesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
"auth_ref": [
"r221",
"r526",
"r527",
"r528"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
"label": "Property, Plant and Equipment Disclosure [Text Block]",
"terseLabel": "Equipment and Other Fixed Assets"
}
}
},
"localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureEquipmentAndOtherFixedAssets"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_PropertyPlantAndEquipmentGross": {
"auth_ref": [
"r26",
"r217"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureEquipmentAndOtherFixedAssetsDetails": {
"order": 2.0,
"parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
"label": "Property, Plant and Equipment, Gross",
"terseLabel": "Equipment and other fixed assets, gross"
}
}
},
"localname": "PropertyPlantAndEquipmentGross",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureEquipmentAndOtherFixedAssetsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PropertyPlantAndEquipmentLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Property, Plant and Equipment [Line Items]"
}
}
},
"localname": "PropertyPlantAndEquipmentLineItems",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureEquipmentAndOtherFixedAssetsDetails",
"http://www.adapthealth.com/role/DisclosureGeneralInformationDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_PropertyPlantAndEquipmentNet": {
"auth_ref": [
"r9",
"r10",
"r219",
"r505"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureEquipmentAndOtherFixedAssetsDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
},
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets": {
"order": 6.0,
"parentTag": "us-gaap_Assets",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
"label": "Property, Plant and Equipment, Net",
"terseLabel": "Equipment and other fixed assets, net",
"totalLabel": "Equipment and other fixed assets, net"
}
}
},
"localname": "PropertyPlantAndEquipmentNet",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureEquipmentAndOtherFixedAssetsDetails",
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PropertyPlantAndEquipmentOtherTypesMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Long-lived, physical assets used to produce goods and services and not intended for resale, classified as other.",
"label": "Property Plant And Equipment Other Types [Member]",
"terseLabel": "Other"
}
}
},
"localname": "PropertyPlantAndEquipmentOtherTypesMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureEquipmentAndOtherFixedAssetsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_PropertyPlantAndEquipmentTextBlock": {
"auth_ref": [
"r9",
"r219"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
"label": "Property, Plant and Equipment [Table Text Block]",
"terseLabel": "Schedule of equipment and other fixed assets"
}
}
},
"localname": "PropertyPlantAndEquipmentTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureEquipmentAndOtherFixedAssetsTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_PropertyPlantAndEquipmentTypeDomain": {
"auth_ref": [
"r9",
"r217"
],
"lang": {
"en-US": {
"role": {
"documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
"label": "Property Plant And Equipment Type [Domain]",
"terseLabel": "Property, Plant and Equipment, Type [Domain]"
}
}
},
"localname": "PropertyPlantAndEquipmentTypeDomain",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureEquipmentAndOtherFixedAssetsDetails",
"http://www.adapthealth.com/role/DisclosureLeasesCapitalLeasesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent": {
"auth_ref": [
"r52"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.",
"label": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net",
"terseLabel": "Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income"
}
}
},
"localname": "ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesEffectOnAccumulatedOtherComprehensiveIncomeDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_RelatedPartyDomain": {
"auth_ref": [
"r278",
"r441",
"r442"
],
"lang": {
"en-US": {
"role": {
"documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
"label": "Related Party [Domain]",
"terseLabel": "Related Party [Domain]"
}
}
},
"localname": "RelatedPartyDomain",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureRelatedPartyTransactionsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": {
"auth_ref": [
"r441"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
"label": "Related Party Transaction, Expenses from Transactions with Related Party",
"terseLabel": "Expense for related party"
}
}
},
"localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureRelatedPartyTransactionsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_RelatedPartyTransactionLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Related Party Transaction [Line Items]"
}
}
},
"localname": "RelatedPartyTransactionLineItems",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureRelatedPartyTransactionsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_RelatedPartyTransactionsAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Related Party Transactions"
}
}
},
"localname": "RelatedPartyTransactionsAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
"auth_ref": [
"r278",
"r441",
"r445",
"r465",
"r466",
"r467",
"r468",
"r469",
"r470",
"r471",
"r472",
"r473",
"r474",
"r475",
"r476"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
"label": "Related Party [Axis]"
}
}
},
"localname": "RelatedPartyTransactionsByRelatedPartyAxis",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureRelatedPartyTransactionsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
"auth_ref": [
"r439",
"r440",
"r442",
"r446",
"r447"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
"label": "Related Party Transactions Disclosure [Text Block]",
"verboseLabel": "Related Party Transactions"
}
}
},
"localname": "RelatedPartyTransactionsDisclosureTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureRelatedPartyTransactions"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_RepaymentsOfLinesOfCredit": {
"auth_ref": [
"r78",
"r104"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
"label": "Repayments of Lines of Credit",
"terseLabel": "Repayment of credit facility"
}
}
},
"localname": "RepaymentsOfLinesOfCredit",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtLongTermDebtDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_RepaymentsOfLongTermCapitalLeaseObligations": {
"auth_ref": [
"r78"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows": {
"order": 2.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The cash outflow for the obligation for a lease meeting the criteria for capitalization (with maturities exceeding one year or beyond the operating cycle of the entity, if longer).",
"label": "Finance Lease, Principal Payments",
"negatedLabel": "Payments on capital leases"
}
}
},
"localname": "RepaymentsOfLongTermCapitalLeaseObligations",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_RepaymentsOfLongTermDebt": {
"auth_ref": [
"r78"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows": {
"order": 1.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
"label": "Repayments of Long-term Debt",
"negatedLabel": "Repayments on long-term debt and lines of credit",
"terseLabel": "Repayment of loan"
}
}
},
"localname": "RepaymentsOfLongTermDebt",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtLongTermDebtDetails",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_RestrictedStockMember": {
"auth_ref": [
"r146"
],
"lang": {
"en-US": {
"role": {
"documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
"label": "Restricted Stock [Member]",
"terseLabel": "Restricted Stock"
}
}
},
"localname": "RestrictedStockMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityRestrictedStockDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_RetainedEarningsAccumulatedDeficit": {
"auth_ref": [
"r19",
"r245",
"r312",
"r502",
"r523",
"r525"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets": {
"order": 5.0,
"parentTag": "us-gaap_StockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
"label": "Retained Earnings (Accumulated Deficit)",
"terseLabel": "Accumulated deficit"
}
}
},
"localname": "RetainedEarningsAccumulatedDeficit",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_RetainedEarningsMember": {
"auth_ref": [
"r107",
"r108",
"r109",
"r111",
"r117",
"r119",
"r196",
"r309",
"r310",
"r311",
"r325",
"r326",
"r520",
"r522"
],
"lang": {
"en-US": {
"role": {
"documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
"label": "Retained Earnings [Member]",
"terseLabel": "Accumulated Deficit"
}
}
},
"localname": "RetainedEarningsMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit"
],
"xbrltype": "domainItemType"
},
"us-gaap_RevenueFromContractWithCustomerAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Revenue from Contract with Customer [Abstract]"
}
}
},
"localname": "RevenueFromContractWithCustomerAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
"auth_ref": [
"r165",
"r166",
"r176",
"r181",
"r182",
"r186",
"r187",
"r188",
"r258",
"r259",
"r462"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfOperations": {
"order": 2.0,
"parentTag": "us-gaap_OperatingIncomeLoss",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
"label": "Revenue from Contract with Customer, Excluding Assessed Tax",
"terseLabel": "Net revenue",
"verboseLabel": "Total net revenues"
}
}
},
"localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureRevenueRecognitionAndAccountsReceivableDetails",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfOperations"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_RevenueFromContractWithCustomerTextBlock": {
"auth_ref": [
"r250",
"r251",
"r252",
"r253",
"r254",
"r255",
"r256",
"r257",
"r261",
"r269"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
"label": "Revenue from Contract with Customer [Text Block]",
"verboseLabel": "Revenue Recognition and Accounts Receivable"
}
}
},
"localname": "RevenueFromContractWithCustomerTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureRevenueRecognitionAndAccountsReceivable"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_RevenuesAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Revenues [Abstract]",
"terseLabel": "Revenue:"
}
}
},
"localname": "RevenuesAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfOperations"
],
"xbrltype": "stringItemType"
},
"us-gaap_RevolvingCreditFacilityMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
"label": "Revolving Credit Facility [Member]",
"terseLabel": "Revolving credit facility/revolver"
}
}
},
"localname": "RevolvingCreditFacilityMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtDetails",
"http://www.adapthealth.com/role/DisclosureDebtLongTermDebtDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_SaleOfStockNameOfTransactionDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
"label": "Sale Of Stock Name Of Transaction [Domain]",
"terseLabel": "Sale of Stock [Domain]"
}
}
},
"localname": "SaleOfStockNameOfTransactionDomain",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitParenthetical"
],
"xbrltype": "domainItemType"
},
"us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
"label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
"terseLabel": "Schedule of components accounts payable and accrued expenses"
}
}
},
"localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureAccountsPayableAndAccruedExpensesTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock": {
"auth_ref": [
"r207"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of the characteristics, including initial carrying value, residual amount, weighted average useful life, of finite-lived intangible assets acquired during the period by major class. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.",
"label": "Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]",
"terseLabel": "Schedule of identifiable intangible assets"
}
}
},
"localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureGoodwillAndIdentifiableIntangibleAssetsTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable": {
"auth_ref": [
"r360"
],
"lang": {
"en-US": {
"role": {
"documentation": "Schedule of information about a contingent payment arrangement including the terms that will result in payment and the accounting treatment that will be followed if such contingency occurs, including the potential impact on earnings per share if the contingency is to be settled in shares of common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.",
"label": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]"
}
}
},
"localname": "ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureFairValueContingentConsiderationDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.",
"label": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]",
"terseLabel": "Reconciliation of contingent consideration liabilities related to acquisitions"
}
}
},
"localname": "ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureFairValueOfAssetsAndLiabilitiesTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable": {
"auth_ref": [
"r358"
],
"lang": {
"en-US": {
"role": {
"documentation": "Schedule of the equity interest (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire an entity in a business combination.",
"label": "Schedule of Business Acquisitions by Acquisition, Equity Interest Issued or Issuable [Table]"
}
}
},
"localname": "ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsBusinessCombinationDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
"auth_ref": [
"r341",
"r342"
],
"lang": {
"en-US": {
"role": {
"documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
"label": "Schedule of Business Acquisitions, by Acquisition [Table]"
}
}
},
"localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsConsiderationAndAllocationDetails",
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsTables",
"http://www.adapthealth.com/role/DisclosureStockholdersEquityTables"
],
"xbrltype": "stringItemType"
},
"us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
"auth_ref": [
"r341",
"r342"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.",
"label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
"terseLabel": "Summary of estimated fair values of the net assets acquired"
}
}
},
"localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfCapitalLeasedAsssetsTable": {
"auth_ref": [
"r436"
],
"lang": {
"en-US": {
"role": {
"documentation": "Schedule of long-lived, depreciable assets that are subject to a lease meeting the criteria for capitalization and are used in the normal conduct of business to produce goods and services. Examples may include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
"label": "Schedule of Capital Leased Assets [Table]"
}
}
},
"localname": "ScheduleOfCapitalLeasedAsssetsTable",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureLeasesCapitalLeasesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
"auth_ref": [
"r36",
"r103",
"r238",
"r242",
"r243",
"r244",
"r424",
"r425",
"r427",
"r496"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
"label": "Schedule of Long-term Debt Instruments [Table Text Block]",
"terseLabel": "Schedule of summary of long term debt"
}
}
},
"localname": "ScheduleOfDebtInstrumentsTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
"auth_ref": [
"r388"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of derivative instruments (including nonderivative instruments that are designated and qualify as hedging instruments) of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.",
"label": "Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block]",
"terseLabel": "Summary of fair value of derivative financial instruments as well as their classification on the consolidated balance sheets"
}
}
},
"localname": "ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
"auth_ref": [
"r145"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
"label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
"terseLabel": "Schedule of calculation of basic and diluted earnings per share"
}
}
},
"localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureEarningsPerShareTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
"auth_ref": [
"r402",
"r403"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
"label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
"terseLabel": "Summary of financial assets and liabilities measured at fair value on a recurring basis"
}
}
},
"localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureFairValueOfAssetsAndLiabilitiesTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
"auth_ref": [
"r207",
"r210",
"r463"
],
"lang": {
"en-US": {
"role": {
"documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
"label": "Schedule of Finite-Lived Intangible Assets [Table]"
}
}
},
"localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureGoodwillAndIdentifiableIntangibleAssetsIntangibleAssetsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock": {
"auth_ref": [
"r437"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of future minimum lease payments as of the date of the latest balance sheet presented, in aggregate and for each of the five years succeeding fiscal years, with separate deductions from the total for the amount representing executor costs, including any profit thereon, included in the minimum lease payments and for the amount of the imputed interest necessary to reduce the net minimum lease payments to present value.",
"label": "Schedule of Future Minimum Lease Payments for Capital Leases [Table Text Block]",
"terseLabel": "Summary of future annual minimum payments required under lease obligations"
}
}
},
"localname": "ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureLeasesTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock": {
"auth_ref": [
"r432"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.",
"label": "Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]",
"terseLabel": "Summary of minimum annual lease commitments under noncancelable leases"
}
}
},
"localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureLeasesTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfGoodwillTextBlock": {
"auth_ref": [
"r202",
"r204"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
"label": "Schedule of Goodwill [Table Text Block]",
"terseLabel": "Schedule of change in the carrying amount of goodwill"
}
}
},
"localname": "ScheduleOfGoodwillTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureGoodwillAndIdentifiableIntangibleAssetsTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
"auth_ref": [
"r27",
"r219"
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
"label": "Property, Plant and Equipment [Table]"
}
}
},
"localname": "ScheduleOfPropertyPlantAndEquipmentTable",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureEquipmentAndOtherFixedAssetsDetails",
"http://www.adapthealth.com/role/DisclosureGeneralInformationDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
"auth_ref": [
"r102",
"r443",
"r445"
],
"lang": {
"en-US": {
"role": {
"documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
"label": "Schedule of Related Party Transactions, by Related Party [Table]"
}
}
},
"localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureRelatedPartyTransactionsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
"auth_ref": [
"r288",
"r308"
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of information about share-based payment arrangement.",
"label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
}
}
},
"localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityCommonStockAwardsDetails",
"http://www.adapthealth.com/role/DisclosureStockholdersEquityEquityBasedCompensationDetails",
"http://www.adapthealth.com/role/DisclosureStockholdersEquityIncentiveUnitsDetails",
"http://www.adapthealth.com/role/DisclosureStockholdersEquityOptionsActivityAndAssumptionsDetails",
"http://www.adapthealth.com/role/DisclosureStockholdersEquityRestrictedStockDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
"auth_ref": [
"r300"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
"label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
"terseLabel": "Schedule of assumptions used to determine the grant date fair value"
}
}
},
"localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfStockByClassTable": {
"auth_ref": [
"r40",
"r98",
"r153",
"r154",
"r234",
"r235",
"r236",
"r238",
"r239",
"r240",
"r242",
"r243",
"r244",
"r245"
],
"lang": {
"en-US": {
"role": {
"documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
"label": "Schedule of Stock by Class [Table]"
}
}
},
"localname": "ScheduleOfStockByClassTable",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
"auth_ref": [
"r210"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
"label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
"terseLabel": "Schedule of future amortization expense related to identifiable intangible assets"
}
}
},
"localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureGoodwillAndIdentifiableIntangibleAssetsTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_SecuredDebtMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
"label": "Secured Debt [Member]",
"terseLabel": "Secured term loans"
}
}
},
"localname": "SecuredDebtMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtDetails",
"http://www.adapthealth.com/role/DisclosureDebtLongTermDebtDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_SegmentReportingPolicyPolicyTextBlock": {
"auth_ref": [
"r97",
"r170",
"r171",
"r172",
"r173",
"r174",
"r175",
"r187"
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of accounting policy for segment reporting.",
"label": "Segment Reporting, Policy [Policy Text Block]",
"terseLabel": "Business segment"
}
}
},
"localname": "SegmentReportingPolicyPolicyTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureGeneralInformationPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ShareBasedCompensation": {
"auth_ref": [
"r88"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows": {
"order": 3.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of noncash expense for share-based payment arrangement.",
"label": "Share-based Compensation",
"terseLabel": "Equity-based compensation"
}
}
},
"localname": "ShareBasedCompensation",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of additional cost recognized for award under share-based payment arrangement from occurrence of event accelerating recognition of cost.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award Accelerated Compensation Cost",
"terseLabel": "Accelerated vesting cost"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityEquityBasedCompensationDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
"auth_ref": [
"r289"
],
"lang": {
"en-US": {
"role": {
"documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
"terseLabel": "Vesting period"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityIncentiveUnitsDetails",
"http://www.adapthealth.com/role/DisclosureStockholdersEquityRestrictedStockDetails"
],
"xbrltype": "durationItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
"auth_ref": [
"r294"
],
"lang": {
"en-US": {
"role": {
"documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
"negatedLabel": "Forfeited, shares"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityRestrictedStockDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
"auth_ref": [
"r298"
],
"lang": {
"en-US": {
"role": {
"documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
"terseLabel": "Forfeited, grant date fair value"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityRestrictedStockDetails"
],
"xbrltype": "perShareItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
"auth_ref": [
"r296"
],
"lang": {
"en-US": {
"role": {
"documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
"terseLabel": "Granted, shares"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityCommonStockAwardsDetails",
"http://www.adapthealth.com/role/DisclosureStockholdersEquityRestrictedStockDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
"auth_ref": [
"r296"
],
"lang": {
"en-US": {
"role": {
"documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
"terseLabel": "Granted, grant date fair value"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityRestrictedStockDetails"
],
"xbrltype": "perShareItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
"auth_ref": [
"r295"
],
"lang": {
"en-US": {
"role": {
"documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
"periodEndLabel": "Non-vested balance at end of period",
"periodStartLabel": "Non-vested balance at beginning of period"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityRestrictedStockDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityRestrictedStockDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
"auth_ref": [
"r295"
],
"lang": {
"en-US": {
"role": {
"documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
"periodEndLabel": "Non-vested, grant date fair value at end of period",
"periodStartLabel": "Non-vested, grant date fair value at beginning of period"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityRestrictedStockDetails"
],
"xbrltype": "perShareItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityRestrictedStockDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
"auth_ref": [
"r297"
],
"lang": {
"en-US": {
"role": {
"documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
"negatedLabel": "Vested, shares"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityRestrictedStockDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
"auth_ref": [
"r299"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
"terseLabel": "Grant date fair value"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityIncentiveUnitsDetails",
"http://www.adapthealth.com/role/DisclosureStockholdersEquityRestrictedStockDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
"auth_ref": [
"r297"
],
"lang": {
"en-US": {
"role": {
"documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
"terseLabel": "Vested, grant date fair value"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityRestrictedStockDetails"
],
"xbrltype": "perShareItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
"auth_ref": [
"r302"
],
"lang": {
"en-US": {
"role": {
"documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
"terseLabel": "Expected volatility"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityOptionsActivityAndAssumptionsDetails"
],
"xbrltype": "percentItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
"auth_ref": [
"r303"
],
"lang": {
"en-US": {
"role": {
"documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
"terseLabel": "Risk-free interest rate"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityOptionsActivityAndAssumptionsDetails"
],
"xbrltype": "percentItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
"verboseLabel": "Equitybased Compensation"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityCommonStockAwardsDetails",
"http://www.adapthealth.com/role/DisclosureStockholdersEquityEquityBasedCompensationDetails",
"http://www.adapthealth.com/role/DisclosureStockholdersEquityIncentiveUnitsDetails",
"http://www.adapthealth.com/role/DisclosureStockholdersEquityOptionsActivityAndAssumptionsDetails",
"http://www.adapthealth.com/role/DisclosureStockholdersEquityRestrictedStockDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
"auth_ref": [
"r290"
],
"lang": {
"en-US": {
"role": {
"documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
"terseLabel": "Shares authorized for issuance"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityEquityBasedCompensationDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
"auth_ref": [
"r293"
],
"lang": {
"en-US": {
"role": {
"documentation": "Net number of share options (or share units) granted during the period.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures",
"terseLabel": "Equity-based compensation (in shares)"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit"
],
"xbrltype": "sharesItemType"
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Gross number of share options (or share units) granted during the period.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
"verboseLabel": "Options granted"
}
}
},
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityOptionsActivityAndAssumptionsDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
"auth_ref": [
"r286",
"r291"
],
"lang": {
"en-US": {
"role": {
"documentation": "Award under share-based payment arrangement.",
"label": "Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]",
"terseLabel": "Award Type [Domain]"
}
}
},
"localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityCommonStockAwardsDetails",
"http://www.adapthealth.com/role/DisclosureStockholdersEquityOptionsActivityAndAssumptionsDetails",
"http://www.adapthealth.com/role/DisclosureStockholdersEquityRestrictedStockDetails",
"http://www.adapthealth.com/role/DisclosureStockholdersEquityTables"
],
"xbrltype": "domainItemType"
},
"us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
"label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
"terseLabel": "Options granted, exercise price"
}
}
},
"localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityOptionsActivityAndAssumptionsDetails"
],
"xbrltype": "perShareItemType"
},
"us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
"label": "Share Based Compensation Award Tranche One [Member]",
"terseLabel": "Tranche 1"
}
}
},
"localname": "ShareBasedCompensationAwardTrancheOneMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityIncentiveUnitsDetails",
"http://www.adapthealth.com/role/DisclosureStockholdersEquityRestrictedStockDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_ShareBasedCompensationAwardTrancheTwoMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
"label": "Share Based Compensation Award Tranche Two [Member]",
"terseLabel": "Tranche 2"
}
}
},
"localname": "ShareBasedCompensationAwardTrancheTwoMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityIncentiveUnitsDetails",
"http://www.adapthealth.com/role/DisclosureStockholdersEquityRestrictedStockDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_SharePrice": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Price of a single share of a number of saleable stocks of a company.",
"label": "Share Price"
}
}
},
"localname": "SharePrice",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails"
],
"xbrltype": "perShareItemType"
},
"us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
"auth_ref": [
"r289"
],
"lang": {
"en-US": {
"role": {
"documentation": "Percentage of vesting of award under share-based payment arrangement.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage",
"terseLabel": "Vesting percentage"
}
}
},
"localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityIncentiveUnitsDetails",
"http://www.adapthealth.com/role/DisclosureStockholdersEquityOptionsActivityAndAssumptionsDetails",
"http://www.adapthealth.com/role/DisclosureStockholdersEquityRestrictedStockDetails"
],
"xbrltype": "percentItemType"
},
"us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
"auth_ref": [
"r301",
"r313"
],
"lang": {
"en-US": {
"role": {
"documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
"terseLabel": "Expected term"
}
}
},
"localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityOptionsActivityAndAssumptionsDetails"
],
"xbrltype": "durationItemType"
},
"us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
"auth_ref": [
"r292"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.",
"label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value",
"terseLabel": "Grant date value"
}
}
},
"localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityOptionsActivityAndAssumptionsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_SharesOutstanding": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
"label": "Shares, Outstanding",
"periodEndLabel": "Shares, Outstanding, Ending Balance",
"periodStartLabel": "Shares, Outstanding, Beginning Balance"
}
}
},
"localname": "SharesOutstanding",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit"
],
"xbrltype": "sharesItemType"
},
"us-gaap_StatementClassOfStockAxis": {
"auth_ref": [
"r14",
"r15",
"r16",
"r98",
"r100",
"r124",
"r129",
"r137",
"r141",
"r145",
"r153",
"r154",
"r155",
"r195",
"r237",
"r414"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by the different classes of stock of the entity.",
"label": "Class of Stock [Axis]"
}
}
},
"localname": "StatementClassOfStockAxis",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsBusinessCombinationDetails",
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails",
"http://www.adapthealth.com/role/DisclosureSubsequentEventsFinancingAndAcquisitionsDetails",
"http://www.adapthealth.com/role/DocumentDocumentAndEntityInformation",
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets",
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheetsParenthetical",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit"
],
"xbrltype": "stringItemType"
},
"us-gaap_StatementEquityComponentsAxis": {
"auth_ref": [
"r42",
"r107",
"r108",
"r109",
"r111",
"r117",
"r119",
"r152",
"r196",
"r237",
"r245",
"r309",
"r310",
"r311",
"r325",
"r326",
"r416",
"r417",
"r418",
"r419",
"r420",
"r421",
"r520",
"r521",
"r522"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by component of equity.",
"label": "Equity Components [Axis]"
}
}
},
"localname": "StatementEquityComponentsAxis",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit"
],
"xbrltype": "stringItemType"
},
"us-gaap_StatementLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Statement [Line Items]"
}
}
},
"localname": "StatementLineItems",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets",
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheetsParenthetical",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitParenthetical"
],
"xbrltype": "stringItemType"
},
"us-gaap_StatementOfCashFlowsAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Consolidated Statements of Cash Flows"
}
}
},
"localname": "StatementOfCashFlowsAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_StatementOfFinancialPositionAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Consolidated Balance Sheets"
}
}
},
"localname": "StatementOfFinancialPositionAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Consolidated Statements of Comprehensive Income (Loss)"
}
}
},
"localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_StatementOfStockholdersEquityAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Consolidated Statements of Changes in Stockholders' Equity (Deficit) / Members' Equity (Deficit)"
}
}
},
"localname": "StatementOfStockholdersEquityAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_StatementTable": {
"auth_ref": [
"r107",
"r108",
"r109",
"r152",
"r462"
],
"lang": {
"en-US": {
"role": {
"documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
"label": "Statement [Table]"
}
}
},
"localname": "StatementTable",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets",
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheetsParenthetical",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitParenthetical"
],
"xbrltype": "stringItemType"
},
"us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation": {
"auth_ref": [
"r285",
"r315"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Value, after forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
"label": "Stock Granted, Value, Share-based Compensation, Net of Forfeitures",
"terseLabel": "Equity-based compensation"
}
}
},
"localname": "StockGrantedDuringPeriodValueSharebasedCompensation",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
"auth_ref": [
"r15",
"r16",
"r245"
],
"lang": {
"en-US": {
"role": {
"documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
"label": "Stock Issued During Period, Shares, Acquisitions",
"terseLabel": "Issuance of common stock for acquisitions (in shares)"
}
}
},
"localname": "StockIssuedDuringPeriodSharesAcquisitions",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSubsequentEventsFinancingAndAcquisitionsDetails",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit"
],
"xbrltype": "sharesItemType"
},
"us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
"auth_ref": [
"r15",
"r16",
"r237",
"r245"
],
"lang": {
"en-US": {
"role": {
"documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
"label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
"terseLabel": "Class A Common Stock issued in connection with Employee Stock Purchase Plan (in shares)"
}
}
},
"localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit"
],
"xbrltype": "sharesItemType"
},
"us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
"auth_ref": [
"r15",
"r16",
"r237",
"r245"
],
"lang": {
"en-US": {
"role": {
"documentation": "Number of new stock issued during the period.",
"label": "Stock Issued During Period, Shares, New Issues",
"terseLabel": "Sale of stock (in shares)",
"verboseLabel": "Shares issued"
}
}
},
"localname": "StockIssuedDuringPeriodSharesNewIssues",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit"
],
"xbrltype": "sharesItemType"
},
"us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
"auth_ref": [
"r42",
"r237",
"r245"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Value of stock issued pursuant to acquisitions during the period.",
"label": "Stock Issued During Period, Value, Acquisitions",
"terseLabel": "Issuance of common stock for acquisitions"
}
}
},
"localname": "StockIssuedDuringPeriodValueAcquisitions",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_StockIssuedDuringPeriodValueNewIssues": {
"auth_ref": [
"r15",
"r16",
"r237",
"r245"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
"label": "Stock Issued During Period, Value, New Issues",
"terseLabel": "Proceeds from sale of stock",
"verboseLabel": "Sale of stock, net of offering costs"
}
}
},
"localname": "StockIssuedDuringPeriodValueNewIssues",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSignificantTransactionsBusinessCombinationDetails",
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_StockholdersEquity": {
"auth_ref": [
"r16",
"r21",
"r22",
"r100",
"r192",
"r195",
"r414"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets": {
"order": 2.0,
"parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
"label": "Stockholders' Equity Attributable to Parent",
"totalLabel": "Total stockholders' equity (deficit) attributable to AdaptHealth Corp."
}
}
},
"localname": "StockholdersEquity",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
"auth_ref": [
"r100",
"r107",
"r108",
"r109",
"r111",
"r117",
"r195",
"r196",
"r245",
"r309",
"r310",
"r311",
"r325",
"r326",
"r363",
"r364",
"r377",
"r414",
"r416",
"r417",
"r421",
"r521",
"r522"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets": {
"order": 1.0,
"parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
"label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
"periodEndLabel": "Balance at end of period",
"periodStartLabel": "Balance at beginning of period",
"totalLabel": "Total Stockholders' Equity (Deficit)"
}
}
},
"localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
"terseLabel": "Stockholders' Equity (Deficit)"
}
}
},
"localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedBalanceSheets",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit"
],
"xbrltype": "stringItemType"
},
"us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
"auth_ref": [
"r99",
"r245",
"r247"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
"label": "Stockholders' Equity Note Disclosure [Text Block]",
"terseLabel": "Stockholders' Equity"
}
}
},
"localname": "StockholdersEquityNoteDisclosureTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquity"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_SubsequentEventLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
"label": "Subsequent Event [Line Items]",
"terseLabel": "Subsequent Event"
}
}
},
"localname": "SubsequentEventLineItems",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSubsequentEventsFinancingAndAcquisitionsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_SubsequentEventMember": {
"auth_ref": [
"r422",
"r449"
],
"lang": {
"en-US": {
"role": {
"documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
"label": "Subsequent Event [Member]",
"terseLabel": "Subsequent Event"
}
}
},
"localname": "SubsequentEventMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSubsequentEventsFinancingAndAcquisitionsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_SubsequentEventTable": {
"auth_ref": [
"r422",
"r449"
],
"lang": {
"en-US": {
"role": {
"documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
"label": "Subsequent Event [Table]"
}
}
},
"localname": "SubsequentEventTable",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSubsequentEventsFinancingAndAcquisitionsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_SubsequentEventTypeAxis": {
"auth_ref": [
"r422",
"r449"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
"label": "Subsequent Event Type [Axis]"
}
}
},
"localname": "SubsequentEventTypeAxis",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSubsequentEventsFinancingAndAcquisitionsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_SubsequentEventTypeDomain": {
"auth_ref": [
"r422",
"r449"
],
"lang": {
"en-US": {
"role": {
"documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
"label": "Subsequent Event Type [Domain]",
"terseLabel": "Subsequent Event Type [Domain]"
}
}
},
"localname": "SubsequentEventTypeDomain",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSubsequentEventsFinancingAndAcquisitionsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_SubsequentEventsAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Subsequent Events"
}
}
},
"localname": "SubsequentEventsAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_SubsequentEventsTextBlock": {
"auth_ref": [
"r448",
"r451"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
"label": "Subsequent Events [Text Block]",
"terseLabel": "Subsequent Events"
}
}
},
"localname": "SubsequentEventsTextBlock",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureSubsequentEvents"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_SubsidiarySaleOfStockAxis": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by type of sale of the entity's stock.",
"label": "Sale of Stock [Axis]"
}
}
},
"localname": "SubsidiarySaleOfStockAxis",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitMembersEquityDeficit",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitParenthetical"
],
"xbrltype": "stringItemType"
},
"us-gaap_SupplementalCashFlowInformationAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Supplemental Cash Flow Information [Abstract]",
"terseLabel": "Supplemental disclosures:"
}
}
},
"localname": "SupplementalCashFlowInformationAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "stringItemType"
},
"us-gaap_SupplementalDeferredPurchasePrice": {
"auth_ref": [
"r93",
"r94",
"r95"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "A device of credit enhancement where a part of the purchase price for the receivable/ payable is retained to serve as a cash collateral.",
"label": "Supplemental Deferred Purchase Price",
"terseLabel": "Deferred purchase price in connection with acquisitions"
}
}
},
"localname": "SupplementalDeferredPurchasePrice",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_TechnologyBasedIntangibleAssetsMember": {
"auth_ref": [
"r347"
],
"lang": {
"en-US": {
"role": {
"documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
"label": "Technology Based Intangible Assets [Member]",
"terseLabel": "Developed technology"
}
}
},
"localname": "TechnologyBasedIntangibleAssetsMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureGeneralInformationDetails",
"http://www.adapthealth.com/role/DisclosureGoodwillAndIdentifiableIntangibleAssetsIntangibleAssetsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_TimingOfTransferOfGoodOrServiceAxis": {
"auth_ref": [
"r259",
"r267"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by timing of transfer of good or service to customer.",
"label": "Timing of Transfer of Good or Service [Axis]"
}
}
},
"localname": "TimingOfTransferOfGoodOrServiceAxis",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureRevenueRecognitionAndAccountsReceivableDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_TimingOfTransferOfGoodOrServiceDomain": {
"auth_ref": [
"r259",
"r267"
],
"lang": {
"en-US": {
"role": {
"documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time.",
"label": "Timing Of Transfer Of Good Or Service [Domain]",
"terseLabel": "Timing of Transfer of Good or Service [Domain]"
}
}
},
"localname": "TimingOfTransferOfGoodOrServiceDomain",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureRevenueRecognitionAndAccountsReceivableDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_TradeNamesMember": {
"auth_ref": [
"r348"
],
"lang": {
"en-US": {
"role": {
"documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
"label": "Trade Names [Member]",
"terseLabel": "Tradenames [Member]"
}
}
},
"localname": "TradeNamesMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureGeneralInformationDetails",
"http://www.adapthealth.com/role/DisclosureGoodwillAndIdentifiableIntangibleAssetsIntangibleAssetsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_TransferredAtPointInTimeMember": {
"auth_ref": [
"r267"
],
"lang": {
"en-US": {
"role": {
"documentation": "Contract with customer in which good or service is transferred at point in time.",
"label": "Transferred At Point In Time [Member]",
"terseLabel": "Transferred at Point in Time [Member]"
}
}
},
"localname": "TransferredAtPointInTimeMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureRevenueRecognitionAndAccountsReceivableDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_TransferredOverTimeMember": {
"auth_ref": [
"r267"
],
"lang": {
"en-US": {
"role": {
"documentation": "Contract with customer in which good or service is transferred over time.",
"label": "Transferred Over Time [Member]",
"terseLabel": "Transferred over Time [Member]"
}
}
},
"localname": "TransferredOverTimeMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureRevenueRecognitionAndAccountsReceivableDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_TypeOfCostGoodOrServiceExtensibleList": {
"auth_ref": [
"r262"
],
"lang": {
"en-US": {
"role": {
"documentation": "Indicates type of cost from product sold and service rendered.",
"label": "Cost, Product and Service [Extensible List]"
}
}
},
"localname": "TypeOfCostGoodOrServiceExtensibleList",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfOperations"
],
"xbrltype": "extensibleListItemType"
},
"us-gaap_TypeOfRevenueExtensibleList": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Indicates type of revenue from product and service. Includes, but is not limited to, revenue from contract with customer and other sources.",
"label": "Revenue, Product and Service [Extensible List]"
}
}
},
"localname": "TypeOfRevenueExtensibleList",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfOperations"
],
"xbrltype": "extensibleListItemType"
},
"us-gaap_UnbilledReceivablesCurrent": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount received for services rendered and products shipped, but not yet billed, for non-contractual agreements due within one year or the normal operating cycle, if longer.",
"label": "Unbilled Receivables, Current",
"terseLabel": "Unbilled revenue"
}
}
},
"localname": "UnbilledReceivablesCurrent",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureRevenueRecognitionAndAccountsReceivableDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic": {
"auth_ref": [
"r139",
"r142",
"r143"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureEarningsPerShareDetails": {
"order": 2.0,
"parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.",
"label": "Undistributed Earnings (Loss) Allocated to Participating Securities, Basic",
"terseLabel": "Earnings allocated to participating securities"
}
}
},
"localname": "UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureEarningsPerShareDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_UnrealizedGainLossOnDerivatives": {
"auth_ref": [
"r89"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows": {
"order": 5.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.",
"label": "Unrealized Gain (Loss) on Derivatives",
"negatedLabel": "Change in fair value of interest rate swaps, net of reclassification adjustment"
}
}
},
"localname": "UnrealizedGainLossOnDerivatives",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_UnrecognizedTaxBenefits": {
"auth_ref": [
"r316",
"r321"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of unrecognized tax benefits.",
"label": "Unrecognized Tax Benefits",
"verboseLabel": "Uncertain tax positions"
}
}
},
"localname": "UnrecognizedTaxBenefits",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureIncomeTaxesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_UseOfEstimates": {
"auth_ref": [
"r156",
"r157",
"r159",
"r160",
"r161",
"r162",
"r163"
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
"label": "Use of Estimates, Policy [Policy Text Block]",
"terseLabel": "Accounting Estimates"
}
}
},
"localname": "UseOfEstimates",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureGeneralInformationPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_VariableRateAxis": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by type of variable rate.",
"label": "Variable Rate [Axis]"
}
}
},
"localname": "VariableRateAxis",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_VariableRateDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
"label": "Variable Rate [Domain]",
"terseLabel": "Variable Rate [Domain]"
}
}
},
"localname": "VariableRateDomain",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtNotesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_VehiclesMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Equipment used primarily for road transportation.",
"label": "Vehicles [Member]",
"terseLabel": "Delivery vehicles"
}
}
},
"localname": "VehiclesMember",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureEquipmentAndOtherFixedAssetsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_VestingAxis": {
"auth_ref": [
"r308"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by vesting schedule of award under share-based payment arrangement.",
"label": "Vesting [Axis]"
}
}
},
"localname": "VestingAxis",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityIncentiveUnitsDetails",
"http://www.adapthealth.com/role/DisclosureStockholdersEquityRestrictedStockDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_VestingDomain": {
"auth_ref": [
"r308"
],
"lang": {
"en-US": {
"role": {
"documentation": "Vesting schedule of award under share-based payment arrangement.",
"label": "Vesting [Domain]",
"terseLabel": "Vesting [Domain]"
}
}
},
"localname": "VestingDomain",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityIncentiveUnitsDetails",
"http://www.adapthealth.com/role/DisclosureStockholdersEquityRestrictedStockDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_WarrantsAndRightsNoteDisclosureAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Warrants and Rights Note Disclosure [Abstract]"
}
}
},
"localname": "WarrantsAndRightsNoteDisclosureAbstract",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureStockholdersEquityDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
"auth_ref": [
"r123",
"r145"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureEarningsPerShareDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"lang": {
"en-US": {
"role": {
"documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
"label": "Weighted Average Number of Shares Outstanding, Diluted",
"terseLabel": "Diluted",
"totalLabel": "Diluted weighted average common shares outstanding"
}
}
},
"localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureEarningsPerShareDetails",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfOperations"
],
"xbrltype": "sharesItemType"
},
"us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
"auth_ref": [
"r121",
"r145"
],
"calculation": {
"http://www.adapthealth.com/role/DisclosureEarningsPerShareDetails": {
"order": 4.0,
"parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
"weight": 1.0
}
},
"lang": {
"en-US": {
"role": {
"documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
"label": "Weighted Average Number of Shares Outstanding, Basic",
"terseLabel": "Basic"
}
}
},
"localname": "WeightedAverageNumberOfSharesOutstandingBasic",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureEarningsPerShareDetails",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfOperations"
],
"xbrltype": "sharesItemType"
},
"us-gaap_WriteOffOfDeferredDebtIssuanceCost": {
"auth_ref": [
"r72"
],
"calculation": {
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows": {
"order": 12.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.",
"label": "Write off of Deferred Debt Issuance Cost",
"verboseLabel": "Write-off of deferred financing costs"
}
}
},
"localname": "WriteOffOfDeferredDebtIssuanceCost",
"nsuri": "http://fasb.org/us-gaap/2020-01-31",
"presentation": [
"http://www.adapthealth.com/role/DisclosureDebtLongTermDebtDetails",
"http://www.adapthealth.com/role/StatementConsolidatedStatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
}
},
"unitCount": 5
}
},
"std_ref": {
"r0": {
"Name": "Accounting Standards Codification",
"Paragraph": "7",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "205",
"URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
},
"r1": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
},
"r10": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(14))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r100": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.4-08(g)(1)(ii))",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
},
"r101": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.4-08(h))",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
},
"r102": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.4-08(k))",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
},
"r103": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.4-08.(e),(f))",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
},
"r104": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.4-08.(f))",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
},
"r105": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.4-08.(k)(1))",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
},
"r106": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "235",
"URI": "http://asc.fasb.org/topic&trid=2122369"
},
"r107": {
"Name": "Accounting Standards Codification",
"Paragraph": "23",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
},
"r108": {
"Name": "Accounting Standards Codification",
"Paragraph": "24",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
},
"r109": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
},
"r11": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(19))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r110": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)(2)",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
},
"r111": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)(3)",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
},
"r112": {
"Name": "Accounting Standards Codification",
"Paragraph": "11",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
},
"r113": {
"Name": "Accounting Standards Codification",
"Paragraph": "11",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
},
"r114": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
},
"r115": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
},
"r116": {
"Name": "Accounting Standards Codification",
"Paragraph": "7",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
},
"r117": {
"Name": "Accounting Standards Codification",
"Paragraph": "7",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
},
"r118": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
},
"r119": {
"Name": "Accounting Standards Codification",
"Paragraph": "9",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
},
"r12": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(20))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r120": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "250",
"URI": "http://asc.fasb.org/topic&trid=2122394"
},
"r121": {
"Name": "Accounting Standards Codification",
"Paragraph": "10",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
},
"r122": {
"Name": "Accounting Standards Codification",
"Paragraph": "11",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1377-109256"
},
"r123": {
"Name": "Accounting Standards Codification",
"Paragraph": "16",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
},
"r124": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
},
"r125": {
"Name": "Accounting Standards Codification",
"Paragraph": "22",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1707-109256"
},
"r126": {
"Name": "Accounting Standards Codification",
"Paragraph": "23",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1757-109256"
},
"r127": {
"Name": "Accounting Standards Codification",
"Paragraph": "26",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1828-109256"
},
"r128": {
"Name": "Accounting Standards Codification",
"Paragraph": "28A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1500-109256"
},
"r129": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256"
},
"r13": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(22))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r130": {
"Name": "Accounting Standards Codification",
"Paragraph": "44",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2062-109256"
},
"r131": {
"Name": "Accounting Standards Codification",
"Paragraph": "48",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2538-109256"
},
"r132": {
"Name": "Accounting Standards Codification",
"Paragraph": "48",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2538-109256"
},
"r133": {
"Name": "Accounting Standards Codification",
"Paragraph": "51",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2574-109256"
},
"r134": {
"Name": "Accounting Standards Codification",
"Paragraph": "52",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2597-109256"
},
"r135": {
"Name": "Accounting Standards Codification",
"Paragraph": "53",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2600-109256"
},
"r136": {
"Name": "Accounting Standards Codification",
"Paragraph": "54",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2603-109256"
},
"r137": {
"Name": "Accounting Standards Codification",
"Paragraph": "55",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2626-109256"
},
"r138": {
"Name": "Accounting Standards Codification",
"Paragraph": "60B",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
},
"r139": {
"Name": "Accounting Standards Codification",
"Paragraph": "60B",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
},
"r14": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(27))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r140": {
"Name": "Accounting Standards Codification",
"Paragraph": "60B",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
},
"r141": {
"Name": "Accounting Standards Codification",
"Paragraph": "60B",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
},
"r142": {
"Name": "Accounting Standards Codification",
"Paragraph": "65",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2793-109256"
},
"r143": {
"Name": "Accounting Standards Codification",
"Paragraph": "66",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2814-109256"
},
"r144": {
"Name": "Accounting Standards Codification",
"Paragraph": "7",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
},
"r145": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
},
"r146": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
},
"r147": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
},
"r148": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
},
"r149": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
},
"r15": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(28))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r150": {
"Name": "Accounting Standards Codification",
"Paragraph": "52",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
},
"r151": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "260",
"URI": "http://asc.fasb.org/topic&trid=2144383"
},
"r152": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "272",
"URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
},
"r153": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "272",
"URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054"
},
"r154": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "272",
"URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
},
"r155": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "272",
"URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
},
"r156": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "275",
"URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
},
"r157": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "275",
"URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
},
"r158": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "275",
"URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
},
"r159": {
"Name": "Accounting Standards Codification",
"Paragraph": "11",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "275",
"URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
},
"r16": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(29))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r160": {
"Name": "Accounting Standards Codification",
"Paragraph": "12",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "275",
"URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
},
"r161": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "275",
"URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
},
"r162": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "275",
"URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
},
"r163": {
"Name": "Accounting Standards Codification",
"Paragraph": "9",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "275",
"URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
},
"r164": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "275",
"URI": "http://asc.fasb.org/topic&trid=2134479"
},
"r165": {
"Name": "Accounting Standards Codification",
"Paragraph": "22",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
},
"r166": {
"Name": "Accounting Standards Codification",
"Paragraph": "22",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
},
"r167": {
"Name": "Accounting Standards Codification",
"Paragraph": "22",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
},
"r168": {
"Name": "Accounting Standards Codification",
"Paragraph": "22",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(h)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
},
"r169": {
"Name": "Accounting Standards Codification",
"Paragraph": "22",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
},
"r17": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(3))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r170": {
"Name": "Accounting Standards Codification",
"Paragraph": "29",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
},
"r171": {
"Name": "Accounting Standards Codification",
"Paragraph": "29",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
},
"r172": {
"Name": "Accounting Standards Codification",
"Paragraph": "29",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
},
"r173": {
"Name": "Accounting Standards Codification",
"Paragraph": "29",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
},
"r174": {
"Name": "Accounting Standards Codification",
"Paragraph": "29",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(e)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
},
"r175": {
"Name": "Accounting Standards Codification",
"Paragraph": "29",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
},
"r176": {
"Name": "Accounting Standards Codification",
"Paragraph": "30",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
},
"r177": {
"Name": "Accounting Standards Codification",
"Paragraph": "30",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
},
"r178": {
"Name": "Accounting Standards Codification",
"Paragraph": "30",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
},
"r179": {
"Name": "Accounting Standards Codification",
"Paragraph": "30",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
},
"r18": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(30)(a)(1))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r180": {
"Name": "Accounting Standards Codification",
"Paragraph": "31",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
},
"r181": {
"Name": "Accounting Standards Codification",
"Paragraph": "32",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
},
"r182": {
"Name": "Accounting Standards Codification",
"Paragraph": "32",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
},
"r183": {
"Name": "Accounting Standards Codification",
"Paragraph": "32",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
},
"r184": {
"Name": "Accounting Standards Codification",
"Paragraph": "32",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
},
"r185": {
"Name": "Accounting Standards Codification",
"Paragraph": "32",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(f)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
},
"r186": {
"Name": "Accounting Standards Codification",
"Paragraph": "40",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
},
"r187": {
"Name": "Accounting Standards Codification",
"Paragraph": "41",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
},
"r188": {
"Name": "Accounting Standards Codification",
"Paragraph": "42",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
},
"r189": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "310",
"URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4647-111522"
},
"r19": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(30)(a)(3))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r190": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "310",
"URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
},
"r191": {
"Name": "Accounting Standards Codification",
"Paragraph": "9",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "310",
"URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
},
"r192": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SAB Topic 4.E)",
"Topic": "310",
"URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
},
"r193": {
"Name": "Accounting Standards Codification",
"Paragraph": "11",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "320",
"URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26853-111562"
},
"r194": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)(1)",
"Topic": "323",
"URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
},
"r195": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "323",
"URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
},
"r196": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
},
"r197": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "20",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
},
"r198": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "20",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
},
"r199": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "20",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
},
"r2": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
},
"r20": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(30)(a)(4))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r200": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(b)",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
},
"r201": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(e)",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
},
"r202": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
},
"r203": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(b)",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
},
"r204": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
},
"r205": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
},
"r206": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
},
"r207": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(a)",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
},
"r208": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(d)",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
},
"r209": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "((a)(1),(b))",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
},
"r21": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(30))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r210": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(a)",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
},
"r211": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(a)(1)",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
},
"r212": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(a)(2)",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
},
"r213": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(d)",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
},
"r214": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(b)",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
},
"r215": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "350",
"URI": "http://asc.fasb.org/topic&trid=2144416"
},
"r216": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "360",
"URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
},
"r217": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "360",
"URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
},
"r218": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "360",
"URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
},
"r219": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "360",
"URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
},
"r22": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(31))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r220": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "360",
"URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
},
"r221": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "360",
"URI": "http://asc.fasb.org/topic&trid=2155823"
},
"r222": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "440",
"URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
},
"r223": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "440",
"URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
},
"r224": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "440",
"URI": "http://asc.fasb.org/topic&trid=2144648"
},
"r225": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "450",
"URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
},
"r226": {
"Name": "Accounting Standards Codification",
"Paragraph": "10",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "450",
"URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
},
"r227": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "450",
"URI": "http://asc.fasb.org/topic&trid=2127136"
},
"r228": {
"Name": "Accounting Standards Codification",
"Paragraph": "10",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "470",
"URI": "http://asc.fasb.org/extlink&oid=99376301&loc=d3e1243-112600"
},
"r229": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(b)(1)",
"Topic": "470",
"URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
},
"r23": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(32))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r230": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(b)(3)",
"Topic": "470",
"URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
},
"r231": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "40",
"SubTopic": "50",
"Topic": "470",
"URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12317-112629"
},
"r232": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "40",
"SubTopic": "50",
"Topic": "470",
"URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12355-112629"
},
"r233": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "470",
"URI": "http://asc.fasb.org/topic&trid=2208564"
},
"r234": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(CFRR 211.02)",
"Topic": "480",
"URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764"
},
"r235": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
},
"r236": {
"Name": "Accounting Standards Codification",
"Paragraph": "10",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644"
},
"r237": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
},
"r238": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
},
"r239": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644"
},
"r24": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(7))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r240": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644"
},
"r241": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
},
"r242": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
},
"r243": {
"Name": "Accounting Standards Codification",
"Paragraph": "7",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
},
"r244": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
},
"r245": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.3-04)",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
},
"r246": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SAB Topic 4.F)",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187171-122770"
},
"r247": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "505",
"URI": "http://asc.fasb.org/topic&trid=2208762"
},
"r248": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044"
},
"r249": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130532-203044"
},
"r25": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(8))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r250": {
"Name": "Accounting Standards Codification",
"Paragraph": "10",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045"
},
"r251": {
"Name": "Accounting Standards Codification",
"Paragraph": "12",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
},
"r252": {
"Name": "Accounting Standards Codification",
"Paragraph": "12",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
},
"r253": {
"Name": "Accounting Standards Codification",
"Paragraph": "12",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
},
"r254": {
"Name": "Accounting Standards Codification",
"Paragraph": "12",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
},
"r255": {
"Name": "Accounting Standards Codification",
"Paragraph": "12",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(e)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
},
"r256": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)(2)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
},
"r257": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045"
},
"r258": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
},
"r259": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
},
"r26": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.13)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r260": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
},
"r261": {
"Name": "Accounting Standards Codification",
"Paragraph": "9",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045"
},
"r262": {
"Name": "Accounting Standards Codification",
"Paragraph": "91",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
},
"r263": {
"Name": "Accounting Standards Codification",
"Paragraph": "91",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
},
"r264": {
"Name": "Accounting Standards Codification",
"Paragraph": "91",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
},
"r265": {
"Name": "Accounting Standards Codification",
"Paragraph": "91",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
},
"r266": {
"Name": "Accounting Standards Codification",
"Paragraph": "91",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Subparagraph": "(e)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
},
"r267": {
"Name": "Accounting Standards Codification",
"Paragraph": "91",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Subparagraph": "(f)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
},
"r268": {
"Name": "Accounting Standards Codification",
"Paragraph": "91",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Subparagraph": "(g)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
},
"r269": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "606",
"URI": "http://asc.fasb.org/topic&trid=49130388"
},
"r27": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.14)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r270": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(d)(i)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
},
"r271": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(d)(ii)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
},
"r272": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(d)(iv)(01)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
},
"r273": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(d)(iv)(02)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
},
"r274": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(d)(iv)(02)(A)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
},
"r275": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(d)(iv)(02)(B)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
},
"r276": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(d)(iv)(02)(C)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
},
"r277": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(d)(iv)(03)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
},
"r278": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(n)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
},
"r279": {
"Name": "Accounting Standards Codification",
"Paragraph": "17",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "20",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
},
"r28": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.17)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r280": {
"Name": "Accounting Standards Codification",
"Paragraph": "11",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "80",
"Subparagraph": "(a)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
},
"r281": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "80",
"Subparagraph": "(d)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
},
"r282": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "80",
"Subparagraph": "(f)(3)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
},
"r283": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "80",
"Subparagraph": "(a)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
},
"r284": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "80",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
},
"r285": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "30",
"SubTopic": "10",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=121321822&loc=d3e3913-113898"
},
"r286": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
},
"r287": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
},
"r288": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
},
"r289": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)(1)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
},
"r29": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.19(a))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r290": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)(3)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
},
"r291": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a),(g)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
},
"r292": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
},
"r293": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)(1)(iv)(1)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
},
"r294": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)(1)(iv)(3)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
},
"r295": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)(2)(i)-(ii)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
},
"r296": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)(2)(iii)(1)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
},
"r297": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)(2)(iii)(2)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
},
"r298": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)(2)(iii)(3)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
},
"r299": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)(2)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
},
"r3": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
},
"r30": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.19(b),22(b))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r300": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(f)(2)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
},
"r301": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(f)(2)(i)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
},
"r302": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(f)(2)(ii)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
},
"r303": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(f)(2)(iv)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
},
"r304": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(g)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
},
"r305": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(h)(1)(i)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
},
"r306": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(h)(1)(ii)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
},
"r307": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(i)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
},
"r308": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
},
"r309": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(e)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
},
"r31": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.19,20)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r310": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(f)(1)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
},
"r311": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(f)(2)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
},
"r312": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(g)(2)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
},
"r313": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SAB Topic 14.D.2)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
},
"r314": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SAB Topic 14.F)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
},
"r315": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "35",
"SubTopic": "30",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=121323062&loc=d3e15009-113911"
},
"r316": {
"Name": "Accounting Standards Codification",
"Paragraph": "10B",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318"
},
"r317": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318"
},
"r318": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
},
"r319": {
"Name": "Accounting Standards Codification",
"Paragraph": "10",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
},
"r32": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.19-26)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r320": {
"Name": "Accounting Standards Codification",
"Paragraph": "14",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
},
"r321": {
"Name": "Accounting Standards Codification",
"Paragraph": "15A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
},
"r322": {
"Name": "Accounting Standards Codification",
"Paragraph": "17",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
},
"r323": {
"Name": "Accounting Standards Codification",
"Paragraph": "21",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
},
"r324": {
"Name": "Accounting Standards Codification",
"Paragraph": "9",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
},
"r325": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(d)(2)",
"Topic": "740"
},
"r326": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(d)(3)",
"Topic": "740"
},
"r327": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
},
"r328": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SAB TOPIC 6.I.7)",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
},
"r329": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SAB Topic 6.I.7)",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
},
"r33": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.20)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r330": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SAB Topic 6.I.Fact.1)",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
},
"r331": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SAB Topic 6.I.Fact.2)",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
},
"r332": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SAB Topic 11.C)",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
},
"r333": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "20",
"Subparagraph": "(a)",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
},
"r334": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "270",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
},
"r335": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(a)",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
},
"r336": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "740",
"URI": "http://asc.fasb.org/topic&trid=2144680"
},
"r337": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
},
"r338": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(h)(1)",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
},
"r339": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(h)(2)",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
},
"r34": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.21)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r340": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(h)(3)",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
},
"r341": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
},
"r342": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
},
"r343": {
"Name": "Accounting Standards Codification",
"Paragraph": "37",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=121600890&loc=d3e2207-128464"
},
"r344": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(c)",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
},
"r345": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(d)(1)",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
},
"r346": {
"Name": "Accounting Standards Codification",
"Paragraph": "4A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(c)",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=121647850&loc=SL65897772-128472"
},
"r347": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "20",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5227-128473"
},
"r348": {
"Name": "Accounting Standards Codification",
"Paragraph": "14",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "20",
"Subparagraph": "(a)",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
},
"r349": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "25",
"SubTopic": "30",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6405-128476"
},
"r35": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.22(a)(1))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r350": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "25",
"SubTopic": "30",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
},
"r351": {
"Name": "Accounting Standards Codification",
"Paragraph": "7",
"Publisher": "FASB",
"Section": "30",
"SubTopic": "30",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
},
"r352": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "30",
"SubTopic": "30",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
},
"r353": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "35",
"SubTopic": "30",
"Subparagraph": "(b)",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
},
"r354": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(b)",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
},
"r355": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(b)(1)",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
},
"r356": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(b)(2)",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
},
"r357": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(b)(3)",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
},
"r358": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(b)(4)",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
},
"r359": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(c)(1)",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
},
"r36": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.22)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r360": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "c",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
},
"r361": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(a)(1)",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
},
"r362": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(a)(2)",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
},
"r363": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
},
"r364": {
"Name": "Accounting Standards Codification",
"Paragraph": "16",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
},
"r365": {
"Name": "Accounting Standards Codification",
"Paragraph": "19",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
},
"r366": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
},
"r367": {
"Name": "Accounting Standards Codification",
"Paragraph": "21",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613674-111683"
},
"r368": {
"Name": "Accounting Standards Codification",
"Paragraph": "25",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
},
"r369": {
"Name": "Accounting Standards Codification",
"Paragraph": "25",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
},
"r37": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.23)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r370": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
},
"r371": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)(1)",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
},
"r372": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)(2)",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
},
"r373": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)(1)",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
},
"r374": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c),(3)",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
},
"r375": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(bb)",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
},
"r376": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
},
"r377": {
"Name": "Accounting Standards Codification",
"Paragraph": "4I",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
},
"r378": {
"Name": "Accounting Standards Codification",
"Paragraph": "4J",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
},
"r379": {
"Name": "Accounting Standards Codification",
"Paragraph": "4K",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
},
"r38": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.24)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r380": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "810",
"URI": "http://asc.fasb.org/topic&trid=2197479"
},
"r381": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
},
"r382": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
},
"r383": {
"Name": "Accounting Standards Codification",
"Paragraph": "1B",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5580258-113959"
},
"r384": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
},
"r385": {
"Name": "Accounting Standards Codification",
"Paragraph": "4A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
},
"r386": {
"Name": "Accounting Standards Codification",
"Paragraph": "4A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
},
"r387": {
"Name": "Accounting Standards Codification",
"Paragraph": "4A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)(1)",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
},
"r388": {
"Name": "Accounting Standards Codification",
"Paragraph": "4A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
},
"r389": {
"Name": "Accounting Standards Codification",
"Paragraph": "4B",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)(1)",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
},
"r39": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.25)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r390": {
"Name": "Accounting Standards Codification",
"Paragraph": "4B",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
},
"r391": {
"Name": "Accounting Standards Codification",
"Paragraph": "4C",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(e)",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
},
"r392": {
"Name": "Accounting Standards Codification",
"Paragraph": "4C",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
},
"r393": {
"Name": "Accounting Standards Codification",
"Paragraph": "4CC",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109998890-113959"
},
"r394": {
"Name": "Accounting Standards Codification",
"Paragraph": "4D",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)(1)",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
},
"r395": {
"Name": "Accounting Standards Codification",
"Paragraph": "4D",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
},
"r396": {
"Name": "Accounting Standards Codification",
"Paragraph": "4D",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
},
"r397": {
"Name": "Accounting Standards Codification",
"Paragraph": "4E",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624181-113959"
},
"r398": {
"Name": "Accounting Standards Codification",
"Paragraph": "182",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=121582272&loc=SL5629052-113961"
},
"r399": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "25",
"Subparagraph": "(a)(1)",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
},
"r4": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
},
"r40": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.28,29)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r400": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "25",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
},
"r401": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "815",
"URI": "http://asc.fasb.org/topic&trid=2229140"
},
"r402": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "820",
"URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
},
"r403": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "820",
"URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
},
"r404": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(bb)",
"Topic": "820",
"URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
},
"r405": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(bbb)",
"Topic": "820",
"URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
},
"r406": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(bbb)(1)",
"Topic": "820",
"URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
},
"r407": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(bbb)(2)",
"Topic": "820",
"URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
},
"r408": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "820",
"URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
},
"r409": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(h)",
"Topic": "820",
"URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
},
"r41": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.29)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r410": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "820",
"URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
},
"r411": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "820",
"URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
},
"r412": {
"Name": "Accounting Standards Codification",
"Paragraph": "6A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "820",
"URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
},
"r413": {
"Name": "Accounting Standards Codification",
"Paragraph": "10",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "825",
"URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611"
},
"r414": {
"Name": "Accounting Standards Codification",
"Paragraph": "28",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(f)",
"Topic": "825",
"URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
},
"r415": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "230",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
},
"r416": {
"Name": "Accounting Standards Codification",
"Paragraph": "17",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
},
"r417": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Subparagraph": "(a)",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
},
"r418": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Subparagraph": "(b)",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
},
"r419": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Subparagraph": "(c)",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
},
"r42": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.29-31)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r420": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Subparagraph": "(d)",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
},
"r421": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
},
"r422": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
},
"r423": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(a)",
"Topic": "835",
"URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
},
"r424": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Topic": "835",
"URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
},
"r425": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Topic": "835",
"URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
},
"r426": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Topic": "835",
"URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
},
"r427": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "30",
"Topic": "835",
"URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
},
"r428": {
"Name": "Accounting Standards Codification",
"Paragraph": "40",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Subparagraph": "(Note 2)",
"Topic": "840",
"URI": "http://asc.fasb.org/extlink&oid=121580752&loc=d3e38371-112697"
},
"r429": {
"Name": "Accounting Standards Codification",
"Paragraph": "40",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Subparagraph": "(Note 3)",
"Topic": "840",
"URI": "http://asc.fasb.org/extlink&oid=121580752&loc=d3e38371-112697"
},
"r43": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.31)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r430": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(a)",
"Topic": "840",
"URI": "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41502-112717"
},
"r431": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(b)",
"Topic": "840",
"URI": "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41502-112717"
},
"r432": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "840",
"URI": "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41502-112717"
},
"r433": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Topic": "840",
"URI": "http://asc.fasb.org/extlink&oid=121569800&loc=d3e45014-112735"
},
"r434": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Topic": "840",
"URI": "http://asc.fasb.org/extlink&oid=121569800&loc=d3e45023-112735"
},
"r435": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Topic": "840",
"URI": "http://asc.fasb.org/extlink&oid=121569800&loc=d3e45031-112735"
},
"r436": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(a)",
"Topic": "840",
"URI": "http://asc.fasb.org/extlink&oid=121616839&loc=d3e45280-112737"
},
"r437": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(b)",
"Topic": "840",
"URI": "http://asc.fasb.org/extlink&oid=121616839&loc=d3e45280-112737"
},
"r438": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "840",
"URI": "http://asc.fasb.org/topic&trid=2208923"
},
"r439": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "850",
"URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
},
"r44": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.6(a))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r440": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "850",
"URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
},
"r441": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "850",
"URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
},
"r442": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "850",
"URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
},
"r443": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "850",
"URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
},
"r444": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "850",
"URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
},
"r445": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "850",
"URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
},
"r446": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "850",
"URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
},
"r447": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "850",
"URI": "http://asc.fasb.org/topic&trid=2122745"
},
"r448": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "855",
"URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
},
"r449": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "855",
"URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
},
"r45": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.9)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r450": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "855",
"URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
},
"r451": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "855",
"URI": "http://asc.fasb.org/topic&trid=2122774"
},
"r452": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(bb)(1)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
},
"r453": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(bb)(2)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
},
"r454": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(bb)(3)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
},
"r455": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(c)(1)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
},
"r456": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(c)(2)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
},
"r457": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(c)(3)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
},
"r458": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(b)(1)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
},
"r459": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(b)(2)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
},
"r46": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(c)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
},
"r460": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(b)(3)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
},
"r461": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "910",
"URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
},
"r462": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SAB Topic 11.L)",
"Topic": "924",
"URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
},
"r463": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "926",
"URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
},
"r464": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "340",
"Topic": "928",
"URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
},
"r465": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(a)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
},
"r466": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(b)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
},
"r467": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(a)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
},
"r468": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(b)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
},
"r469": {
"Name": "Accounting Standards Codification",
"Paragraph": "28",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(a)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
},
"r47": {
"Name": "Accounting Standards Codification",
"Paragraph": "10",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "20",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
},
"r470": {
"Name": "Accounting Standards Codification",
"Paragraph": "28",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(b)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
},
"r471": {
"Name": "Accounting Standards Codification",
"Paragraph": "33",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(a)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
},
"r472": {
"Name": "Accounting Standards Codification",
"Paragraph": "33",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(b)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
},
"r473": {
"Name": "Accounting Standards Codification",
"Paragraph": "35A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(a)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
},
"r474": {
"Name": "Accounting Standards Codification",
"Paragraph": "35A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(b)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
},
"r475": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(c)(1)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
},
"r476": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(c)(2)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
},
"r477": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "25",
"SubTopic": "20",
"Topic": "940",
"URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953"
},
"r478": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.9-03(10)(1))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
},
"r479": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.9-03(11))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
},
"r48": {
"Name": "Accounting Standards Codification",
"Paragraph": "10A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
},
"r480": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.9-03(13))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
},
"r481": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.9-03(16))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
},
"r482": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.9-03(22))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
},
"r483": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.9-03(23))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
},
"r484": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.9-03.17)",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
},
"r485": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.7-04(19))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
},
"r486": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.9-04(15))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
},
"r487": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.9-04(20))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
},
"r488": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.9-04(22))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
},
"r489": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.9-04(24))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
},
"r49": {
"Name": "Accounting Standards Codification",
"Paragraph": "10A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
},
"r490": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.9-04(25))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
},
"r491": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.9-04(26))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
},
"r492": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.9-04(27))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
},
"r493": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.9-04.9)",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
},
"r494": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "235",
"Subparagraph": "(SX 210.9-05(b)(2))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
},
"r495": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "470",
"Subparagraph": "e",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
},
"r496": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "470",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
},
"r497": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "825",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=108315417&loc=d3e61044-112788"
},
"r498": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03(16))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
},
"r499": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03(a)(12))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
},
"r5": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6904-107765"
},
"r50": {
"Name": "Accounting Standards Codification",
"Paragraph": "11",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
},
"r500": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03(a)(16))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
},
"r501": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
},
"r502": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
},
"r503": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03(a)(24))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
},
"r504": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03(a)(25))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
},
"r505": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03(a)(8))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
},
"r506": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03.(a),19)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
},
"r507": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.7-04(11))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
},
"r508": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.7-04(18))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
},
"r509": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.7-04(20))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
},
"r51": {
"Name": "Accounting Standards Codification",
"Paragraph": "14",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
},
"r510": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.7-04(21))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
},
"r511": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.7-04(22))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
},
"r512": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.7-04(23))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
},
"r513": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.7-04(8))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
},
"r514": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.7-04(9))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
},
"r515": {
"Name": "Accounting Standards Codification",
"Paragraph": "4H",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "40",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
},
"r516": {
"Name": "Accounting Standards Codification",
"Paragraph": "7A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "40",
"Subparagraph": "(d)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
},
"r517": {
"Name": "Accounting Standards Codification",
"Paragraph": "13H",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "40",
"Subparagraph": "(a)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
},
"r518": {
"Name": "Accounting Standards Codification",
"Paragraph": "13H",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "40",
"Subparagraph": "(c)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
},
"r519": {
"Name": "Accounting Standards Codification",
"Paragraph": "29F",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "40",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
},
"r52": {
"Name": "Accounting Standards Codification",
"Paragraph": "14A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
},
"r520": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "40",
"Subparagraph": "(e)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
},
"r521": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "40",
"Subparagraph": "(f)(1)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
},
"r522": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "40",
"Subparagraph": "(f)(2)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
},
"r523": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "40",
"Subparagraph": "(g)(2)(i)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
},
"r524": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "40",
"Subparagraph": "(g)(2)(ii)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
},
"r525": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "40",
"Subparagraph": "(h)(2)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
},
"r526": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "360",
"Subparagraph": "(d)",
"Topic": "958",
"URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
},
"r527": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "360",
"Topic": "958",
"URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
},
"r528": {
"Name": "Accounting Standards Codification",
"Paragraph": "7",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "360",
"Topic": "958",
"URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
},
"r529": {
"Name": "Exchange Act",
"Number": "240",
"Publisher": "SEC",
"Section": "12",
"Subsection": "b"
},
"r53": {
"Name": "Accounting Standards Codification",
"Paragraph": "17B",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
},
"r530": {
"Name": "Exchange Act",
"Number": "240",
"Publisher": "SEC",
"Section": "12",
"Subsection": "d1-1"
},
"r531": {
"Name": "Form 10-Q",
"Number": "240",
"Publisher": "SEC",
"Section": "308",
"Subsection": "a"
},
"r532": {
"Name": "Forms 10-K, 10-Q, 20-F",
"Number": "240",
"Publisher": "SEC",
"Section": "13",
"Subsection": "a-1"
},
"r533": {
"Name": "Regulation 12B",
"Number": "240",
"Publisher": "SEC",
"Section": "12",
"Subsection": "b-2"
},
"r534": {
"Name": "Regulation S-T",
"Number": "232",
"Publisher": "SEC",
"Section": "405"
},
"r535": {
"Name": "Securities Act",
"Number": "7A",
"Publisher": "SEC",
"Section": "B",
"Subsection": "2"
},
"r54": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
},
"r55": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
},
"r56": {
"Name": "Accounting Standards Codification",
"Paragraph": "1B",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
},
"r57": {
"Name": "Accounting Standards Codification",
"Paragraph": "1B",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
},
"r58": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
},
"r59": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03(13))",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868656-224227"
},
"r6": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765"
},
"r60": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(210.5-03(11))",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
},
"r61": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03(10))",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
},
"r62": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03(20))",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
},
"r63": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03(22))",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
},
"r64": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03(23))",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
},
"r65": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03(24))",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
},
"r66": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03(25))",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
},
"r67": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03(4))",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
},
"r68": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03(8))",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
},
"r69": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
},
"r7": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765"
},
"r70": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03.2(a),(d))",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
},
"r71": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03.4)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
},
"r72": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03.8)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
},
"r73": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
},
"r74": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
},
"r75": {
"Name": "Accounting Standards Codification",
"Paragraph": "14",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
},
"r76": {
"Name": "Accounting Standards Codification",
"Paragraph": "14",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
},
"r77": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
},
"r78": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
},
"r79": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(e)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
},
"r8": {
"Name": "Accounting Standards Codification",
"Paragraph": "9",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765"
},
"r80": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(f)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
},
"r81": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
},
"r82": {
"Name": "Accounting Standards Codification",
"Paragraph": "17",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
},
"r83": {
"Name": "Accounting Standards Codification",
"Paragraph": "17",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(ee)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
},
"r84": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585"
},
"r85": {
"Name": "Accounting Standards Codification",
"Paragraph": "24",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
},
"r86": {
"Name": "Accounting Standards Codification",
"Paragraph": "25",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(e)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
},
"r87": {
"Name": "Accounting Standards Codification",
"Paragraph": "25",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
},
"r88": {
"Name": "Accounting Standards Codification",
"Paragraph": "28",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
},
"r89": {
"Name": "Accounting Standards Codification",
"Paragraph": "28",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
},
"r9": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(13))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r90": {
"Name": "Accounting Standards Codification",
"Paragraph": "28",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
},
"r91": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
},
"r92": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586"
},
"r93": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586"
},
"r94": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586"
},
"r95": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586"
},
"r96": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
},
"r97": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
},
"r98": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.4-08(d))",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
},
"r99": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.4-08(e)(1))",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
}
},
"version": "2.1"
} |
